data_2k37_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k37 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 p . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.152 0.501 . . . . 1.8500000000000001 111.309 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.494 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 28.5 t80 -56.79 -43.74 81.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.334 -0.848 . . . . 2.0099999999999998 111.344 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 11' ' ' LEU . 58.3 m -65.66 -31.57 72.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.62 -0.432 . . . . 1.1100000000000001 110.205 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -37.53 83.33 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.986 -1.116 . . . . 2.1800000000000002 107.986 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 73.4 mt -64.19 -40.06 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 114.272 -1.331 . . . . 1.1200000000000001 108.033 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 8' ' ' THR . 39.2 mt -66.87 -38.79 86.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.918 -1.492 . . . . 2.0600000000000001 109.512 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.4 85.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.767 -1.106 . . . . 1.01 109.597 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -65.41 -58.22 6.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.048 -0.978 . . . . 0.94999999999999996 110.061 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.63 78.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 123.269 0.355 . . . . 1.04 110.571 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -57.62 -43.24 94.39 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.034 -1.226 . . . . 0.20000000000000001 110.034 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.1 mmt180 -70.29 -33.09 71.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.242 -0.479 . . . . 5.1200000000000001 110.412 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.7 mt -65.93 -61.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.373 -1.343 . . . . 1.04 107.373 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG22 ' A' ' 22' ' ' VAL . 48.3 t80 -53.31 -39.36 63.96 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.476 -2.147 . . . . 0.35999999999999999 110.281 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.3 mt-10 -62.51 -54.46 39.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 110.89 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 16' ' ' ARG . 22.2 m -63.81 -26.18 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.323 -0.992 . . . . 1.04 108.323 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -73.02 -30.58 63.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.444 -1.253 . . . . 2.2599999999999998 108.755 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -75.65 -40.62 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.626 -1.17 . . . . 1.0700000000000001 111.003 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 9.7 mm-40 -57.16 -41.86 79.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.631 -0.507 . . . . 2.6400000000000001 109.631 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -67.73 -28.99 73.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.817 -0.913 . . . . 0.42999999999999999 110.817 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.0 t60 -60.36 -47.95 83.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.226 -0.657 . . . . 0.87 109.226 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.561 ' O ' HG21 ' A' ' 29' ' ' VAL . 83.5 m95 -77.45 -6.6 54.06 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.32 -0.855 . . . . 1.8500000000000001 111.47 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 6.6 mm-40 -69.68 -40.38 76.4 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.592 -0.843 . . . . 0.85999999999999999 108.939 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.0 -22.2 45.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.249 -0.887 . . . . 1.97 110.703 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.632 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 21.4 m -60.99 -32.65 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 C-N-CA 120.338 -0.545 . . . . 1.45 111.424 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -51.44 -6.89 0.2 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 119.67 -1.252 . . . . 1.52 110.707 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.604 ' H ' ' C ' ' A' ' 29' ' ' VAL . 14.7 mmt -104.89 -68.13 0.87 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 3.4700000000000002 110.411 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.632 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -60.6 -40.55 92.22 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.819 -0.628 . . . . 2.0299999999999998 110.586 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -65.9 -39.23 90.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.522 -0.763 . . . . 1.95 109.538 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -61.72 -34.73 76.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.345 -0.843 . . . . 2.48 110.997 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.468 ' HB2' HD23 ' A' ' 36' ' ' LEU . 58.9 m -58.85 -24.19 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 3.52 110.952 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -148.15 34.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.047 0.451 . . . . 3.29 111.849 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.503 -0.692 0 N-CA-C 109.405 -1.478 . . . . 2.46 109.405 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.9 mt . . . . . 0 CA--C 1.518 -0.288 0 CA-C-O 121.028 0.442 . . . . 6.1399999999999997 110.074 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 42.4 m-80 -61.63 -51.09 69.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.277 -0.874 . . . . 7.25 111.198 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' GLY . 8.1 mmm180 -53.38 -47.56 69.38 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.35 -0.386 . . . . 10.48 110.163 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -67.02 -40.96 87.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.41 -0.959 . . . . 9.1999999999999993 108.41 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -68.94 -2.81 10.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.129 -0.941 . . . . 9.5 110.084 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -122.91 -12.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 11.31 112.004 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . -59.17 -13.57 21.4 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.899 -0.667 . . . . 12.640000000000001 112.579 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -166.7 -31.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.241 0.543 . . . . 13.01 110.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 24.1 mmt -71.08 -28.59 64.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 11.789999999999999 111.157 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 12.99 112.703 -179.575 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 121.114 0.483 . . . . 1.8500000000000001 110.01 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 31.1 t80 -61.64 -28.78 69.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 2.0099999999999998 109.949 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 90.0 m -70.2 -37.06 74.99 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.971 -0.558 . . . . 1.1100000000000001 110.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -44.16 92.33 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 108.127 -1.064 . . . . 2.1800000000000002 108.127 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 62.3 mt -57.06 -32.21 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 113.669 -1.605 . . . . 1.1200000000000001 108.009 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 8' ' ' THR . 20.2 mt -76.66 -38.75 54.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.681 -1.6 . . . . 2.0600000000000001 110.279 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.19 -51.65 50.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.644 -1.162 . . . . 1.01 110.503 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.96 -53.59 55.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.109 -0.95 . . . . 0.94999999999999996 110.075 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.47 79.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.721 0.296 . . . . 1.04 110.956 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -56.52 -41.45 88.79 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.892 -1.283 . . . . 0.20000000000000001 109.892 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.6 mmt180 -71.35 -35.12 71.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.821 -0.689 . . . . 5.1200000000000001 110.548 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.3 mt -66.81 -61.16 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 107.88 -1.155 . . . . 1.04 107.88 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 22' ' ' VAL . 32.5 t80 -52.48 -41.25 63.2 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.78 -2.009 . . . . 0.35999999999999999 110.41 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.4 mm-40 -60.24 -53.55 56.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.924 -0.58 . . . . 2.2999999999999998 110.969 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 17.2 m -68.31 -25.34 31.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.843 -0.799 . . . . 1.04 108.843 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 21.6 mmm -73.71 -28.22 61.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.842 -1.072 . . . . 2.2599999999999998 108.791 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -78.83 -42.55 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.79 -1.095 . . . . 1.0700000000000001 111.357 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 7.4 pt-20 -57.09 -39.65 75.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.915 0.388 . . . . 2.6400000000000001 110.014 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -70.99 -28.44 70.49 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.094 -0.802 . . . . 0.42999999999999999 111.094 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.487 ' O ' HG13 ' A' ' 29' ' ' VAL . 77.9 t60 -58.77 -45.35 89.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.356 -0.609 . . . . 0.87 109.356 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.596 ' O ' HG23 ' A' ' 29' ' ' VAL . 81.4 m95 -78.67 -6.35 55.48 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.587 -0.733 . . . . 1.8500000000000001 111.443 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 28.8 mm-40 -71.64 -40.75 69.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.616 -0.834 . . . . 0.85999999999999999 108.871 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.44 HG22 HD23 ' A' ' 32' ' ' LEU . 1.2 t -80.14 -20.72 44.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.295 -0.866 . . . . 1.97 110.657 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 26' ' ' TRP . 32.7 m -59.43 -33.66 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 120.184 -0.606 . . . . 1.45 111.072 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -50.52 -9.8 0.3 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.324 -1.417 . . . . 1.52 110.719 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.558 ' H ' ' C ' ' A' ' 29' ' ' VAL . 91.1 mmm -102.27 -69.65 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.454 0.702 . . . . 3.4700000000000002 110.255 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 2.3 pp -60.17 -43.03 96.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.394 -0.821 . . . . 2.0299999999999998 110.73 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.596 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 33.9 t80 -66.27 -32.7 74.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.211 -0.904 . . . . 1.95 109.796 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -59.67 -33.62 71.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.796 -0.638 . . . . 2.48 110.608 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 m -56.1 -17.65 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.451 -0.574 . . . . 3.52 109.451 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.74 29.24 0.84 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.181 -0.918 . . . . 3.29 110.243 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.526 0 N-CA-C 110.164 -1.174 . . . . 2.46 110.164 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.767 0.318 . . . . 6.1399999999999997 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -64.02 -44.6 92.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 7.25 110.876 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 48' ' ' TYR . 4.6 tpm_? -60.57 -53.57 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 10.48 110.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.15 -36.38 77.42 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.183 -0.673 . . . . 9.1999999999999993 109.183 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -65.4 -42.8 92.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 9.5 109.731 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.557 ' HB3' HH21 ' A' ' 45' ' ' ARG . 0.3 OUTLIER -66.05 -21.09 66.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.345 -0.843 . . . . 11.31 110.62 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.28 -2.75 0.27 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.657 -0.701 . . . . 12.640000000000001 113.21 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 48' ' ' TYR . 33.3 t -165.23 -36.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.757 0.313 . . . . 13.01 110.824 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 95.2 mmm -71.78 -32.85 68.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 11.789999999999999 110.355 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.657 . . . . 12.99 112.224 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 1.4 p . . . . . 0 N--CA 1.446 -0.626 0 CA-C-O 120.986 0.422 . . . . 1.8500000000000001 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.417 ' HA ' HD12 ' A' ' 10' ' ' ILE . 28.1 t80 -61.89 -30.03 70.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.527 -0.546 . . . . 2.0099999999999998 109.527 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 28.8 m -72.7 -36.17 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.625 -0.716 . . . . 1.1100000000000001 110.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -63.92 -43.52 95.67 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.171 -1.048 . . . . 2.1800000000000002 108.171 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 7' ' ' PHE . 66.6 mt -57.0 -32.29 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 113.544 -1.662 . . . . 1.1200000000000001 107.947 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' THR . 27.2 mt -77.72 -37.68 48.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.5 -1.682 . . . . 2.0600000000000001 110.236 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 -50.1 63.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.725 -1.125 . . . . 1.01 110.274 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -61.45 -55.25 33.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.047 -0.979 . . . . 0.94999999999999996 110.133 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.89 -44.93 82.79 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 120.729 0.299 . . . . 1.04 110.635 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.54 -42.08 95.81 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.059 -1.217 . . . . 0.20000000000000001 110.059 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.493 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.2 mmt180 -71.08 -34.53 71.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -0.632 . . . . 5.1200000000000001 110.423 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.1 mt -66.29 -61.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.794 -1.188 . . . . 1.04 107.794 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' HG21 ' A' ' 22' ' ' VAL . 37.7 t80 -53.37 -40.66 65.15 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.688 -2.051 . . . . 0.35999999999999999 110.503 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.2 mt-10 -61.51 -54.56 41.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.862 -0.608 . . . . 2.2999999999999998 111.207 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 16' ' ' ARG . 23.0 m -65.07 -26.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.484 -0.932 . . . . 1.04 108.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.68 -31.48 66.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.504 -1.225 . . . . 2.2599999999999998 108.713 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 18' ' ' PHE . 5.1 t -76.89 -48.0 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.494 -1.23 . . . . 1.0700000000000001 110.823 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 13.5 mm-40 -57.33 -45.01 84.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.25 -0.648 . . . . 2.6400000000000001 109.25 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.21 -29.38 75.18 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.147 -0.933 . . . . 0.42999999999999999 110.912 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.452 ' O ' HG13 ' A' ' 29' ' ' VAL . 56.9 t60 -59.62 -47.05 87.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.346 -0.613 . . . . 0.87 109.346 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.547 ' HA ' HG23 ' A' ' 29' ' ' VAL . 75.0 m95 -78.16 -15.46 58.82 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.579 -0.737 . . . . 1.8500000000000001 111.486 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.3 mm-40 -63.04 -36.58 84.05 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.831 -1.174 . . . . 0.85999999999999999 107.831 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.7 m -75.03 -30.64 61.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.434 -1.712 . . . . 1.97 110.89 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.747 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 6.4 m -65.05 -37.35 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 112.864 0.69 . . . . 1.45 112.864 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' HG22 ' A' ' 29' ' ' VAL . . . -49.56 -11.17 0.27 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 119.315 -1.422 . . . . 1.52 110.82 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.548 ' H ' ' C ' ' A' ' 29' ' ' VAL . 9.3 mmt -105.5 -68.09 0.88 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.998 0.519 . . . . 3.4700000000000002 110.891 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.747 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.2 pp -59.56 -34.1 72.26 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.119 -0.491 . . . . 2.0299999999999998 110.812 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -70.24 -39.45 75.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.622 -0.717 . . . . 1.95 109.717 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.31 -37.91 73.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.039 -0.982 . . . . 2.48 111.543 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -59.27 -30.23 68.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 3.52 110.978 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.7 32.12 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 3.29 111.015 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 C--O 1.215 -1.086 0 N-CA-C 109.623 -1.391 . . . . 2.46 109.623 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mt . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 120.785 0.326 . . . . 6.1399999999999997 110.215 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -59.04 -39.58 82.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 7.25 110.236 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -62.78 -51.45 67.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.12 -0.491 . . . . 10.48 110.532 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -60.49 -37.57 81.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.181 -0.674 . . . . 9.1999999999999993 109.181 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.07 92.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.926 -1.034 . . . . 9.5 110.026 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -65.62 -24.48 67.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.452 -0.795 . . . . 11.31 110.633 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.21 2.73 0.15 Allowed Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.499 -0.773 . . . . 12.640000000000001 113.536 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 48' ' ' TYR . 69.8 m -163.06 -38.16 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.965 0.383 . . . . 13.01 110.538 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.69 -24.92 60.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 11.789999999999999 110.817 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.846 -0.693 . . . . 12.99 112.404 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 109.23 -0.656 . . . . 1.8500000000000001 109.23 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 33.0 t80 -61.58 -39.64 91.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 110.582 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.673 ' HA ' HD23 ' A' ' 11' ' ' LEU . 94.2 m -67.63 -29.87 69.29 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.155 0.503 . . . . 1.1100000000000001 109.932 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.48 -41.27 84.83 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.291 -1.374 . . . . 2.1800000000000002 107.291 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.7 mt -66.11 -36.02 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 113.729 -1.578 . . . . 1.1200000000000001 109.085 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -70.54 -41.29 72.69 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.395 -1.275 . . . . 2.0600000000000001 108.836 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -55.38 30.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.646 -1.616 . . . . 1.01 110.01 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.21 -51.77 66.44 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.28 -0.873 . . . . 0.94999999999999996 110.558 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.76 74.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.424 -0.511 . . . . 1.04 110.09 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -60.55 -51.37 59.12 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.722 -0.752 . . . . 0.20000000000000001 111.278 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -71.68 -28.7 63.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.679 0.276 . . . . 5.1200000000000001 110.795 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.6 mt -66.54 -59.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 106.71 -1.589 . . . . 1.04 106.71 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.451 ' O ' HG23 ' A' ' 22' ' ' VAL . 33.8 t80 -55.18 -38.66 68.63 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.616 -2.084 . . . . 0.35999999999999999 109.587 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.4 mt-10 -60.74 -51.1 70.78 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.597 -0.728 . . . . 2.2999999999999998 110.953 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 16' ' ' ARG . 18.8 m -68.5 -28.53 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.952 -0.759 . . . . 1.04 108.952 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -72.04 -27.66 62.86 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.977 -1.011 . . . . 2.2599999999999998 108.813 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 18' ' ' PHE . 3.4 t -83.31 -43.25 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.532 -1.213 . . . . 1.0700000000000001 111.785 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.1 -40.83 82.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.893 0.377 . . . . 2.6400000000000001 110.022 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.51 -35.31 91.79 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.088 -1.205 . . . . 0.42999999999999999 110.088 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.499 ' O ' HG12 ' A' ' 29' ' ' VAL . 78.0 t60 -62.43 -41.86 99.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.501 -0.925 . . . . 0.87 108.501 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.578 ' HA ' HG22 ' A' ' 29' ' ' VAL . 22.9 m95 -74.31 -15.06 60.97 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.715 -1.13 . . . . 1.8500000000000001 110.929 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -42.61 58.71 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.85999999999999999 109.861 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.39 -22.17 55.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.241 -0.89 . . . . 1.97 111.207 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.658 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 33.3 m -61.07 -36.07 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 119.97 -0.692 . . . . 1.45 110.684 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.52 -11.0 0.13 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 119.832 -1.175 . . . . 1.52 111.036 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.544 ' H ' ' C ' ' A' ' 29' ' ' VAL . 17.3 mmt -102.02 -67.62 0.86 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.337 0.655 . . . . 3.4700000000000002 110.743 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -59.2 -38.41 79.82 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.816 -0.629 . . . . 2.0299999999999998 110.801 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.9 t80 -65.93 -39.33 90.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.638 -0.71 . . . . 1.95 109.708 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -38.58 82.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.355 -0.839 . . . . 2.48 111.301 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.4 ' HB3' HD22 ' A' ' 36' ' ' LEU . 47.9 t -53.94 -28.78 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 3.52 110.38 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.4 HD22 ' HB3' ' A' ' 35' ' ' SER . 0.6 OUTLIER -141.35 38.09 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 3.29 110.71 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 109.779 -1.328 . . . . 2.46 109.779 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mt . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.908 0.385 . . . . 6.1399999999999997 110.231 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.99 -40.93 95.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.676 -0.693 . . . . 7.25 110.737 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.03 -53.02 60.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 10.48 110.799 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -60.4 -36.69 78.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.243 -0.651 . . . . 9.1999999999999993 109.243 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.35 87.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.031 -0.986 . . . . 9.5 110.073 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -63.89 -20.49 65.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.542 -0.754 . . . . 11.31 110.807 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.11 -5.45 0.45 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.688 -0.687 . . . . 12.640000000000001 113.168 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.36 -34.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 13.01 110.66 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.1 mmm -73.39 -24.75 60.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 11.789999999999999 110.955 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 12.99 112.56 -179.842 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.1 t . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.757 -0.46 . . . . 1.8500000000000001 109.757 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -63.17 -34.88 78.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.896 0.379 . . . . 2.0099999999999998 110.035 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 -36.03 75.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.806 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -34.88 79.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.037 -1.098 . . . . 2.1800000000000002 108.037 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 7' ' ' PHE . 71.6 mt -64.48 -42.68 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.043 -1.435 . . . . 1.1200000000000001 108.074 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -66.65 -37.53 85.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.011 -1.449 . . . . 2.0600000000000001 109.612 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.93 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.739 -1.119 . . . . 1.01 109.69 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.31 -58.79 5.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.861 -1.063 . . . . 0.94999999999999996 109.999 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 -42.94 76.9 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.916 0.389 . . . . 1.04 110.582 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.28 -55.31 25.09 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.711 -0.956 . . . . 0.20000000000000001 110.711 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.526 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.2 mtp180 -69.33 -32.15 71.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.834 -0.683 . . . . 5.1200000000000001 111.666 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.0 mt -61.92 -60.76 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.167 -1.79 . . . . 1.04 106.167 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.9 t80 -54.93 -40.96 70.46 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.29 -2.232 . . . . 0.35999999999999999 110.323 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -62.56 -54.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.778 -0.646 . . . . 2.2999999999999998 111.205 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 16' ' ' ARG . 17.9 m -63.86 -26.59 40.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.236 -1.024 . . . . 1.04 108.236 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -72.65 -31.04 64.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.529 -1.214 . . . . 2.2599999999999998 108.819 177.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 18' ' ' PHE . 8.6 t -78.15 -44.45 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.677 -1.147 . . . . 1.0700000000000001 111.167 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 7.1 mm-40 -57.85 -42.88 85.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.519 -0.549 . . . . 2.6400000000000001 109.519 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -29.52 74.99 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.872 -0.891 . . . . 0.42999999999999999 110.872 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.427 ' O ' HG12 ' A' ' 29' ' ' VAL . 59.7 t60 -60.25 -48.23 82.63 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.221 -0.659 . . . . 0.87 109.221 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.558 ' O ' HG21 ' A' ' 29' ' ' VAL . 83.9 m95 -77.98 -6.82 55.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.386 -0.825 . . . . 1.8500000000000001 111.605 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -70.09 -40.52 74.91 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.391 -0.924 . . . . 0.85999999999999999 108.996 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -21.74 47.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.352 -0.84 . . . . 1.97 110.677 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.652 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 24.4 m -60.69 -33.39 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 120.281 -0.568 . . . . 1.45 111.099 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -52.43 -5.09 0.17 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 119.744 -1.217 . . . . 1.52 110.843 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -107.91 -67.23 0.98 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.485 0.714 . . . . 3.4700000000000002 110.265 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.5 pp -59.68 -40.8 89.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.888 -0.596 . . . . 2.0299999999999998 110.237 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -67.1 -41.93 85.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.278 -0.874 . . . . 1.95 109.49 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 2.48 111.256 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.443 ' HB2' HD21 ' A' ' 36' ' ' LEU . 61.3 m -57.96 -15.74 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.492 . . . . 3.52 109.805 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.443 HD21 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -160.04 33.0 0.18 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.48 -0.782 . . . . 3.29 110.792 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.505 -0.534 0 N-CA-C 110.302 -1.119 . . . . 2.46 110.302 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.227 -0.097 0 CA-C-O 120.444 0.164 . . . . 6.1399999999999997 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -59.88 -48.11 83.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.597 -0.274 . . . . 7.25 111.212 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -51.64 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 10.48 111.113 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.37 -34.45 75.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.107 -0.701 . . . . 9.1999999999999993 109.107 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.19 -41.91 85.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.185 -0.916 . . . . 9.5 109.989 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.08 -23.19 67.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.695 -0.684 . . . . 11.31 110.628 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.55 1.53 0.28 Allowed Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.632 -0.713 . . . . 12.640000000000001 113.118 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.33 -38.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 13.01 110.724 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.0 mmt -73.36 -28.24 61.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.969 -0.56 . . . . 11.789999999999999 110.828 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.822 -0.704 . . . . 12.99 112.545 -179.653 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.858 0.837 . . . . 1.8500000000000001 109.717 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.9 t80 -63.42 -44.85 93.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.331 -1.304 . . . . 2.0099999999999998 110.789 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 16.7 m -60.98 -30.78 70.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.891 -0.411 . . . . 1.1100000000000001 109.891 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -46.82 72.84 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.527 -0.916 . . . . 2.1800000000000002 108.527 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 50.6 mt -55.28 -30.27 24.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.069 -1.423 . . . . 1.1200000000000001 108.087 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' THR . 30.0 mt -79.07 -42.15 27.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.586 -1.643 . . . . 2.0600000000000001 110.764 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -49.04 65.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.01 110.239 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -59.72 -59.27 5.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.66 -1.155 . . . . 0.94999999999999996 110.018 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.37 87.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.006 0.431 . . . . 1.04 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -51.7 -52.03 35.95 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.828 -1.177 . . . . 0.20000000000000001 110.391 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.517 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.7 ttt180 -71.83 -34.36 69.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 124.136 0.551 . . . . 5.1200000000000001 111.453 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.7 mt -63.86 -62.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.113 -1.439 . . . . 1.04 107.113 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 22' ' ' VAL . 70.3 t80 -51.68 -42.06 61.87 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.322 -2.217 . . . . 0.35999999999999999 110.141 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -62.78 -56.38 18.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.819 -0.628 . . . . 2.2999999999999998 111.173 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 16' ' ' ARG . 18.6 m -60.59 -27.16 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.978 -1.119 . . . . 1.04 107.978 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 5.7 mmt -73.29 -31.65 64.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.334 -1.303 . . . . 2.2599999999999998 108.553 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 18' ' ' PHE . 4.7 t -75.31 -42.08 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.613 -1.176 . . . . 1.0700000000000001 111.075 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.5 mm-40 -58.92 -46.7 87.28 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.485 -0.561 . . . . 2.6400000000000001 109.485 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -59.58 -34.7 82.74 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.097 -1.201 . . . . 0.42999999999999999 110.097 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.537 ' O ' HG11 ' A' ' 29' ' ' VAL . 79.9 t60 -63.15 -41.91 99.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.385 -0.969 . . . . 0.87 108.385 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.534 ' HA ' HG23 ' A' ' 29' ' ' VAL . 23.2 m95 -73.82 -15.75 61.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.578 -1.192 . . . . 1.8500000000000001 110.828 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 7.9 mm-40 -72.79 -44.63 61.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.382 0.611 . . . . 0.85999999999999999 109.637 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 31' ' ' MET . 0.5 OUTLIER -78.2 -19.94 52.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.047 -0.979 . . . . 1.97 111.211 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.645 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 27.0 m -56.32 -32.98 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 119.365 -0.934 . . . . 1.45 109.895 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.73 -9.96 0.07 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.877 -1.154 . . . . 1.52 111.597 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.618 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.44 -57.99 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.266 0.226 . . . . 3.4700000000000002 111.459 179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.645 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.1 pp -64.84 -32.19 73.77 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.719 . . . . 2.0299999999999998 109.803 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -72.6 -48.32 40.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.63 -1.168 . . . . 1.95 109.152 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.55 -43.04 75.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.9 -1.045 . . . . 2.48 111.771 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.462 ' HB3' HD23 ' A' ' 36' ' ' LEU . 48.3 t -54.0 -21.72 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 3.52 110.908 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -155.95 44.27 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 3.29 110.672 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.504 -0.617 0 N-CA-C 109.142 -1.583 . . . . 2.46 109.142 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 111.878 0.325 . . . . 6.1399999999999997 111.878 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.403 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 1.0 OUTLIER -59.6 -59.89 4.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 111.919 0.341 . . . . 7.25 111.919 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -55.06 -47.05 75.36 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.545 0.212 . . . . 10.48 111.298 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.65 -34.06 77.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.115 -0.698 . . . . 9.1999999999999993 109.115 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 44' ' ' ASN . . . -67.21 -48.26 68.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.176 -0.92 . . . . 9.5 110.102 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.409 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -61.69 -18.09 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.856 . . . . 11.31 111.286 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.28 -9.14 1.36 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.833 -0.698 . . . . 12.640000000000001 112.679 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 48' ' ' TYR . 44.2 t -166.55 -31.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.709 0.29 . . . . 13.01 111.101 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.1 mmm -71.85 -31.03 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 11.789999999999999 111.078 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.887 -0.673 . . . . 12.99 112.535 -179.553 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.089 0.471 . . . . 1.8500000000000001 111.235 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 29.9 t80 -58.34 -42.27 86.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.485 -0.78 . . . . 2.0099999999999998 111.299 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -65.53 -31.63 72.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.692 -0.403 . . . . 1.1100000000000001 110.295 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.16 85.03 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.843 -1.169 . . . . 2.1800000000000002 107.843 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.2 mt -64.52 -39.64 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 114.158 -1.383 . . . . 1.1200000000000001 108.153 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.78 -38.26 83.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.895 -1.502 . . . . 2.0600000000000001 109.753 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.39 79.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.747 -1.115 . . . . 1.01 109.855 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -57.15 10.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.073 -0.967 . . . . 0.94999999999999996 110.187 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.74 78.88 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.78 0.324 . . . . 1.04 110.471 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -61.09 -40.51 98.62 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 109.941 -1.264 . . . . 0.20000000000000001 109.941 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.501 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.6 mmt180 -71.23 -34.86 71.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.2 -0.5 . . . . 5.1200000000000001 110.151 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.9 mt -66.0 -58.85 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 107.902 -1.148 . . . . 1.04 107.902 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.46 ' O ' HG21 ' A' ' 22' ' ' VAL . 26.3 t80 -55.99 -39.6 72.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.895 -1.957 . . . . 0.35999999999999999 110.043 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.2 mm-40 -61.24 -51.57 68.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.922 -0.581 . . . . 2.2999999999999998 110.709 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 16' ' ' ARG . 21.6 m -69.23 -26.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.017 -0.734 . . . . 1.04 109.017 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.68 -29.34 63.33 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.219 -0.9 . . . . 2.2599999999999998 108.685 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 18' ' ' PHE . 4.1 t -79.54 -45.44 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.718 -1.128 . . . . 1.0700000000000001 110.732 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 8.4 pt-20 -59.76 -40.22 87.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.188 -0.671 . . . . 2.6400000000000001 109.188 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -62.72 -35.45 91.92 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.114 -1.194 . . . . 0.42999999999999999 110.114 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -62.3 -38.34 89.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.87 108.422 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.571 ' HA ' HG23 ' A' ' 29' ' ' VAL . 36.5 m95 -76.3 -17.03 59.64 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.966 -1.015 . . . . 1.8500000000000001 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 16.2 mm-40 -73.43 -41.86 62.74 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.248 -1.019 . . . . 0.85999999999999999 108.248 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 m -68.97 -31.13 69.76 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.435 -1.711 . . . . 1.97 111.257 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.792 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 27.3 m -62.09 -36.69 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 120.347 -0.541 . . . . 1.45 111.407 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.37 -8.76 0.19 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.031 -1.08 . . . . 1.52 111.655 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.558 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -113.61 -55.67 2.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.157 0.183 . . . . 3.4700000000000002 111.34 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.792 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.4 pp -64.99 -26.52 68.33 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.48 0.657 . . . . 2.0299999999999998 109.534 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 6.1 t80 -72.93 -47.42 45.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.014 -0.994 . . . . 1.95 109.091 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.51 -40.35 91.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.584 -1.189 . . . . 2.48 110.828 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 36' ' ' LEU . 52.5 m -48.31 -31.37 5.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 3.52 110.434 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -141.8 39.35 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.804 -0.635 . . . . 3.29 110.725 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.512 0 N-CA-C 109.997 -1.241 . . . . 2.46 109.997 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mt . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.012 0.435 . . . . 6.1399999999999997 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -60.02 -43.72 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 7.25 111.299 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -49.3 73.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 10.48 110.903 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.64 -36.8 83.98 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.695 . . . . 9.1999999999999993 109.125 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.65 90.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 9.5 110.035 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -67.24 -18.94 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 11.31 110.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.72 1.72 0.47 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.878 -0.601 . . . . 12.640000000000001 113.265 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 48' ' ' TYR . 48.1 t -166.13 -34.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.346 . . . . 13.01 110.752 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -73.73 -22.3 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 11.789999999999999 111.084 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 12.99 112.562 -179.769 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.019 0.438 . . . . 1.8500000000000001 111.297 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.483 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.6 t80 -57.3 -43.16 82.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.519 -0.764 . . . . 2.0099999999999998 111.072 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 m -65.83 -31.08 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.68 -0.408 . . . . 1.1100000000000001 109.914 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.15 83.97 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.965 -1.124 . . . . 2.1800000000000002 107.965 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 72.7 mt -63.59 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.313 -1.312 . . . . 1.1200000000000001 108.08 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.44 -38.21 84.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.896 -1.502 . . . . 2.0600000000000001 109.751 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.46 -46.06 77.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.77 -1.105 . . . . 1.01 110.034 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.491 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.87 -55.63 21.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.109 -0.95 . . . . 0.94999999999999996 110.11 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.6 77.28 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.793 0.33 . . . . 1.04 110.389 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.12 -41.6 94.73 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.954 -1.259 . . . . 0.20000000000000001 109.954 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.9 mmt180 -70.8 -33.54 70.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.103 -0.549 . . . . 5.1200000000000001 110.279 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.25 -62.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.636 -1.246 . . . . 1.04 107.636 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 t80 -51.68 -41.23 61.27 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 112.688 -2.051 . . . . 0.35999999999999999 110.218 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.8 mt-10 -61.85 -55.63 27.87 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 111.17 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 16' ' ' ARG . 26.7 m -63.59 -26.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.371 -0.974 . . . . 1.04 108.371 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -72.07 -31.45 66.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.492 -1.231 . . . . 2.2599999999999998 108.441 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 18' ' ' PHE . 7.0 t -75.42 -45.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.534 -1.212 . . . . 1.0700000000000001 110.717 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 8.1 mm-40 -59.62 -45.76 90.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.12 -0.696 . . . . 2.6400000000000001 109.12 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.11 85.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.497 ' O ' HG13 ' A' ' 29' ' ' VAL . 81.8 t60 -63.67 -39.02 93.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.55 -0.907 . . . . 0.87 108.55 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.559 ' HA ' HG21 ' A' ' 29' ' ' VAL . 28.2 m95 -76.22 -16.48 59.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.853 -1.067 . . . . 1.8500000000000001 110.503 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -73.86 -41.67 61.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.337 -0.616 . . . . 0.85999999999999999 109.337 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -75.63 -22.71 56.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.078 -0.965 . . . . 1.97 111.032 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 34.5 m -60.85 -33.99 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 C-N-CA 119.871 -0.732 . . . . 1.45 110.248 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -48.56 -10.58 0.12 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.781 -1.2 . . . . 1.52 110.806 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.574 ' H ' ' C ' ' A' ' 29' ' ' VAL . 19.4 mmt -101.19 -68.18 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.374 0.67 . . . . 3.4700000000000002 110.446 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -59.64 -41.35 90.3 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.859 -0.61 . . . . 2.0299999999999998 110.675 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.1 t80 -64.68 -37.11 86.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 1.95 109.504 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -59.81 -34.12 72.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.475 -0.784 . . . . 2.48 110.696 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.5 m -59.71 -27.85 66.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.953 -0.567 . . . . 3.52 110.154 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.41 35.53 2.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 3.29 110.936 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.507 -0.431 0 N-CA-C 109.742 -1.343 . . . . 2.46 109.742 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.087 0.47 . . . . 6.1399999999999997 110.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -60.14 -48.94 79.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 7.25 111.538 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -60.66 -51.61 68.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.595 -0.275 . . . . 10.48 111.19 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.24 -34.5 76.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.19 -0.67 . . . . 9.1999999999999993 109.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 -40.62 88.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.387 -0.824 . . . . 9.5 109.885 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.36 -24.06 67.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.382 -0.826 . . . . 11.31 110.499 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.61 2.99 0.27 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.617 -0.719 . . . . 12.640000000000001 113.33 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 48' ' ' TYR . 70.8 m -163.5 -39.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 13.01 110.542 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.3 mtt -72.92 -28.95 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 11.789999999999999 110.523 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.906 -0.664 . . . . 12.99 111.904 179.832 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.986 0.422 . . . . 1.8500000000000001 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.579 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.8 t80 -57.31 -42.42 81.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.589 -0.732 . . . . 2.0099999999999998 110.582 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 m -67.43 -32.67 73.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.72 -0.392 . . . . 1.1100000000000001 110.066 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -35.12 79.9 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.711 -1.218 . . . . 2.1800000000000002 107.711 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 68.4 mt -65.27 -41.59 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.011 -1.45 . . . . 1.1200000000000001 107.854 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.35 -37.87 88.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.095 -1.412 . . . . 2.0600000000000001 109.252 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.89 81.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.734 -1.121 . . . . 1.01 109.383 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.66 -58.07 8.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.95 -1.023 . . . . 0.94999999999999996 110.037 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.79 76.87 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.002 0.43 . . . . 1.04 109.885 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.39 -41.62 63.38 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.67 -1.372 . . . . 0.20000000000000001 109.67 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.508 ' O ' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -72.66 -37.89 67.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.053 -0.574 . . . . 5.1200000000000001 110.86 178.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.09 -63.08 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 122.623 1.201 . . . . 1.04 108.08 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 22' ' ' VAL . 53.6 t80 -50.62 -39.8 51.17 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 112.654 -2.066 . . . . 0.35999999999999999 110.394 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -61.84 -53.78 51.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.916 0.388 . . . . 2.2999999999999998 110.885 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.508 HG11 ' O ' ' A' ' 16' ' ' ARG . 13.2 m -64.92 -26.11 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.011 -1.107 . . . . 1.04 108.011 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 5.4 mmt -74.96 -26.98 59.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.434 -1.257 . . . . 2.2599999999999998 108.549 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 18' ' ' PHE . 2.6 t -78.02 -36.39 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.482 -1.235 . . . . 1.0700000000000001 111.35 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 5.8 pt-20 -58.76 -44.6 90.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.801 -0.444 . . . . 2.6400000000000001 109.801 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -64.0 -33.05 86.21 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.562 ' O ' HG12 ' A' ' 29' ' ' VAL . 79.1 t60 -62.23 -37.09 84.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.356 -0.979 . . . . 0.87 108.356 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.528 ' HA ' HG22 ' A' ' 29' ' ' VAL . 19.0 m95 -74.22 -16.4 60.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.952 -1.022 . . . . 1.8500000000000001 110.166 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 11.1 mm-40 -75.23 -42.78 54.61 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -78.17 -18.92 54.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.821 -1.081 . . . . 1.97 111.259 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.686 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 31.0 m -57.61 -33.36 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 119.811 -0.756 . . . . 1.45 110.193 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.05 -11.99 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.738 -1.22 . . . . 1.52 111.502 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.55 ' H ' ' C ' ' A' ' 29' ' ' VAL . 13.9 mmt -103.89 -65.08 1.04 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.981 0.512 . . . . 3.4700000000000002 110.898 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.686 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -60.0 -34.39 73.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 110.727 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.12 -34.81 78.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 1.95 109.379 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 31' ' ' MET . 3.2 t70 -59.55 -34.04 72.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.379 -0.828 . . . . 2.48 110.453 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -74.13 -5.47 41.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.404 0.621 . . . . 3.52 109.476 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 2.3 mt -126.28 6.11 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.026 -0.988 . . . . 3.29 110.059 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.501 0 N-CA-C 106.868 -2.493 . . . . 2.46 106.868 178.174 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.694 0.283 . . . . 6.1399999999999997 110.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -59.12 -41.32 87.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 7.25 110.569 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.57 -51.97 65.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.241 -0.436 . . . . 10.48 110.767 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -60.85 -36.39 79.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.211 -0.663 . . . . 9.1999999999999993 109.211 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.88 87.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 9.5 109.967 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -63.23 -22.82 67.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.455 -0.793 . . . . 11.31 110.558 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.44 -7.79 0.26 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.404 -0.816 . . . . 12.640000000000001 113.156 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' TYR . 42.2 t -163.4 -35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.894 0.378 . . . . 13.01 110.94 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.66 -30.68 64.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 11.789999999999999 110.635 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.89 -0.671 . . . . 12.99 111.997 -179.669 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.838 0.351 . . . . 7.6500000000000004 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -120.11 107.07 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 4.8799999999999999 110.853 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.76 -83.0 0.35 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.808 -0.71 . . . . 3.5499999999999998 112.457 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.57 -10.4 7.86 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.891 -0.671 . . . . 1.76 112.673 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.85 -61.61 7.01 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.354 -0.927 . . . . 2.1400000000000001 111.503 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.8 p -64.76 -44.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.152 0.501 . . . . 1.8500000000000001 111.309 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.494 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 28.5 t80 -56.79 -43.74 81.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.334 -0.848 . . . . 2.0099999999999998 111.344 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.407 ' HA ' HD12 ' A' ' 11' ' ' LEU . 58.3 m -65.66 -31.57 72.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.62 -0.432 . . . . 1.1100000000000001 110.205 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -37.53 83.33 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.986 -1.116 . . . . 2.1800000000000002 107.986 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.494 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 73.4 mt -64.19 -40.06 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 114.272 -1.331 . . . . 1.1200000000000001 108.033 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 8' ' ' THR . 39.2 mt -66.87 -38.79 86.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.918 -1.492 . . . . 2.0600000000000001 109.512 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.4 85.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.767 -1.106 . . . . 1.01 109.597 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -65.41 -58.22 6.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.048 -0.978 . . . . 0.94999999999999996 110.061 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.63 78.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 123.269 0.355 . . . . 1.04 110.571 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -57.62 -43.24 94.39 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.034 -1.226 . . . . 0.20000000000000001 110.034 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.511 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.1 mmt180 -70.29 -33.09 71.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.242 -0.479 . . . . 5.1200000000000001 110.412 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.7 mt -65.93 -61.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.373 -1.343 . . . . 1.04 107.373 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG22 ' A' ' 22' ' ' VAL . 48.3 t80 -53.31 -39.36 63.96 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.476 -2.147 . . . . 0.35999999999999999 110.281 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.3 mt-10 -62.51 -54.46 39.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 110.89 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 16' ' ' ARG . 22.2 m -63.81 -26.18 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.323 -0.992 . . . . 1.04 108.323 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -73.02 -30.58 63.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.444 -1.253 . . . . 2.2599999999999998 108.755 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -75.65 -40.62 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.626 -1.17 . . . . 1.0700000000000001 111.003 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 9.7 mm-40 -57.16 -41.86 79.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.631 -0.507 . . . . 2.6400000000000001 109.631 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -67.73 -28.99 73.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.817 -0.913 . . . . 0.42999999999999999 110.817 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.414 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.0 t60 -60.36 -47.95 83.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.226 -0.657 . . . . 0.87 109.226 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.561 ' O ' HG21 ' A' ' 29' ' ' VAL . 83.5 m95 -77.45 -6.6 54.06 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.32 -0.855 . . . . 1.8500000000000001 111.47 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 6.6 mm-40 -69.68 -40.38 76.4 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.592 -0.843 . . . . 0.85999999999999999 108.939 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.0 -22.2 45.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.249 -0.887 . . . . 1.97 110.703 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.632 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 21.4 m -60.99 -32.65 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 C-N-CA 120.338 -0.545 . . . . 1.45 111.424 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -51.44 -6.89 0.2 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 119.67 -1.252 . . . . 1.52 110.707 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.604 ' H ' ' C ' ' A' ' 29' ' ' VAL . 14.7 mmt -104.89 -68.13 0.87 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 3.4700000000000002 110.411 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.632 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -60.6 -40.55 92.22 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.819 -0.628 . . . . 2.0299999999999998 110.586 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -65.9 -39.23 90.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.522 -0.763 . . . . 1.95 109.538 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -61.72 -34.73 76.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.345 -0.843 . . . . 2.48 110.997 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.468 ' HB2' HD23 ' A' ' 36' ' ' LEU . 58.9 m -58.85 -24.19 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 3.52 110.952 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.468 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -148.15 34.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.047 0.451 . . . . 3.29 111.849 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.24 -40.18 0.24 Allowed Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.405 -1.478 . . . . 2.46 109.405 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -79.14 -49.94 11.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.961 -1.119 . . . . 3.8999999999999999 108.169 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.72 60.18 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.306 -1.316 . . . . 3.9700000000000002 111.091 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.506 ' HA ' HD11 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -65.12 -39.43 93.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.74 -0.384 . . . . 4.3099999999999996 111.021 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.0 mtm -46.64 -36.38 6.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 4.9100000000000001 110.409 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -70.34 -42.65 71.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.029 -0.532 . . . . 8.6999999999999993 109.734 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.506 HD11 ' HA ' ' A' ' 40' ' ' THR . 25.9 mt -58.73 -50.37 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.755 . . . . 6.1399999999999997 110.074 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 42.4 m-80 -61.63 -51.09 69.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.277 -0.874 . . . . 7.25 111.198 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' GLY . 8.1 mmm180 -53.38 -47.56 69.38 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.35 -0.386 . . . . 10.48 110.163 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -67.02 -40.96 87.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.41 -0.959 . . . . 9.1999999999999993 108.41 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -68.94 -2.81 10.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.129 -0.941 . . . . 9.5 110.084 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -122.91 -12.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 11.31 112.004 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . -59.17 -13.57 21.4 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.899 -0.667 . . . . 12.640000000000001 112.579 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -166.7 -31.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.241 0.543 . . . . 13.01 110.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 24.1 mmt -71.08 -28.59 64.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 11.789999999999999 111.157 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.56 37.85 3.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 12.99 112.703 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.43 -3.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.769 -0.729 . . . . 15.68 112.415 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.6 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.773 -0.727 . . . . 15.949999999999999 112.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -54.47 10.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 14.92 110.814 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mt -110.73 -21.68 11.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.854 -0.612 . . . . 16.219999999999999 111.046 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 47.3 23.29 0.32 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.455 -0.793 . . . . 20.399999999999999 112.137 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.45 30.1 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.997 -0.621 . . . . 17.620000000000001 112.953 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.329 -0.843 . . . . 17.91 110.805 179.875 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.838 0.351 . . . . 7.6500000000000004 110.802 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -168.22 110.79 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 4.8799999999999999 110.921 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.67 -95.14 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.933 -0.651 . . . . 3.5499999999999998 112.001 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' C ' ' H ' ' A' ' 6' ' ' VAL . . . -75.85 5.14 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.539 -0.839 . . . . 1.76 112.238 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.78 4.89 4.97 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.725 -0.75 . . . . 2.1400000000000001 111.423 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' H ' ' C ' ' A' ' 4' ' ' GLY . 1.3 p -170.99 -30.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.664 -0.768 . . . . 1.8500000000000001 110.01 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 31.1 t80 -61.64 -28.78 69.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 2.0099999999999998 109.949 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 90.0 m -70.2 -37.06 74.99 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.971 -0.558 . . . . 1.1100000000000001 110.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -44.16 92.33 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 108.127 -1.064 . . . . 2.1800000000000002 108.127 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 62.3 mt -57.06 -32.21 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 113.669 -1.605 . . . . 1.1200000000000001 108.009 177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 8' ' ' THR . 20.2 mt -76.66 -38.75 54.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.681 -1.6 . . . . 2.0600000000000001 110.279 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.19 -51.65 50.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.644 -1.162 . . . . 1.01 110.503 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.96 -53.59 55.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.109 -0.95 . . . . 0.94999999999999996 110.075 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.47 79.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.721 0.296 . . . . 1.04 110.956 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -56.52 -41.45 88.79 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.892 -1.283 . . . . 0.20000000000000001 109.892 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.478 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.6 mmt180 -71.35 -35.12 71.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.821 -0.689 . . . . 5.1200000000000001 110.548 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.3 mt -66.81 -61.16 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 107.88 -1.155 . . . . 1.04 107.88 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.486 ' O ' HG22 ' A' ' 22' ' ' VAL . 32.5 t80 -52.48 -41.25 63.2 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.78 -2.009 . . . . 0.35999999999999999 110.41 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.4 mm-40 -60.24 -53.55 56.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.924 -0.58 . . . . 2.2999999999999998 110.969 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 17.2 m -68.31 -25.34 31.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.843 -0.799 . . . . 1.04 108.843 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 21.6 mmm -73.71 -28.22 61.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.842 -1.072 . . . . 2.2599999999999998 108.791 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -78.83 -42.55 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.79 -1.095 . . . . 1.0700000000000001 111.357 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 7.4 pt-20 -57.09 -39.65 75.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.915 0.388 . . . . 2.6400000000000001 110.014 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -70.99 -28.44 70.49 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.094 -0.802 . . . . 0.42999999999999999 111.094 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.487 ' O ' HG13 ' A' ' 29' ' ' VAL . 77.9 t60 -58.77 -45.35 89.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.356 -0.609 . . . . 0.87 109.356 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.596 ' O ' HG23 ' A' ' 29' ' ' VAL . 81.4 m95 -78.67 -6.35 55.48 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.587 -0.733 . . . . 1.8500000000000001 111.443 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 28.8 mm-40 -71.64 -40.75 69.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.616 -0.834 . . . . 0.85999999999999999 108.871 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.44 HG22 HD23 ' A' ' 32' ' ' LEU . 1.2 t -80.14 -20.72 44.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.295 -0.866 . . . . 1.97 110.657 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 26' ' ' TRP . 32.7 m -59.43 -33.66 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 120.184 -0.606 . . . . 1.45 111.072 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -50.52 -9.8 0.3 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.324 -1.417 . . . . 1.52 110.719 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.558 ' H ' ' C ' ' A' ' 29' ' ' VAL . 91.1 mmm -102.27 -69.65 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.454 0.702 . . . . 3.4700000000000002 110.255 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.545 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 2.3 pp -60.17 -43.03 96.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.394 -0.821 . . . . 2.0299999999999998 110.73 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.596 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 33.9 t80 -66.27 -32.7 74.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.211 -0.904 . . . . 1.95 109.796 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -59.67 -33.62 71.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.796 -0.638 . . . . 2.48 110.608 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 m -56.1 -17.65 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.451 -0.574 . . . . 3.52 109.451 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.465 ' HA ' HG21 ' A' ' 40' ' ' THR . 0.9 OUTLIER -148.74 29.24 0.84 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.181 -0.918 . . . . 3.29 110.243 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.473 ' C ' ' HB3' ' A' ' 41' ' ' MET . . . -139.98 6.24 2.84 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 110.164 -1.174 . . . . 2.46 110.164 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 37' ' ' GLY . 12.4 tptt -154.8 -43.45 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.532 -1.334 . . . . 3.8999999999999999 108.575 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.83 -18.36 79.64 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.06 -0.973 . . . . 3.9700000000000002 111.967 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.465 HG21 ' HA ' ' A' ' 36' ' ' LEU . 12.8 t -169.83 35.62 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.205 0.446 . . . . 4.3099999999999996 112.205 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.473 ' HB3' ' C ' ' A' ' 37' ' ' GLY . 11.3 ptt? -55.47 -32.79 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.952 -0.567 . . . . 4.9100000000000001 111.032 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' HG3' ' ND2' ' A' ' 46' ' ' ASN . 6.3 tpp180 -66.04 -59.07 4.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.437 -0.347 . . . . 8.6999999999999993 110.486 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.462 HD13 ' OG1' ' A' ' 40' ' ' THR . 55.2 mt -50.44 -44.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 6.1399999999999997 110.187 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -64.02 -44.6 92.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 7.25 110.876 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 48' ' ' TYR . 4.6 tpm_? -60.57 -53.57 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 10.48 110.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.404 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 38.6 m-80 -60.15 -36.38 77.42 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.183 -0.673 . . . . 9.1999999999999993 109.183 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -65.4 -42.8 92.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 9.5 109.731 178.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.557 ' HB3' HH21 ' A' ' 45' ' ' ARG . 0.3 OUTLIER -66.05 -21.09 66.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.345 -0.843 . . . . 11.31 110.62 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.28 -2.75 0.27 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.657 -0.701 . . . . 12.640000000000001 113.21 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 48' ' ' TYR . 33.3 t -165.23 -36.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.757 0.313 . . . . 13.01 110.824 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.49 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 95.2 mmm -71.78 -32.85 68.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 11.789999999999999 110.355 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -83.62 42.17 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.657 . . . . 12.99 112.224 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.88 9.71 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.079 -0.808 . . . . 15.68 111.079 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 56' ' ' LEU . . . -96.4 -82.76 1.64 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.421 . . . . 15.949999999999999 112.768 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.468 ' C ' HD11 ' A' ' 56' ' ' LEU . 20.3 m -75.72 21.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 14.92 111.307 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.567 HD11 ' N ' ' A' ' 56' ' ' LEU . 3.4 mp 56.99 32.52 21.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.795 -0.639 . . . . 16.219999999999999 110.519 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -56.72 -21.56 28.92 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.239 -0.437 . . . . 20.399999999999999 111.255 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.43 -0.93 0.94 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.836 -0.697 . . . . 17.620000000000001 112.588 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.263 -0.875 . . . . 17.91 110.959 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.743 0.306 . . . . 7.6500000000000004 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -66.56 -50.13 64.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.236 0.541 . . . . 4.8799999999999999 110.851 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.63 68.13 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.272 -0.876 . . . . 3.5499999999999998 112.702 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' C ' ' H ' ' A' ' 6' ' ' VAL . . . 171.14 -26.55 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.937 -0.649 . . . . 1.76 112.051 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.23 15.02 7.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 2.1400000000000001 111.556 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.437 ' H ' ' C ' ' A' ' 4' ' ' GLY . 1.4 p -172.0 -38.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.197 -0.502 . . . . 1.8500000000000001 110.854 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.417 ' HA ' HD12 ' A' ' 10' ' ' ILE . 28.1 t80 -61.89 -30.03 70.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.527 -0.546 . . . . 2.0099999999999998 109.527 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 28.8 m -72.7 -36.17 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.625 -0.716 . . . . 1.1100000000000001 110.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -63.92 -43.52 95.67 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.171 -1.048 . . . . 2.1800000000000002 108.171 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 7' ' ' PHE . 66.6 mt -57.0 -32.29 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 113.544 -1.662 . . . . 1.1200000000000001 107.947 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' THR . 27.2 mt -77.72 -37.68 48.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.5 -1.682 . . . . 2.0600000000000001 110.236 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 -50.1 63.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.725 -1.125 . . . . 1.01 110.274 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -61.45 -55.25 33.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.047 -0.979 . . . . 0.94999999999999996 110.133 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.89 -44.93 82.79 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 120.729 0.299 . . . . 1.04 110.635 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.54 -42.08 95.81 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.059 -1.217 . . . . 0.20000000000000001 110.059 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.493 ' O ' HG12 ' A' ' 20' ' ' VAL . 5.2 mmt180 -71.08 -34.53 71.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -0.632 . . . . 5.1200000000000001 110.423 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.1 mt -66.29 -61.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.794 -1.188 . . . . 1.04 107.794 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.492 ' O ' HG21 ' A' ' 22' ' ' VAL . 37.7 t80 -53.37 -40.66 65.15 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.688 -2.051 . . . . 0.35999999999999999 110.503 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.2 mt-10 -61.51 -54.56 41.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.862 -0.608 . . . . 2.2999999999999998 111.207 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 16' ' ' ARG . 23.0 m -65.07 -26.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.484 -0.932 . . . . 1.04 108.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.68 -31.48 66.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.504 -1.225 . . . . 2.2599999999999998 108.713 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 18' ' ' PHE . 5.1 t -76.89 -48.0 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.494 -1.23 . . . . 1.0700000000000001 110.823 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 13.5 mm-40 -57.33 -45.01 84.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.25 -0.648 . . . . 2.6400000000000001 109.25 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.21 -29.38 75.18 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.147 -0.933 . . . . 0.42999999999999999 110.912 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.452 ' O ' HG13 ' A' ' 29' ' ' VAL . 56.9 t60 -59.62 -47.05 87.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.346 -0.613 . . . . 0.87 109.346 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.547 ' HA ' HG23 ' A' ' 29' ' ' VAL . 75.0 m95 -78.16 -15.46 58.82 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.579 -0.737 . . . . 1.8500000000000001 111.486 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.3 mm-40 -63.04 -36.58 84.05 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.831 -1.174 . . . . 0.85999999999999999 107.831 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.7 m -75.03 -30.64 61.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.434 -1.712 . . . . 1.97 110.89 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.747 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 6.4 m -65.05 -37.35 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 112.864 0.69 . . . . 1.45 112.864 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' N ' HG22 ' A' ' 29' ' ' VAL . . . -49.56 -11.17 0.27 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 119.315 -1.422 . . . . 1.52 110.82 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.548 ' H ' ' C ' ' A' ' 29' ' ' VAL . 9.3 mmt -105.5 -68.09 0.88 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.998 0.519 . . . . 3.4700000000000002 110.891 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.747 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.2 pp -59.56 -34.1 72.26 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.119 -0.491 . . . . 2.0299999999999998 110.812 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -70.24 -39.45 75.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.622 -0.717 . . . . 1.95 109.717 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.31 -37.91 73.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.039 -0.982 . . . . 2.48 111.543 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -59.27 -30.23 68.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 3.52 110.978 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.7 32.12 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 3.29 111.015 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' MET . . . -119.5 -48.39 0.34 Allowed Glycine 0 C--O 1.215 -1.086 0 N-CA-C 109.623 -1.391 . . . . 2.46 109.623 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -67.03 -47.53 71.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.564 -1.273 . . . . 3.8999999999999999 107.564 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.73 71.03 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.551 -1.204 . . . . 3.9700000000000002 110.247 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.473 HG21 ' ND2' ' A' ' 44' ' ' ASN . 12.6 t -172.16 74.39 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.148 1.166 . . . . 4.3099999999999996 114.148 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' GLY . 1.5 mtp -78.04 -49.8 13.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.685 -0.689 . . . . 4.9100000000000001 111.031 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -57.79 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 8.6999999999999993 110.85 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' HB ' ' OG1' ' A' ' 40' ' ' THR . 48.6 mt -53.99 -39.87 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 6.1399999999999997 110.215 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.473 ' ND2' HG21 ' A' ' 40' ' ' THR . 1.1 m-80 -59.04 -39.58 82.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 7.25 110.236 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 41' ' ' MET . 9.4 mtm180 -62.78 -51.45 67.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.12 -0.491 . . . . 10.48 110.532 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -60.49 -37.57 81.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.181 -0.674 . . . . 9.1999999999999993 109.181 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.07 92.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.926 -1.034 . . . . 9.5 110.026 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -65.62 -24.48 67.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.452 -0.795 . . . . 11.31 110.633 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.21 2.73 0.15 Allowed Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.499 -0.773 . . . . 12.640000000000001 113.536 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 48' ' ' TYR . 69.8 m -163.06 -38.16 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.965 0.383 . . . . 13.01 110.538 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.69 -24.92 60.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 11.789999999999999 110.817 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.52 -8.83 57.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.846 -0.693 . . . . 12.99 112.404 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 -26.71 30.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.819 -0.705 . . . . 15.68 112.397 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 150.49 53.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 15.949999999999999 112.497 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.488 ' C ' ' H ' ' A' ' 57' ' ' ARG . 60.0 p 39.03 44.09 0.86 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.758 0.79 . . . . 14.92 112.063 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 58' ' ' GLY . 5.9 mp 68.18 -22.42 0.13 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.955 -1.475 . . . . 16.219999999999999 112.731 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' H ' ' C ' ' A' ' 55' ' ' SER . 10.9 ptm180 -82.72 25.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.421 . . . . 20.399999999999999 110.407 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . -146.88 21.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 17.620000000000001 112.384 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.231 -0.89 . . . . 17.91 110.869 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 26.9 ptt? . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.914 0.388 . . . . 7.6500000000000004 110.979 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -148.78 98.39 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 4.8799999999999999 110.78 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.55 -78.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.787 -0.721 . . . . 3.5499999999999998 112.316 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.38 -4.21 43.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.777 -0.725 . . . . 1.76 112.241 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' A' ' 1' ' ' MET . . . -97.45 23.89 33.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.91 -0.662 . . . . 2.1400000000000001 111.923 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -163.51 -53.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 123.355 0.662 . . . . 1.8500000000000001 109.23 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 33.0 t80 -61.58 -39.64 91.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 110.582 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.673 ' HA ' HD23 ' A' ' 11' ' ' LEU . 94.2 m -67.63 -29.87 69.29 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.155 0.503 . . . . 1.1100000000000001 109.932 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.48 -41.27 84.83 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.291 -1.374 . . . . 2.1800000000000002 107.291 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.7 mt -66.11 -36.02 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 113.729 -1.578 . . . . 1.1200000000000001 109.085 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 8' ' ' THR . 0.1 OUTLIER -70.54 -41.29 72.69 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.395 -1.275 . . . . 2.0600000000000001 108.836 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -55.38 30.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.646 -1.616 . . . . 1.01 110.01 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.592 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.21 -51.77 66.44 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.28 -0.873 . . . . 0.94999999999999996 110.558 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.76 74.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.424 -0.511 . . . . 1.04 110.09 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -60.55 -51.37 59.12 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.722 -0.752 . . . . 0.20000000000000001 111.278 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -71.68 -28.7 63.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.679 0.276 . . . . 5.1200000000000001 110.795 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.6 mt -66.54 -59.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 106.71 -1.589 . . . . 1.04 106.71 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.451 ' O ' HG23 ' A' ' 22' ' ' VAL . 33.8 t80 -55.18 -38.66 68.63 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.616 -2.084 . . . . 0.35999999999999999 109.587 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.497 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.4 mt-10 -60.74 -51.1 70.78 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.597 -0.728 . . . . 2.2999999999999998 110.953 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 16' ' ' ARG . 18.8 m -68.5 -28.53 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.952 -0.759 . . . . 1.04 108.952 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -72.04 -27.66 62.86 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.977 -1.011 . . . . 2.2599999999999998 108.813 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 18' ' ' PHE . 3.4 t -83.31 -43.25 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.532 -1.213 . . . . 1.0700000000000001 111.785 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.1 -40.83 82.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.893 0.377 . . . . 2.6400000000000001 110.022 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.51 -35.31 91.79 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.088 -1.205 . . . . 0.42999999999999999 110.088 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.499 ' O ' HG12 ' A' ' 29' ' ' VAL . 78.0 t60 -62.43 -41.86 99.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.501 -0.925 . . . . 0.87 108.501 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.578 ' HA ' HG22 ' A' ' 29' ' ' VAL . 22.9 m95 -74.31 -15.06 60.97 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.715 -1.13 . . . . 1.8500000000000001 110.929 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -42.61 58.71 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.85999999999999999 109.861 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.39 -22.17 55.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.241 -0.89 . . . . 1.97 111.207 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.658 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 33.3 m -61.07 -36.07 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 119.97 -0.692 . . . . 1.45 110.684 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.52 -11.0 0.13 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 119.832 -1.175 . . . . 1.52 111.036 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.544 ' H ' ' C ' ' A' ' 29' ' ' VAL . 17.3 mmt -102.02 -67.62 0.86 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.337 0.655 . . . . 3.4700000000000002 110.743 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.658 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -59.2 -38.41 79.82 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.816 -0.629 . . . . 2.0299999999999998 110.801 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.9 t80 -65.93 -39.33 90.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.638 -0.71 . . . . 1.95 109.708 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -38.58 82.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.355 -0.839 . . . . 2.48 111.301 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.4 ' HB3' HD22 ' A' ' 36' ' ' LEU . 47.9 t -53.94 -28.78 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 3.52 110.38 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.498 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.6 OUTLIER -141.35 38.09 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 3.29 110.71 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA2' ' CG2' ' A' ' 40' ' ' THR . . . -125.4 -33.8 0.7 Allowed Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 109.779 -1.328 . . . . 2.46 109.779 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -76.14 -52.15 10.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.193 -1.04 . . . . 3.8999999999999999 108.193 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.45 63.36 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.438 -1.256 . . . . 3.9700000000000002 111.13 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -67.18 -22.74 65.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.809 0.3 . . . . 4.3099999999999996 111.809 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.461 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 22.5 ptt? -38.68 -48.08 1.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.144 -0.48 . . . . 4.9100000000000001 111.817 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -56.95 -48.89 77.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 8.6999999999999993 110.181 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.421 HD13 ' OG1' ' A' ' 40' ' ' THR . 46.4 mt -53.1 -41.6 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 6.1399999999999997 110.231 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.99 -40.93 95.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.676 -0.693 . . . . 7.25 110.737 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 41' ' ' MET . 32.3 mtm180 -63.03 -53.02 60.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 10.48 110.799 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -60.4 -36.69 78.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.243 -0.651 . . . . 9.1999999999999993 109.243 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.35 87.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.031 -0.986 . . . . 9.5 110.073 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -63.89 -20.49 65.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.542 -0.754 . . . . 11.31 110.807 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.11 -5.45 0.45 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.688 -0.687 . . . . 12.640000000000001 113.168 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.36 -34.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 13.01 110.66 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.1 mmm -73.39 -24.75 60.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 11.789999999999999 110.955 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.41 51.4 0.88 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 12.99 112.56 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.84 -5.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.792 -0.718 . . . . 15.68 112.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -134.56 -22.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.702 . . . . 15.949999999999999 112.198 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -69.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.898 0.38 . . . . 14.92 110.971 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.8 mp -70.14 -30.26 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 16.219999999999999 111.054 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -81.52 24.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 20.399999999999999 110.282 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . -167.97 13.62 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.702 -0.681 . . . . 17.620000000000001 112.555 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.219 -0.896 . . . . 17.91 110.948 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.894 0.378 . . . . 7.6500000000000004 111.001 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -129.11 1.75 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 4.8799999999999999 110.863 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.92 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 3.5499999999999998 112.408 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.587 ' HA2' ' CD2' ' A' ' 7' ' ' PHE . . . -65.93 -4.53 21.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.616 -0.802 . . . . 1.76 112.361 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.42 27.8 3.58 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.796 -0.922 . . . . 2.1400000000000001 110.796 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 4' ' ' GLY . 71.1 t -162.5 -44.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 123.318 0.647 . . . . 1.8500000000000001 109.757 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.587 ' CD2' ' HA2' ' A' ' 4' ' ' GLY . 0.1 OUTLIER -63.17 -34.88 78.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.896 0.379 . . . . 2.0099999999999998 110.035 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 -36.03 75.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.1 -0.5 . . . . 1.1100000000000001 110.806 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -34.88 79.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.037 -1.098 . . . . 2.1800000000000002 108.037 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 7' ' ' PHE . 71.6 mt -64.48 -42.68 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.043 -1.435 . . . . 1.1200000000000001 108.074 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -66.65 -37.53 85.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.011 -1.449 . . . . 2.0600000000000001 109.612 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.93 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.739 -1.119 . . . . 1.01 109.69 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.544 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.31 -58.79 5.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.861 -1.063 . . . . 0.94999999999999996 109.999 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 -42.94 76.9 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.916 0.389 . . . . 1.04 110.582 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.28 -55.31 25.09 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.711 -0.956 . . . . 0.20000000000000001 110.711 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.526 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.2 mtp180 -69.33 -32.15 71.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.834 -0.683 . . . . 5.1200000000000001 111.666 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.0 mt -61.92 -60.76 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.167 -1.79 . . . . 1.04 106.167 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.534 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.9 t80 -54.93 -40.96 70.46 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.29 -2.232 . . . . 0.35999999999999999 110.323 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -62.56 -54.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.778 -0.646 . . . . 2.2999999999999998 111.205 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 16' ' ' ARG . 17.9 m -63.86 -26.59 40.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.236 -1.024 . . . . 1.04 108.236 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -72.65 -31.04 64.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.529 -1.214 . . . . 2.2599999999999998 108.819 177.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 18' ' ' PHE . 8.6 t -78.15 -44.45 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.677 -1.147 . . . . 1.0700000000000001 111.167 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 7.1 mm-40 -57.85 -42.88 85.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.519 -0.549 . . . . 2.6400000000000001 109.519 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -29.52 74.99 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.872 -0.891 . . . . 0.42999999999999999 110.872 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.427 ' O ' HG12 ' A' ' 29' ' ' VAL . 59.7 t60 -60.25 -48.23 82.63 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.221 -0.659 . . . . 0.87 109.221 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.558 ' O ' HG21 ' A' ' 29' ' ' VAL . 83.9 m95 -77.98 -6.82 55.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.386 -0.825 . . . . 1.8500000000000001 111.605 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -70.09 -40.52 74.91 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.391 -0.924 . . . . 0.85999999999999999 108.996 176.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.85 -21.74 47.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.352 -0.84 . . . . 1.97 110.677 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.652 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 24.4 m -60.69 -33.39 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 120.281 -0.568 . . . . 1.45 111.099 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -52.43 -5.09 0.17 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 119.744 -1.217 . . . . 1.52 110.843 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.603 ' H ' ' C ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -107.91 -67.23 0.98 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.485 0.714 . . . . 3.4700000000000002 110.265 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.5 pp -59.68 -40.8 89.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.888 -0.596 . . . . 2.0299999999999998 110.237 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -67.1 -41.93 85.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.278 -0.874 . . . . 1.95 109.49 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 2.48 111.256 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.443 ' HB2' HD21 ' A' ' 36' ' ' LEU . 61.3 m -57.96 -15.74 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.492 . . . . 3.52 109.805 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.612 ' HA ' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -160.04 33.0 0.18 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.48 -0.782 . . . . 3.29 110.792 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.629 ' HA2' ' HG3' ' A' ' 41' ' ' MET . . . -141.67 8.05 2.52 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.302 -1.119 . . . . 2.46 110.302 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.511 ' HD2' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -165.05 -40.55 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.663 -1.269 . . . . 3.8999999999999999 108.661 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.29 -18.4 79.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.498 -1.228 . . . . 3.9700000000000002 112.053 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.612 HG22 ' HA ' ' A' ' 36' ' ' LEU . 6.5 t -170.59 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.395 0.887 . . . . 4.3099999999999996 113.395 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.629 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -46.14 -40.63 11.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.816 0.341 . . . . 4.9100000000000001 111.108 178.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 5.8 tpm_? -59.73 -54.87 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 8.6999999999999993 111.127 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 HD11 ' OG1' ' A' ' 40' ' ' THR . 55.8 mt -58.76 -42.15 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 6.1399999999999997 111.111 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.46 ' ND2' HG21 ' A' ' 40' ' ' THR . 1.7 m-80 -59.88 -48.11 83.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.597 -0.274 . . . . 7.25 111.212 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -51.64 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 10.48 111.113 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.37 -34.45 75.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.107 -0.701 . . . . 9.1999999999999993 109.107 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.19 -41.91 85.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.185 -0.916 . . . . 9.5 109.989 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.08 -23.19 67.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.695 -0.684 . . . . 11.31 110.628 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.55 1.53 0.28 Allowed Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.632 -0.713 . . . . 12.640000000000001 113.118 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.33 -38.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 13.01 110.724 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.0 mmt -73.36 -28.24 61.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.969 -0.56 . . . . 11.789999999999999 110.828 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.23 25.46 27.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.822 -0.704 . . . . 12.99 112.545 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.61 10.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 15.68 112.211 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.03 -39.59 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.005 -0.617 . . . . 15.949999999999999 112.334 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.456 ' C ' ' H ' ' A' ' 57' ' ' ARG . 58.4 m -72.09 -8.82 56.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.74 0.305 . . . . 14.92 110.988 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.74 21.07 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 16.219999999999999 110.589 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' H ' ' C ' ' A' ' 55' ' ' SER . 12.7 ptm180 -82.03 23.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.52 . . . . 20.399999999999999 111.118 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.5 -24.88 29.49 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.751 -0.737 . . . . 17.620000000000001 112.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.333 -0.842 . . . . 17.91 111.068 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 26.5 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.649 0.261 . . . . 7.6500000000000004 110.942 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -60.71 -33.99 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.064 0.459 . . . . 4.8799999999999999 111.019 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.6 30.0 5.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.584 -0.735 . . . . 3.5499999999999998 112.614 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.403 ' HA3' ' HG1' ' A' ' 8' ' ' THR . . . 54.4 38.9 63.62 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 109.91 -1.276 . . . . 1.76 109.91 -178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' A' ' 1' ' ' MET . . . 78.92 24.96 60.89 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 108.143 -1.983 . . . . 2.1400000000000001 108.143 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 78.12 -6.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 113.613 -1.293 . . . . 1.8500000000000001 109.717 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.9 t80 -63.42 -44.85 93.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.331 -1.304 . . . . 2.0099999999999998 110.789 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 16.7 m -60.98 -30.78 70.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.891 -0.411 . . . . 1.1100000000000001 109.891 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -46.82 72.84 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.527 -0.916 . . . . 2.1800000000000002 108.527 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 50.6 mt -55.28 -30.27 24.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.069 -1.423 . . . . 1.1200000000000001 108.087 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' THR . 30.0 mt -79.07 -42.15 27.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.586 -1.643 . . . . 2.0600000000000001 110.764 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -49.04 65.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 1.01 110.239 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.575 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -59.72 -59.27 5.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.66 -1.155 . . . . 0.94999999999999996 110.018 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.37 87.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.006 0.431 . . . . 1.04 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -51.7 -52.03 35.95 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.828 -1.177 . . . . 0.20000000000000001 110.391 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.7 ttt180 -71.83 -34.36 69.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 124.136 0.551 . . . . 5.1200000000000001 111.453 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.575 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.7 mt -63.86 -62.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.113 -1.439 . . . . 1.04 107.113 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.507 ' O ' HG22 ' A' ' 22' ' ' VAL . 70.3 t80 -51.68 -42.06 61.87 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.322 -2.217 . . . . 0.35999999999999999 110.141 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.658 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -62.78 -56.38 18.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.819 -0.628 . . . . 2.2999999999999998 111.173 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 16' ' ' ARG . 18.6 m -60.59 -27.16 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.978 -1.119 . . . . 1.04 107.978 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 5.7 mmt -73.29 -31.65 64.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.334 -1.303 . . . . 2.2599999999999998 108.553 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 18' ' ' PHE . 4.7 t -75.31 -42.08 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.613 -1.176 . . . . 1.0700000000000001 111.075 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.5 mm-40 -58.92 -46.7 87.28 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.485 -0.561 . . . . 2.6400000000000001 109.485 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -59.58 -34.7 82.74 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.097 -1.201 . . . . 0.42999999999999999 110.097 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.537 ' O ' HG11 ' A' ' 29' ' ' VAL . 79.9 t60 -63.15 -41.91 99.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.385 -0.969 . . . . 0.87 108.385 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.534 ' HA ' HG23 ' A' ' 29' ' ' VAL . 23.2 m95 -73.82 -15.75 61.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.578 -1.192 . . . . 1.8500000000000001 110.828 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 7.9 mm-40 -72.79 -44.63 61.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.382 0.611 . . . . 0.85999999999999999 109.637 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.512 ' O ' ' HG3' ' A' ' 31' ' ' MET . 0.5 OUTLIER -78.2 -19.94 52.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.047 -0.979 . . . . 1.97 111.211 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.645 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 27.0 m -56.32 -32.98 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 119.365 -0.934 . . . . 1.45 109.895 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.73 -9.96 0.07 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.877 -1.154 . . . . 1.52 111.597 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.618 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.44 -57.99 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.266 0.226 . . . . 3.4700000000000002 111.459 179.019 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.645 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.1 pp -64.84 -32.19 73.77 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.719 . . . . 2.0299999999999998 109.803 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -72.6 -48.32 40.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.63 -1.168 . . . . 1.95 109.152 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.55 -43.04 75.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.9 -1.045 . . . . 2.48 111.771 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.462 ' HB3' HD23 ' A' ' 36' ' ' LEU . 48.3 t -54.0 -21.72 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 3.52 110.908 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -155.95 44.27 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 3.29 110.672 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -132.52 -30.07 0.51 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 109.142 -1.583 . . . . 2.46 109.142 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 41' ' ' MET . 5.1 tptp -75.19 -50.57 15.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 113.647 -1.277 . . . . 3.8999999999999999 107.847 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.67 -38.27 32.5 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.118 -1.401 . . . . 3.9700000000000002 110.214 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.539 HG23 ' HA2' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -69.88 -12.49 61.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.473 . . . . 4.3099999999999996 111.956 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.408 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -39.52 -46.37 1.72 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.78 0.324 . . . . 4.9100000000000001 111.542 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -67.71 -41.2 83.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.285 0.565 . . . . 8.6999999999999993 109.982 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 40' ' ' THR . 61.0 mt -63.23 -33.1 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.2 -0.909 . . . . 6.1399999999999997 111.878 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.403 ' O ' ' HB1' ' A' ' 47' ' ' ALA . 1.0 OUTLIER -59.6 -59.89 4.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 111.919 0.341 . . . . 7.25 111.919 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -55.06 -47.05 75.36 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.545 0.212 . . . . 10.48 111.298 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.65 -34.06 77.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.115 -0.698 . . . . 9.1999999999999993 109.115 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 44' ' ' ASN . . . -67.21 -48.26 68.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.176 -0.92 . . . . 9.5 110.102 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.409 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -61.69 -18.09 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.856 . . . . 11.31 111.286 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.28 -9.14 1.36 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.833 -0.698 . . . . 12.640000000000001 112.679 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 48' ' ' TYR . 44.2 t -166.55 -31.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.709 0.29 . . . . 13.01 111.101 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.1 mmm -71.85 -31.03 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 11.789999999999999 111.078 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.27 52.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.887 -0.673 . . . . 12.99 112.535 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.89 16.79 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 15.68 112.603 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 56' ' ' LEU . . . -149.62 -41.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.693 -0.765 . . . . 15.949999999999999 112.599 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.433 ' C ' HD11 ' A' ' 56' ' ' LEU . 49.9 m -75.22 24.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 14.92 111.218 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.531 HD11 ' N ' ' A' ' 56' ' ' LEU . 3.8 mp 61.26 29.05 18.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.882 -0.599 . . . . 16.219999999999999 110.425 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 36.98 40.12 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.401 -0.818 . . . . 20.399999999999999 111.722 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.32 -30.6 0.96 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.883 -0.675 . . . . 17.620000000000001 112.671 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.188 -0.91 . . . . 17.91 111.048 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.749 0.309 . . . . 7.6500000000000004 110.851 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 t 58.8 17.44 5.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.082 -0.508 . . . . 4.8799999999999999 111.082 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.37 33.19 2.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.874 -0.679 . . . . 3.5499999999999998 112.306 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.44 -12.39 33.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.955 -0.641 . . . . 1.76 112.498 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.78 -61.81 6.8 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.371 -0.918 . . . . 2.1400000000000001 111.431 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.99 -44.54 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 1.8500000000000001 111.235 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 29.9 t80 -58.34 -42.27 86.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.485 -0.78 . . . . 2.0099999999999998 111.299 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -65.53 -31.63 72.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.692 -0.403 . . . . 1.1100000000000001 110.295 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.16 85.03 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.843 -1.169 . . . . 2.1800000000000002 107.843 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.2 mt -64.52 -39.64 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 114.158 -1.383 . . . . 1.1200000000000001 108.153 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.78 -38.26 83.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.895 -1.502 . . . . 2.0600000000000001 109.753 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.39 79.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.747 -1.115 . . . . 1.01 109.855 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -57.15 10.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.073 -0.967 . . . . 0.94999999999999996 110.187 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.74 78.88 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.78 0.324 . . . . 1.04 110.471 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -61.09 -40.51 98.62 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 109.941 -1.264 . . . . 0.20000000000000001 109.941 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.501 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.6 mmt180 -71.23 -34.86 71.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.2 -0.5 . . . . 5.1200000000000001 110.151 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.9 mt -66.0 -58.85 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 107.902 -1.148 . . . . 1.04 107.902 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.46 ' O ' HG21 ' A' ' 22' ' ' VAL . 26.3 t80 -55.99 -39.6 72.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.895 -1.957 . . . . 0.35999999999999999 110.043 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.2 mm-40 -61.24 -51.57 68.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.922 -0.581 . . . . 2.2999999999999998 110.709 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 16' ' ' ARG . 21.6 m -69.23 -26.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.017 -0.734 . . . . 1.04 109.017 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -72.68 -29.34 63.33 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.219 -0.9 . . . . 2.2599999999999998 108.685 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 18' ' ' PHE . 4.1 t -79.54 -45.44 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.718 -1.128 . . . . 1.0700000000000001 110.732 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 8.4 pt-20 -59.76 -40.22 87.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.188 -0.671 . . . . 2.6400000000000001 109.188 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -62.72 -35.45 91.92 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.114 -1.194 . . . . 0.42999999999999999 110.114 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -62.3 -38.34 89.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.87 108.422 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.571 ' HA ' HG23 ' A' ' 29' ' ' VAL . 36.5 m95 -76.3 -17.03 59.64 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.966 -1.015 . . . . 1.8500000000000001 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 16.2 mm-40 -73.43 -41.86 62.74 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.248 -1.019 . . . . 0.85999999999999999 108.248 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 m -68.97 -31.13 69.76 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.435 -1.711 . . . . 1.97 111.257 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.792 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 27.3 m -62.09 -36.69 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 120.347 -0.541 . . . . 1.45 111.407 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.37 -8.76 0.19 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.031 -1.08 . . . . 1.52 111.655 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.558 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -113.61 -55.67 2.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.157 0.183 . . . . 3.4700000000000002 111.34 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.792 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.4 pp -64.99 -26.52 68.33 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.48 0.657 . . . . 2.0299999999999998 109.534 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 6.1 t80 -72.93 -47.42 45.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.014 -0.994 . . . . 1.95 109.091 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.51 -40.35 91.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.584 -1.189 . . . . 2.48 110.828 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 36' ' ' LEU . 52.5 m -48.31 -31.37 5.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 3.52 110.434 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.531 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.4 OUTLIER -141.8 39.35 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.804 -0.635 . . . . 3.29 110.725 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 40' ' ' THR . . . -126.3 -31.9 0.76 Allowed Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.997 -1.241 . . . . 2.46 109.997 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' O ' ' HB2' ' A' ' 41' ' ' MET . 12.5 tptt -77.17 -49.44 15.19 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.922 -1.14 . . . . 3.8999999999999999 107.922 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.5 59.44 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 114.043 -1.435 . . . . 3.9700000000000002 110.994 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -63.65 -29.35 70.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.088 0.471 . . . . 4.3099999999999996 110.6 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtt -48.9 -32.29 8.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.45 -0.795 . . . . 4.9100000000000001 110.434 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -64.37 -41.26 96.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.389 -0.597 . . . . 8.6999999999999993 109.389 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.466 HD11 ' HA ' ' A' ' 40' ' ' THR . 20.8 mt -65.14 -49.57 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.155 -0.93 . . . . 6.1399999999999997 110.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -60.02 -43.72 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 7.25 111.299 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -49.3 73.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 10.48 110.903 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.64 -36.8 83.98 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.695 . . . . 9.1999999999999993 109.125 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.65 90.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 9.5 110.035 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -67.24 -18.94 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 11.31 110.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.72 1.72 0.47 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.878 -0.601 . . . . 12.640000000000001 113.265 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 48' ' ' TYR . 48.1 t -166.13 -34.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.346 . . . . 13.01 110.752 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -73.73 -22.3 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 11.789999999999999 111.084 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.41 17.69 5.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 12.99 112.562 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -139.09 -22.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.694 -0.765 . . . . 15.68 112.459 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.07 -19.89 3.17 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.777 -0.725 . . . . 15.949999999999999 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 57' ' ' ARG . 34.8 m -72.91 -44.87 60.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.764 0.316 . . . . 14.92 111.435 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.32 17.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.438 . . . . 16.219999999999999 111.145 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.53 ' H ' ' C ' ' A' ' 55' ' ' SER . 74.0 mtp180 -86.38 31.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 20.399999999999999 110.773 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.35 -35.19 1.48 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.758 -0.734 . . . . 17.620000000000001 112.577 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.218 -0.896 . . . . 17.91 110.896 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.761 0.315 . . . . 7.6500000000000004 110.981 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -146.42 16.76 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 4.8799999999999999 110.911 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.84 -65.47 0.59 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 3.5499999999999998 112.554 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.57 -4.58 46.17 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.806 -0.711 . . . . 1.76 112.853 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.54 -62.25 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.407 -0.901 . . . . 2.1400000000000001 111.643 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.67 -43.65 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.019 0.438 . . . . 1.8500000000000001 111.297 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.483 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.6 t80 -57.3 -43.16 82.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.519 -0.764 . . . . 2.0099999999999998 111.072 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.2 m -65.83 -31.08 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.68 -0.408 . . . . 1.1100000000000001 109.914 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.15 83.97 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.965 -1.124 . . . . 2.1800000000000002 107.965 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.483 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 72.7 mt -63.59 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.313 -1.312 . . . . 1.1200000000000001 108.08 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 38.4 mt -67.44 -38.21 84.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.896 -1.502 . . . . 2.0600000000000001 109.751 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.46 -46.06 77.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.77 -1.105 . . . . 1.01 110.034 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.491 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.87 -55.63 21.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.109 -0.95 . . . . 0.94999999999999996 110.11 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.6 77.28 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.793 0.33 . . . . 1.04 110.389 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.12 -41.6 94.73 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.954 -1.259 . . . . 0.20000000000000001 109.954 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' O ' HG11 ' A' ' 20' ' ' VAL . 1.9 mmt180 -70.8 -33.54 70.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.103 -0.549 . . . . 5.1200000000000001 110.279 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.25 -62.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.636 -1.246 . . . . 1.04 107.636 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.499 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 t80 -51.68 -41.23 61.27 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 112.688 -2.051 . . . . 0.35999999999999999 110.218 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.8 mt-10 -61.85 -55.63 27.87 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 111.17 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 16' ' ' ARG . 26.7 m -63.59 -26.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.371 -0.974 . . . . 1.04 108.371 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -72.07 -31.45 66.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.492 -1.231 . . . . 2.2599999999999998 108.441 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 18' ' ' PHE . 7.0 t -75.42 -45.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.534 -1.212 . . . . 1.0700000000000001 110.717 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 8.1 mm-40 -59.62 -45.76 90.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.12 -0.696 . . . . 2.6400000000000001 109.12 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.11 85.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.497 ' O ' HG13 ' A' ' 29' ' ' VAL . 81.8 t60 -63.67 -39.02 93.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.55 -0.907 . . . . 0.87 108.55 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.559 ' HA ' HG21 ' A' ' 29' ' ' VAL . 28.2 m95 -76.22 -16.48 59.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.853 -1.067 . . . . 1.8500000000000001 110.503 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -73.86 -41.67 61.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.337 -0.616 . . . . 0.85999999999999999 109.337 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -75.63 -22.71 56.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.078 -0.965 . . . . 1.97 111.032 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.637 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 34.5 m -60.85 -33.99 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 C-N-CA 119.871 -0.732 . . . . 1.45 110.248 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -48.56 -10.58 0.12 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.781 -1.2 . . . . 1.52 110.806 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.574 ' H ' ' C ' ' A' ' 29' ' ' VAL . 19.4 mmt -101.19 -68.18 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.374 0.67 . . . . 3.4700000000000002 110.446 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.637 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -59.64 -41.35 90.3 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.859 -0.61 . . . . 2.0299999999999998 110.675 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.464 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.1 t80 -64.68 -37.11 86.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 1.95 109.504 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -59.81 -34.12 72.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.475 -0.784 . . . . 2.48 110.696 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.5 m -59.71 -27.85 66.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.953 -0.567 . . . . 3.52 110.154 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.9 OUTLIER -138.41 35.53 2.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 3.29 110.936 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -128.15 -37.79 0.41 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 109.742 -1.343 . . . . 2.46 109.742 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -77.96 -51.79 9.84 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.005 -1.109 . . . . 3.8999999999999999 108.005 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.98 -30.32 61.46 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.103 -1.408 . . . . 3.9700000000000002 111.272 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -64.3 -33.26 75.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.682 -0.407 . . . . 4.3099999999999996 110.82 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 32.7 mtp -46.65 -37.58 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.708 -0.678 . . . . 4.9100000000000001 110.619 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -71.57 -36.9 71.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.883 -0.599 . . . . 8.6999999999999993 110.0 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 40' ' ' THR . 22.5 mt -65.4 -50.48 72.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 6.1399999999999997 110.201 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -60.14 -48.94 79.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 7.25 111.538 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -60.66 -51.61 68.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.595 -0.275 . . . . 10.48 111.19 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.24 -34.5 76.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.19 -0.67 . . . . 9.1999999999999993 109.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 -40.62 88.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.387 -0.824 . . . . 9.5 109.885 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.36 -24.06 67.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.382 -0.826 . . . . 11.31 110.499 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.61 2.99 0.27 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.617 -0.719 . . . . 12.640000000000001 113.33 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 48' ' ' TYR . 70.8 m -163.5 -39.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 13.01 110.542 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.3 mtt -72.92 -28.95 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 11.789999999999999 110.523 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.66 -14.89 33.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.906 -0.664 . . . . 12.99 111.904 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.04 -32.01 76.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.851 -0.69 . . . . 15.68 112.091 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.82 43.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.158 -0.544 . . . . 15.949999999999999 111.838 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 99.1 p 46.81 49.48 14.24 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.809 0.814 . . . . 14.92 111.389 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 55' ' ' SER . 0.3 OUTLIER 37.34 29.43 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.569 -1.65 . . . . 16.219999999999999 112.446 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HG2' ' HG ' ' A' ' 55' ' ' SER . 14.5 mmm180 -82.72 62.16 6.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.962 0.41 . . . . 20.399999999999999 110.886 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.48 -32.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 17.620000000000001 112.378 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 17.91 110.974 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.899 0.381 . . . . 7.6500000000000004 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.3 p -132.31 118.69 19.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 4.8799999999999999 110.568 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 106.44 -79.16 0.26 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 3.5499999999999998 112.155 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.05 87.93 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.766 -0.73 . . . . 1.76 112.341 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.52 24.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.331 -0.938 . . . . 2.1400000000000001 111.392 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.0 -45.17 95.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.986 0.422 . . . . 1.8500000000000001 111.21 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.579 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.8 t80 -57.31 -42.42 81.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.589 -0.732 . . . . 2.0099999999999998 110.582 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 m -67.43 -32.67 73.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.72 -0.392 . . . . 1.1100000000000001 110.066 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -35.12 79.9 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.711 -1.218 . . . . 2.1800000000000002 107.711 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 68.4 mt -65.27 -41.59 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.011 -1.45 . . . . 1.1200000000000001 107.854 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.35 -37.87 88.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.095 -1.412 . . . . 2.0600000000000001 109.252 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.89 81.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.734 -1.121 . . . . 1.01 109.383 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.476 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.66 -58.07 8.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.95 -1.023 . . . . 0.94999999999999996 110.037 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.79 76.87 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.002 0.43 . . . . 1.04 109.885 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.669 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.39 -41.62 63.38 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.67 -1.372 . . . . 0.20000000000000001 109.67 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.508 ' O ' HG11 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -72.66 -37.89 67.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.053 -0.574 . . . . 5.1200000000000001 110.86 178.357 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.09 -63.08 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 122.623 1.201 . . . . 1.04 108.08 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.489 ' O ' HG21 ' A' ' 22' ' ' VAL . 53.6 t80 -50.62 -39.8 51.17 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 112.654 -2.066 . . . . 0.35999999999999999 110.394 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -61.84 -53.78 51.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.916 0.388 . . . . 2.2999999999999998 110.885 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.508 HG11 ' O ' ' A' ' 16' ' ' ARG . 13.2 m -64.92 -26.11 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.011 -1.107 . . . . 1.04 108.011 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.452 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 5.4 mmt -74.96 -26.98 59.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.434 -1.257 . . . . 2.2599999999999998 108.549 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 18' ' ' PHE . 2.6 t -78.02 -36.39 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.482 -1.235 . . . . 1.0700000000000001 111.35 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 5.8 pt-20 -58.76 -44.6 90.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.801 -0.444 . . . . 2.6400000000000001 109.801 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -64.0 -33.05 86.21 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.562 ' O ' HG12 ' A' ' 29' ' ' VAL . 79.1 t60 -62.23 -37.09 84.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.356 -0.979 . . . . 0.87 108.356 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.528 ' HA ' HG22 ' A' ' 29' ' ' VAL . 19.0 m95 -74.22 -16.4 60.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.952 -1.022 . . . . 1.8500000000000001 110.166 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 11.1 mm-40 -75.23 -42.78 54.61 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -78.17 -18.92 54.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.821 -1.081 . . . . 1.97 111.259 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.686 ' HA ' ' HG ' ' A' ' 32' ' ' LEU . 31.0 m -57.61 -33.36 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 119.811 -0.756 . . . . 1.45 110.193 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.05 -11.99 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.738 -1.22 . . . . 1.52 111.502 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.55 ' H ' ' C ' ' A' ' 29' ' ' VAL . 13.9 mmt -103.89 -65.08 1.04 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.981 0.512 . . . . 3.4700000000000002 110.898 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.686 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -60.0 -34.39 73.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.241 -0.436 . . . . 2.0299999999999998 110.727 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.12 -34.81 78.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 1.95 109.379 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 31' ' ' MET . 3.2 t70 -59.55 -34.04 72.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.379 -0.828 . . . . 2.48 110.453 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -74.13 -5.47 41.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.404 0.621 . . . . 3.52 109.476 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 2.3 mt -126.28 6.11 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.026 -0.988 . . . . 3.29 110.059 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.25 -56.33 0.62 Allowed Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 106.868 -2.493 . . . . 2.46 106.868 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -62.23 -32.53 73.21 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.19 -1.505 . . . . 3.8999999999999999 107.001 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.54 46.88 23.55 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 107.662 -2.175 . . . . 3.9700000000000002 107.662 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.477 HG21 ' ND2' ' A' ' 44' ' ' ASN . 1.9 t 39.14 35.24 0.13 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.654 -1.773 . . . . 4.3099999999999996 109.143 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mtt -46.73 -27.12 1.09 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 115.035 -0.984 . . . . 4.9100000000000001 111.081 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -65.66 -65.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 8.6999999999999993 110.046 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.422 ' HB ' ' OG1' ' A' ' 40' ' ' THR . 54.1 mt -53.97 -40.0 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.061 -0.518 . . . . 6.1399999999999997 110.462 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.477 ' ND2' HG21 ' A' ' 40' ' ' THR . 6.4 m-80 -59.12 -41.32 87.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 7.25 110.569 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.57 -51.97 65.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.241 -0.436 . . . . 10.48 110.767 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -60.85 -36.39 79.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.211 -0.663 . . . . 9.1999999999999993 109.211 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.88 87.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 9.5 109.967 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -63.23 -22.82 67.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.455 -0.793 . . . . 11.31 110.558 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.44 -7.79 0.26 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.404 -0.816 . . . . 12.640000000000001 113.156 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' TYR . 42.2 t -163.4 -35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.894 0.378 . . . . 13.01 110.94 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.66 -30.68 64.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 11.789999999999999 110.635 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.73 6.31 47.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.89 -0.671 . . . . 12.99 111.997 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.6 -57.72 0.65 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.445 -0.662 . . . . 15.68 111.445 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 56' ' ' LEU . . . -72.69 0.68 42.16 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.692 -0.766 . . . . 15.949999999999999 111.242 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m 55.36 11.9 0.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.1 -0.704 . . . . 14.92 109.1 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.488 ' H ' ' C ' ' A' ' 54' ' ' GLY . 84.0 mt -79.3 2.36 21.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.877 -1.056 . . . . 16.219999999999999 108.969 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -61.03 -3.38 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.643 -1.162 . . . . 20.399999999999999 111.022 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . -119.86 -17.9 4.48 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.884 -0.674 . . . . 17.620000000000001 112.588 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.197 -0.906 . . . . 17.91 110.947 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 7' ' ' PHE . 6.8 p . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.152 0.501 . . . . 1.25 111.309 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 28.5 t80 -56.79 -43.74 81.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.334 -0.848 . . . . 1.6100000000000001 111.344 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 11' ' ' LEU . 58.3 m -65.66 -31.57 72.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.62 -0.432 . . . . 0.38 110.205 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -37.53 83.33 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.986 -1.116 . . . . 2.1800000000000002 107.986 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 73.4 mt -64.19 -40.06 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 114.272 -1.331 . . . . 0.33000000000000002 108.033 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' THR . 39.2 mt -66.87 -38.79 86.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.918 -1.492 . . . . 1.3999999999999999 109.512 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.4 85.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.767 -1.106 . . . . 0.17000000000000001 109.597 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -65.41 -58.22 6.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.048 -0.978 . . . . 0.23999999999999999 110.061 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.63 78.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 123.269 0.355 . . . . 0.20999999999999999 110.571 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -57.62 -43.24 94.39 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.034 -1.226 . . . . 0.17000000000000001 110.034 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.1 mmt180 -70.29 -33.09 71.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.242 -0.479 . . . . 4.5300000000000002 110.412 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.7 mt -65.93 -61.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.373 -1.343 . . . . 0.28000000000000003 107.373 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 48.3 t80 -53.31 -39.36 63.96 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.476 -2.147 . . . . 0.29999999999999999 110.281 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.3 mt-10 -62.51 -54.46 39.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 110.89 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 17' ' ' ILE . 22.2 m -63.81 -26.18 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.323 -0.992 . . . . 0.16 108.323 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -73.02 -30.58 63.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.444 -1.253 . . . . 1.6599999999999999 108.755 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -75.65 -40.62 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.626 -1.17 . . . . 0.22 111.003 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 9.7 mm-40 -57.16 -41.86 79.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.631 -0.507 . . . . 2.6400000000000001 109.631 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -67.73 -28.99 73.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.817 -0.913 . . . . 0.42999999999999999 110.817 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.0 t60 -60.36 -47.95 83.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.226 -0.657 . . . . 0.73999999999999999 109.226 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.952 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.5 m95 -77.45 -6.6 54.06 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.32 -0.855 . . . . 1.5600000000000001 111.47 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 6.6 mm-40 -69.68 -40.38 76.4 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.592 -0.843 . . . . 0.85999999999999999 108.939 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.0 -22.2 45.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.249 -0.887 . . . . 1.49 110.703 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 26' ' ' TRP . 21.4 m -60.99 -32.65 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 C-N-CA 120.338 -0.545 . . . . 1.1899999999999999 111.424 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -51.44 -6.89 0.2 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 119.67 -1.252 . . . . 1.52 110.707 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.573 ' H ' ' C ' ' A' ' 29' ' ' VAL . 14.7 mmt -104.89 -68.13 0.87 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 3.02 110.411 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -60.6 -40.55 92.22 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.819 -0.628 . . . . 1.9199999999999999 110.586 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -65.9 -39.23 90.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.522 -0.763 . . . . 1.79 109.538 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -61.72 -34.73 76.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.345 -0.843 . . . . 2.48 110.997 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 36' ' ' LEU . 58.9 m -58.85 -24.19 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 3.1699999999999999 110.952 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -148.15 34.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.047 0.451 . . . . 2.7999999999999998 111.849 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.503 -0.692 0 N-CA-C 109.405 -1.478 . . . . 2.46 109.405 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.9 mt . . . . . 0 CA--C 1.518 -0.288 0 CA-C-O 121.028 0.442 . . . . 6.1399999999999997 110.074 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 42.4 m-80 -61.63 -51.09 69.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.277 -0.874 . . . . 7.25 111.198 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' GLY . 8.1 mmm180 -53.38 -47.56 69.38 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.35 -0.386 . . . . 9.8200000000000003 110.163 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -67.02 -40.96 87.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.41 -0.959 . . . . 9.1999999999999993 108.41 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -68.94 -2.81 10.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.129 -0.941 . . . . 9.5 110.084 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -122.91 -12.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 11.26 112.004 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . -59.17 -13.57 21.4 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.899 -0.667 . . . . 12.640000000000001 112.579 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -166.7 -31.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.241 0.543 . . . . 12.960000000000001 110.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 24.1 mmt -71.08 -28.59 64.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 11.789999999999999 111.157 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 12.99 112.703 -179.575 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 121.114 0.483 . . . . 1.25 110.01 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -61.64 -28.78 69.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 1.6100000000000001 109.949 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 90.0 m -70.2 -37.06 74.99 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.38 110.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -44.16 92.33 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 108.127 -1.064 . . . . 2.1800000000000002 108.127 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -57.06 -32.21 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 113.669 -1.605 . . . . 0.33000000000000002 108.009 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' THR . 20.2 mt -76.66 -38.75 54.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.681 -1.6 . . . . 1.3999999999999999 110.279 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.19 -51.65 50.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.644 -1.162 . . . . 0.17000000000000001 110.503 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.96 -53.59 55.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.075 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.47 79.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.721 0.296 . . . . 0.20999999999999999 110.956 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -56.52 -41.45 88.79 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.892 -1.283 . . . . 0.17000000000000001 109.892 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.5 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.6 mmt180 -71.35 -35.12 71.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.821 -0.689 . . . . 4.5300000000000002 110.548 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.3 mt -66.81 -61.16 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 107.88 -1.155 . . . . 0.28000000000000003 107.88 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.5 t80 -52.48 -41.25 63.2 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.78 -2.009 . . . . 0.29999999999999999 110.41 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.4 mm-40 -60.24 -53.55 56.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.924 -0.58 . . . . 2.2999999999999998 110.969 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 17.2 m -68.31 -25.34 31.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 21.6 mmm -73.71 -28.22 61.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.842 -1.072 . . . . 1.6599999999999999 108.791 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -78.83 -42.55 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.79 -1.095 . . . . 0.22 111.357 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 7.4 pt-20 -57.09 -39.65 75.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.915 0.388 . . . . 2.6400000000000001 110.014 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -70.99 -28.44 70.49 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.094 -0.802 . . . . 0.42999999999999999 111.094 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.499 ' O ' HG13 ' A' ' 29' ' ' VAL . 77.9 t60 -58.77 -45.35 89.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.356 -0.609 . . . . 0.73999999999999999 109.356 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.924 ' O ' HG22 ' A' ' 29' ' ' VAL . 81.4 m95 -78.67 -6.35 55.48 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.587 -0.733 . . . . 1.5600000000000001 111.443 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 28.8 mm-40 -71.64 -40.75 69.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.616 -0.834 . . . . 0.85999999999999999 108.871 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 32' ' ' LEU . 1.2 t -80.14 -20.72 44.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.295 -0.866 . . . . 1.49 110.657 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' O ' ' A' ' 26' ' ' TRP . 32.7 m -59.43 -33.66 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 120.184 -0.606 . . . . 1.1899999999999999 111.072 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -50.52 -9.8 0.3 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.324 -1.417 . . . . 1.52 110.719 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' VAL . 91.1 mmm -102.27 -69.65 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.454 0.702 . . . . 3.02 110.255 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 2.3 pp -60.17 -43.03 96.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.394 -0.821 . . . . 1.9199999999999999 110.73 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 33.9 t80 -66.27 -32.7 74.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.211 -0.904 . . . . 1.79 109.796 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -59.67 -33.62 71.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.796 -0.638 . . . . 2.48 110.608 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 m -56.1 -17.65 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.451 -0.574 . . . . 3.1699999999999999 109.451 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.74 29.24 0.84 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.181 -0.918 . . . . 2.7999999999999998 110.243 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.526 0 N-CA-C 110.164 -1.174 . . . . 2.46 110.164 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.767 0.318 . . . . 6.1399999999999997 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -64.02 -44.6 92.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 7.25 110.876 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.58 HH21 ' HB3' ' A' ' 48' ' ' TYR . 4.6 tpm_? -60.57 -53.57 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 9.8200000000000003 110.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.15 -36.38 77.42 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.183 -0.673 . . . . 9.1999999999999993 109.183 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.8 92.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 9.5 109.731 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.58 ' HB3' HH21 ' A' ' 45' ' ' ARG . 0.3 OUTLIER -66.05 -21.09 66.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.345 -0.843 . . . . 11.26 110.62 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.28 -2.75 0.27 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.657 -0.701 . . . . 12.640000000000001 113.21 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 48' ' ' TYR . 33.3 t -165.23 -36.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.757 0.313 . . . . 12.960000000000001 110.824 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.2 mmm -71.78 -32.85 68.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 11.789999999999999 110.355 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.657 . . . . 12.99 112.224 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 1.4 p . . . . . 0 N--CA 1.446 -0.626 0 CA-C-O 120.986 0.422 . . . . 1.25 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 10' ' ' ILE . 28.1 t80 -61.89 -30.03 70.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.527 -0.546 . . . . 1.6100000000000001 109.527 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 28.8 m -72.7 -36.17 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.38 110.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -63.92 -43.52 95.67 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.171 -1.048 . . . . 2.1800000000000002 108.171 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' PHE . 66.6 mt -57.0 -32.29 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 113.544 -1.662 . . . . 0.33000000000000002 107.947 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 8' ' ' THR . 27.2 mt -77.72 -37.68 48.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.5 -1.682 . . . . 1.3999999999999999 110.236 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 -50.1 63.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.725 -1.125 . . . . 0.17000000000000001 110.274 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -61.45 -55.25 33.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.047 -0.979 . . . . 0.23999999999999999 110.133 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.89 -44.93 82.79 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 120.729 0.299 . . . . 0.20999999999999999 110.635 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.54 -42.08 95.81 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.059 -1.217 . . . . 0.17000000000000001 110.059 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.2 mmt180 -71.08 -34.53 71.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -0.632 . . . . 4.5300000000000002 110.423 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.1 mt -66.29 -61.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.794 -1.188 . . . . 0.28000000000000003 107.794 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.7 t80 -53.37 -40.66 65.15 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.503 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.2 mt-10 -61.51 -54.56 41.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.862 -0.608 . . . . 2.2999999999999998 111.207 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 17' ' ' ILE . 23.0 m -65.07 -26.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.484 -0.932 . . . . 0.16 108.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.68 -31.48 66.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.504 -1.225 . . . . 1.6599999999999999 108.713 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 5.1 t -76.89 -48.0 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.494 -1.23 . . . . 0.22 110.823 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 13.5 mm-40 -57.33 -45.01 84.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.25 -0.648 . . . . 2.6400000000000001 109.25 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.21 -29.38 75.18 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.147 -0.933 . . . . 0.42999999999999999 110.912 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 29' ' ' VAL . 56.9 t60 -59.62 -47.05 87.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.346 -0.613 . . . . 0.73999999999999999 109.346 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.949 ' O ' HG22 ' A' ' 29' ' ' VAL . 75.0 m95 -78.16 -15.46 58.82 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 111.486 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.3 mm-40 -63.04 -36.58 84.05 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.831 -1.174 . . . . 0.85999999999999999 107.831 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.7 m -75.03 -30.64 61.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.434 -1.712 . . . . 1.49 110.89 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.4 m -65.05 -37.35 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 112.864 0.69 . . . . 1.1899999999999999 112.864 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -11.17 0.27 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 119.315 -1.422 . . . . 1.52 110.82 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.529 ' N ' ' C ' ' A' ' 29' ' ' VAL . 9.3 mmt -105.5 -68.09 0.88 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.998 0.519 . . . . 3.02 110.891 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.2 pp -59.56 -34.1 72.26 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.119 -0.491 . . . . 1.9199999999999999 110.812 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 1.7 t80 -70.24 -39.45 75.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.622 -0.717 . . . . 1.79 109.717 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.31 -37.91 73.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.039 -0.982 . . . . 2.48 111.543 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -59.27 -30.23 68.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 110.978 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.7 32.12 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 2.7999999999999998 111.015 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 C--O 1.215 -1.086 0 N-CA-C 109.623 -1.391 . . . . 2.46 109.623 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mt . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 120.785 0.326 . . . . 6.1399999999999997 110.215 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -59.04 -39.58 82.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 7.25 110.236 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -62.78 -51.45 67.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.12 -0.491 . . . . 9.8200000000000003 110.532 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -60.49 -37.57 81.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.181 -0.674 . . . . 9.1999999999999993 109.181 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.07 92.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.926 -1.034 . . . . 9.5 110.026 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -65.62 -24.48 67.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.452 -0.795 . . . . 11.26 110.633 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.21 2.73 0.15 Allowed Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.499 -0.773 . . . . 12.640000000000001 113.536 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' TYR . 69.8 m -163.06 -38.16 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.965 0.383 . . . . 12.960000000000001 110.538 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.69 -24.92 60.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 11.789999999999999 110.817 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.846 -0.693 . . . . 12.99 112.404 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 109.23 -0.656 . . . . 1.25 109.23 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 33.0 t80 -61.58 -39.64 91.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.515 -0.766 . . . . 1.6100000000000001 110.582 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.709 ' HA ' HD23 ' A' ' 11' ' ' LEU . 94.2 m -67.63 -29.87 69.29 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.155 0.503 . . . . 0.38 109.932 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.48 -41.27 84.83 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.291 -1.374 . . . . 2.1800000000000002 107.291 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.7 mt -66.11 -36.02 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 113.729 -1.578 . . . . 0.33000000000000002 109.085 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.746 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -70.54 -41.29 72.69 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.395 -1.275 . . . . 1.3999999999999999 108.836 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -55.38 30.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.646 -1.616 . . . . 0.17000000000000001 110.01 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.21 -51.77 66.44 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.28 -0.873 . . . . 0.23999999999999999 110.558 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.76 74.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.424 -0.511 . . . . 0.20999999999999999 110.09 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -60.55 -51.37 59.12 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.722 -0.752 . . . . 0.17000000000000001 111.278 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -71.68 -28.7 63.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.679 0.276 . . . . 4.5300000000000002 110.795 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.6 mt -66.54 -59.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 106.71 -1.589 . . . . 0.28000000000000003 106.71 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CE1' HG21 ' A' ' 22' ' ' VAL . 33.8 t80 -55.18 -38.66 68.63 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.616 -2.084 . . . . 0.29999999999999999 109.587 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.4 mt-10 -60.74 -51.1 70.78 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.597 -0.728 . . . . 2.2999999999999998 110.953 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 17' ' ' ILE . 18.8 m -68.5 -28.53 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.952 -0.759 . . . . 0.16 108.952 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -72.04 -27.66 62.86 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.977 -1.011 . . . . 1.6599999999999999 108.813 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 18' ' ' PHE . 3.4 t -83.31 -43.25 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.532 -1.213 . . . . 0.22 111.785 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.1 -40.83 82.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.893 0.377 . . . . 2.6400000000000001 110.022 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.51 -35.31 91.79 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.088 -1.205 . . . . 0.42999999999999999 110.088 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.611 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.0 t60 -62.43 -41.86 99.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.501 -0.925 . . . . 0.73999999999999999 108.501 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 22.9 m95 -74.31 -15.06 60.97 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.715 -1.13 . . . . 1.5600000000000001 110.929 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -42.61 58.71 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.85999999999999999 109.861 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.39 -22.17 55.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.241 -0.89 . . . . 1.49 111.207 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 26' ' ' TRP . 33.3 m -61.07 -36.07 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 119.97 -0.692 . . . . 1.1899999999999999 110.684 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.52 -11.0 0.13 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 119.832 -1.175 . . . . 1.52 111.036 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' VAL . 17.3 mmt -102.02 -67.62 0.86 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.337 0.655 . . . . 3.02 110.743 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.669 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -59.2 -38.41 79.82 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.816 -0.629 . . . . 1.9199999999999999 110.801 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.9 t80 -65.93 -39.33 90.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.638 -0.71 . . . . 1.79 109.708 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -38.58 82.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.355 -0.839 . . . . 2.48 111.301 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' HD23 ' A' ' 36' ' ' LEU . 47.9 t -53.94 -28.78 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 3.1699999999999999 110.38 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -141.35 38.09 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 2.7999999999999998 110.71 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 109.779 -1.328 . . . . 2.46 109.779 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mt . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.908 0.385 . . . . 6.1399999999999997 110.231 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.99 -40.93 95.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.676 -0.693 . . . . 7.25 110.737 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.03 -53.02 60.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 9.8200000000000003 110.799 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -60.4 -36.69 78.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.243 -0.651 . . . . 9.1999999999999993 109.243 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.35 87.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.031 -0.986 . . . . 9.5 110.073 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -63.89 -20.49 65.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.542 -0.754 . . . . 11.26 110.807 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.11 -5.45 0.45 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.688 -0.687 . . . . 12.640000000000001 113.168 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.36 -34.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 12.960000000000001 110.66 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.1 mmm -73.39 -24.75 60.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 11.789999999999999 110.955 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 12.99 112.56 -179.842 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.1 t . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.757 -0.46 . . . . 1.25 109.757 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -63.17 -34.88 78.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.896 0.379 . . . . 1.6100000000000001 110.035 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 -36.03 75.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.1 -0.5 . . . . 0.38 110.806 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -34.88 79.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.037 -1.098 . . . . 2.1800000000000002 108.037 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 7' ' ' PHE . 71.6 mt -64.48 -42.68 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.043 -1.435 . . . . 0.33000000000000002 108.074 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -66.65 -37.53 85.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.011 -1.449 . . . . 1.3999999999999999 109.612 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.93 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.739 -1.119 . . . . 0.17000000000000001 109.69 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.31 -58.79 5.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.861 -1.063 . . . . 0.23999999999999999 109.999 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 -42.94 76.9 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.916 0.389 . . . . 0.20999999999999999 110.582 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.28 -55.31 25.09 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.711 -0.956 . . . . 0.17000000000000001 110.711 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.2 mtp180 -69.33 -32.15 71.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.834 -0.683 . . . . 4.5300000000000002 111.666 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.0 mt -61.92 -60.76 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.167 -1.79 . . . . 0.28000000000000003 106.167 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.9 t80 -54.93 -40.96 70.46 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.29 -2.232 . . . . 0.29999999999999999 110.323 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -62.56 -54.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.778 -0.646 . . . . 2.2999999999999998 111.205 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 16' ' ' ARG . 17.9 m -63.86 -26.59 40.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.236 -1.024 . . . . 0.16 108.236 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -72.65 -31.04 64.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.529 -1.214 . . . . 1.6599999999999999 108.819 177.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 18' ' ' PHE . 8.6 t -78.15 -44.45 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.677 -1.147 . . . . 0.22 111.167 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 7.1 mm-40 -57.85 -42.88 85.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.519 -0.549 . . . . 2.6400000000000001 109.519 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -29.52 74.99 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.872 -0.891 . . . . 0.42999999999999999 110.872 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.431 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.7 t60 -60.25 -48.23 82.63 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.221 -0.659 . . . . 0.73999999999999999 109.221 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.939 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.9 m95 -77.98 -6.82 55.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.386 -0.825 . . . . 1.5600000000000001 111.605 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.6 mm-40 -70.09 -40.52 74.91 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.391 -0.924 . . . . 0.85999999999999999 108.996 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -78.85 -21.74 47.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.352 -0.84 . . . . 1.49 110.677 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 26' ' ' TRP . 24.4 m -60.69 -33.39 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 120.281 -0.568 . . . . 1.1899999999999999 111.099 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -52.43 -5.09 0.17 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 119.744 -1.217 . . . . 1.52 110.843 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.602 ' H ' ' C ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -107.91 -67.23 0.98 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.485 0.714 . . . . 3.02 110.265 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.5 pp -59.68 -40.8 89.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.888 -0.596 . . . . 1.9199999999999999 110.237 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -67.1 -41.93 85.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.278 -0.874 . . . . 1.79 109.49 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 2.48 111.256 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 36' ' ' LEU . 61.3 m -57.96 -15.74 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.492 . . . . 3.1699999999999999 109.805 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -160.04 33.0 0.18 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.48 -0.782 . . . . 2.7999999999999998 110.792 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.505 -0.534 0 N-CA-C 110.302 -1.119 . . . . 2.46 110.302 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.227 -0.097 0 CA-C-O 120.444 0.164 . . . . 6.1399999999999997 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 36' ' ' LEU . 1.7 m-80 -59.88 -48.11 83.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.597 -0.274 . . . . 7.25 111.212 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -51.64 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 9.8200000000000003 111.113 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.37 -34.45 75.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.107 -0.701 . . . . 9.1999999999999993 109.107 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.19 -41.91 85.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.185 -0.916 . . . . 9.5 109.989 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.08 -23.19 67.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.695 -0.684 . . . . 11.26 110.628 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.55 1.53 0.28 Allowed Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.632 -0.713 . . . . 12.640000000000001 113.118 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.33 -38.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 12.960000000000001 110.724 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.0 mmt -73.36 -28.24 61.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.969 -0.56 . . . . 11.789999999999999 110.828 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.822 -0.704 . . . . 12.99 112.545 -179.653 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.858 0.837 . . . . 1.25 109.717 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.9 t80 -63.42 -44.85 93.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.331 -1.304 . . . . 1.6100000000000001 110.789 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 16.7 m -60.98 -30.78 70.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.891 -0.411 . . . . 0.38 109.891 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -46.82 72.84 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.527 -0.916 . . . . 2.1800000000000002 108.527 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 50.6 mt -55.28 -30.27 24.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.069 -1.423 . . . . 0.33000000000000002 108.087 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' THR . 30.0 mt -79.07 -42.15 27.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.586 -1.643 . . . . 1.3999999999999999 110.764 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -49.04 65.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 0.17000000000000001 110.239 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -59.72 -59.27 5.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.66 -1.155 . . . . 0.23999999999999999 110.018 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.37 87.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.006 0.431 . . . . 0.20999999999999999 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.657 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -51.7 -52.03 35.95 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.828 -1.177 . . . . 0.17000000000000001 110.391 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.7 ttt180 -71.83 -34.36 69.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 124.136 0.551 . . . . 4.5300000000000002 111.453 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.7 mt -63.86 -62.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.113 -1.439 . . . . 0.28000000000000003 107.113 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 22' ' ' VAL . 70.3 t80 -51.68 -42.06 61.87 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.322 -2.217 . . . . 0.29999999999999999 110.141 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -62.78 -56.38 18.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.819 -0.628 . . . . 2.2999999999999998 111.173 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 16' ' ' ARG . 18.6 m -60.59 -27.16 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.978 -1.119 . . . . 0.16 107.978 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 5.7 mmt -73.29 -31.65 64.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.334 -1.303 . . . . 1.6599999999999999 108.553 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.7 t -75.31 -42.08 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.613 -1.176 . . . . 0.22 111.075 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.5 mm-40 -58.92 -46.7 87.28 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.485 -0.561 . . . . 2.6400000000000001 109.485 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -59.58 -34.7 82.74 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.097 -1.201 . . . . 0.42999999999999999 110.097 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.619 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.9 t60 -63.15 -41.91 99.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.385 -0.969 . . . . 0.73999999999999999 108.385 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.881 ' O ' HG22 ' A' ' 29' ' ' VAL . 23.2 m95 -73.82 -15.75 61.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.578 -1.192 . . . . 1.5600000000000001 110.828 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 7.9 mm-40 -72.79 -44.63 61.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.382 0.611 . . . . 0.85999999999999999 109.637 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.528 ' O ' ' HG3' ' A' ' 31' ' ' MET . 0.5 OUTLIER -78.2 -19.94 52.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.047 -0.979 . . . . 1.49 111.211 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.0 m -56.32 -32.98 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 119.365 -0.934 . . . . 1.1899999999999999 109.895 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.73 -9.96 0.07 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.877 -1.154 . . . . 1.52 111.597 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.606 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.44 -57.99 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.266 0.226 . . . . 3.02 111.459 179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.1 pp -64.84 -32.19 73.77 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.719 . . . . 1.9199999999999999 109.803 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -72.6 -48.32 40.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.63 -1.168 . . . . 1.79 109.152 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.55 -43.04 75.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.9 -1.045 . . . . 2.48 111.771 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.457 ' HB3' HD23 ' A' ' 36' ' ' LEU . 48.3 t -54.0 -21.72 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 3.1699999999999999 110.908 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -155.95 44.27 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 2.7999999999999998 110.672 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.504 -0.617 0 N-CA-C 109.142 -1.583 . . . . 2.46 109.142 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 111.878 0.325 . . . . 6.1399999999999997 111.878 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -59.89 4.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 111.919 0.341 . . . . 7.25 111.919 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 7.9 ttp180 -55.06 -47.05 75.36 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.545 0.212 . . . . 9.8200000000000003 111.298 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.65 -34.06 77.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.115 -0.698 . . . . 9.1999999999999993 109.115 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.21 -48.26 68.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.176 -0.92 . . . . 9.5 110.102 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -18.09 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.856 . . . . 11.26 111.286 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.28 -9.14 1.36 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.833 -0.698 . . . . 12.640000000000001 112.679 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 t -166.55 -31.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.709 0.29 . . . . 12.960000000000001 111.101 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.1 mmm -71.85 -31.03 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 11.789999999999999 111.078 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.887 -0.673 . . . . 12.99 112.535 -179.553 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.5 p . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.089 0.471 . . . . 1.25 111.235 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 29.9 t80 -58.34 -42.27 86.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.485 -0.78 . . . . 1.6100000000000001 111.299 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -65.53 -31.63 72.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.692 -0.403 . . . . 0.38 110.295 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.16 85.03 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.843 -1.169 . . . . 2.1800000000000002 107.843 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.2 mt -64.52 -39.64 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 114.158 -1.383 . . . . 0.33000000000000002 108.153 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.78 -38.26 83.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.895 -1.502 . . . . 1.3999999999999999 109.753 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.39 79.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.747 -1.115 . . . . 0.17000000000000001 109.855 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -57.15 10.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.073 -0.967 . . . . 0.23999999999999999 110.187 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.74 78.88 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.78 0.324 . . . . 0.20999999999999999 110.471 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -61.09 -40.51 98.62 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 109.941 -1.264 . . . . 0.17000000000000001 109.941 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.6 mmt180 -71.23 -34.86 71.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.2 -0.5 . . . . 4.5300000000000002 110.151 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.9 mt -66.0 -58.85 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 107.902 -1.148 . . . . 0.28000000000000003 107.902 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' VAL . 26.3 t80 -55.99 -39.6 72.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.895 -1.957 . . . . 0.29999999999999999 110.043 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.2 mm-40 -61.24 -51.57 68.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.922 -0.581 . . . . 2.2999999999999998 110.709 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 21.6 m -69.23 -26.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.017 -0.734 . . . . 0.16 109.017 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -72.68 -29.34 63.33 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.219 -0.9 . . . . 1.6599999999999999 108.685 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.1 t -79.54 -45.44 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.718 -1.128 . . . . 0.22 110.732 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 8.4 pt-20 -59.76 -40.22 87.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.188 -0.671 . . . . 2.6400000000000001 109.188 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -62.72 -35.45 91.92 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.114 -1.194 . . . . 0.42999999999999999 110.114 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.64 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.9 t60 -62.3 -38.34 89.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.73999999999999999 108.422 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.815 ' O ' HG22 ' A' ' 29' ' ' VAL . 36.5 m95 -76.3 -17.03 59.64 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.966 -1.015 . . . . 1.5600000000000001 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 16.2 mm-40 -73.43 -41.86 62.74 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.248 -1.019 . . . . 0.85999999999999999 108.248 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 m -68.97 -31.13 69.76 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.435 -1.711 . . . . 1.49 111.257 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.3 m -62.09 -36.69 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 120.347 -0.541 . . . . 1.1899999999999999 111.407 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.37 -8.76 0.19 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.031 -1.08 . . . . 1.52 111.655 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.553 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -113.61 -55.67 2.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.157 0.183 . . . . 3.02 111.34 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.4 pp -64.99 -26.52 68.33 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.48 0.657 . . . . 1.9199999999999999 109.534 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 6.1 t80 -72.93 -47.42 45.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.014 -0.994 . . . . 1.79 109.091 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.51 -40.35 91.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.584 -1.189 . . . . 2.48 110.828 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.5 ' HB2' HD23 ' A' ' 36' ' ' LEU . 52.5 m -48.31 -31.37 5.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 3.1699999999999999 110.434 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -141.8 39.35 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.804 -0.635 . . . . 2.7999999999999998 110.725 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.512 0 N-CA-C 109.997 -1.241 . . . . 2.46 109.997 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mt . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.012 0.435 . . . . 6.1399999999999997 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -60.02 -43.72 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 7.25 111.299 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -49.3 73.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 9.8200000000000003 110.903 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.64 -36.8 83.98 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.695 . . . . 9.1999999999999993 109.125 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.65 90.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 9.5 110.035 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -67.24 -18.94 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 11.26 110.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.72 1.72 0.47 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.878 -0.601 . . . . 12.640000000000001 113.265 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 48' ' ' TYR . 48.1 t -166.13 -34.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.346 . . . . 12.960000000000001 110.752 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -73.73 -22.3 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 11.789999999999999 111.084 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 12.99 112.562 -179.769 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.7 p . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.019 0.438 . . . . 1.25 111.297 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.6 t80 -57.3 -43.16 82.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.519 -0.764 . . . . 1.6100000000000001 111.072 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 11' ' ' LEU . 62.2 m -65.83 -31.08 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.68 -0.408 . . . . 0.38 109.914 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.15 83.97 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.965 -1.124 . . . . 2.1800000000000002 107.965 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 72.7 mt -63.59 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.313 -1.312 . . . . 0.33000000000000002 108.08 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 8' ' ' THR . 38.4 mt -67.44 -38.21 84.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.896 -1.502 . . . . 1.3999999999999999 109.751 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.46 -46.06 77.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.77 -1.105 . . . . 0.17000000000000001 110.034 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.87 -55.63 21.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.11 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.6 77.28 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.20999999999999999 110.389 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.12 -41.6 94.73 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.954 -1.259 . . . . 0.17000000000000001 109.954 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.9 mmt180 -70.8 -33.54 70.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.103 -0.549 . . . . 4.5300000000000002 110.279 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.25 -62.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.636 -1.246 . . . . 0.28000000000000003 107.636 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 t80 -51.68 -41.23 61.27 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.218 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.8 mt-10 -61.85 -55.63 27.87 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 111.17 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ILE . 26.7 m -63.59 -26.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.371 -0.974 . . . . 0.16 108.371 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -72.07 -31.45 66.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.492 -1.231 . . . . 1.6599999999999999 108.441 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' PHE . 7.0 t -75.42 -45.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.534 -1.212 . . . . 0.22 110.717 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 8.1 mm-40 -59.62 -45.76 90.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.12 -0.696 . . . . 2.6400000000000001 109.12 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.11 85.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . 81.8 t60 -63.67 -39.02 93.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.55 -0.907 . . . . 0.73999999999999999 108.55 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.877 ' O ' HG22 ' A' ' 29' ' ' VAL . 28.2 m95 -76.22 -16.48 59.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.853 -1.067 . . . . 1.5600000000000001 110.503 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -73.86 -41.67 61.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.337 -0.616 . . . . 0.85999999999999999 109.337 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -75.63 -22.71 56.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.078 -0.965 . . . . 1.49 111.032 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 26' ' ' TRP . 34.5 m -60.85 -33.99 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 C-N-CA 119.871 -0.732 . . . . 1.1899999999999999 110.248 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -48.56 -10.58 0.12 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.781 -1.2 . . . . 1.52 110.806 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' VAL . 19.4 mmt -101.19 -68.18 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.374 0.67 . . . . 3.02 110.446 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -59.64 -41.35 90.3 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.859 -0.61 . . . . 1.9199999999999999 110.675 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.1 t80 -64.68 -37.11 86.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 1.79 109.504 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -59.81 -34.12 72.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.475 -0.784 . . . . 2.48 110.696 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.5 m -59.71 -27.85 66.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.953 -0.567 . . . . 3.1699999999999999 110.154 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.41 35.53 2.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 2.7999999999999998 110.936 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.507 -0.431 0 N-CA-C 109.742 -1.343 . . . . 2.46 109.742 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.087 0.47 . . . . 6.1399999999999997 110.201 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -60.14 -48.94 79.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 7.25 111.538 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -60.66 -51.61 68.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.595 -0.275 . . . . 9.8200000000000003 111.19 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.24 -34.5 76.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.19 -0.67 . . . . 9.1999999999999993 109.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 -40.62 88.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.387 -0.824 . . . . 9.5 109.885 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.36 -24.06 67.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.382 -0.826 . . . . 11.26 110.499 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.61 2.99 0.27 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.617 -0.719 . . . . 12.640000000000001 113.33 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 48' ' ' TYR . 70.8 m -163.5 -39.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 12.960000000000001 110.542 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.3 mtt -72.92 -28.95 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 11.789999999999999 110.523 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.906 -0.664 . . . . 12.99 111.904 179.832 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.3 p . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.986 0.422 . . . . 1.25 111.21 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.576 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.8 t80 -57.31 -42.42 81.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.589 -0.732 . . . . 1.6100000000000001 110.582 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 m -67.43 -32.67 73.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.72 -0.392 . . . . 0.38 110.066 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -35.12 79.9 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.711 -1.218 . . . . 2.1800000000000002 107.711 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 68.4 mt -65.27 -41.59 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.011 -1.45 . . . . 0.33000000000000002 107.854 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.35 -37.87 88.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.095 -1.412 . . . . 1.3999999999999999 109.252 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.89 81.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.734 -1.121 . . . . 0.17000000000000001 109.383 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.66 -58.07 8.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.95 -1.023 . . . . 0.23999999999999999 110.037 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.79 76.87 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.002 0.43 . . . . 0.20999999999999999 109.885 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.39 -41.62 63.38 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.67 -1.372 . . . . 0.17000000000000001 109.67 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.6 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -72.66 -37.89 67.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.053 -0.574 . . . . 4.5300000000000002 110.86 178.357 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.5 mt -67.09 -63.08 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 122.623 1.201 . . . . 0.28000000000000003 108.08 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 21' ' ' MET . 53.6 t80 -50.62 -39.8 51.17 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 112.654 -2.066 . . . . 0.29999999999999999 110.394 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.667 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -61.84 -53.78 51.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.916 0.388 . . . . 2.2999999999999998 110.885 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 17' ' ' ILE . 13.2 m -64.92 -26.11 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.011 -1.107 . . . . 0.16 108.011 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 5.4 mmt -74.96 -26.98 59.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.434 -1.257 . . . . 1.6599999999999999 108.549 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' PHE . 2.6 t -78.02 -36.39 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.482 -1.235 . . . . 0.22 111.35 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 5.8 pt-20 -58.76 -44.6 90.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.801 -0.444 . . . . 2.6400000000000001 109.801 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -64.0 -33.05 86.21 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.653 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.1 t60 -62.23 -37.09 84.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.356 -0.979 . . . . 0.73999999999999999 108.356 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.862 ' O ' HG22 ' A' ' 29' ' ' VAL . 19.0 m95 -74.22 -16.4 60.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.952 -1.022 . . . . 1.5600000000000001 110.166 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 11.1 mm-40 -75.23 -42.78 54.61 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -78.17 -18.92 54.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.821 -1.081 . . . . 1.49 111.259 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 ' O ' ' A' ' 26' ' ' TRP . 31.0 m -57.61 -33.36 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 119.811 -0.756 . . . . 1.1899999999999999 110.193 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.05 -11.99 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.738 -1.22 . . . . 1.52 111.502 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 13.9 mmt -103.89 -65.08 1.04 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.981 0.512 . . . . 3.02 110.898 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.676 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -60.0 -34.39 73.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.241 -0.436 . . . . 1.9199999999999999 110.727 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.12 -34.81 78.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 1.79 109.379 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 31' ' ' MET . 3.2 t70 -59.55 -34.04 72.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.379 -0.828 . . . . 2.48 110.453 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -74.13 -5.47 41.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.404 0.621 . . . . 3.1699999999999999 109.476 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 2.3 mt -126.28 6.11 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.026 -0.988 . . . . 2.7999999999999998 110.059 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.501 0 N-CA-C 106.868 -2.493 . . . . 2.46 106.868 178.174 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.694 0.283 . . . . 6.1399999999999997 110.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -59.12 -41.32 87.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 7.25 110.569 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.57 -51.97 65.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.241 -0.436 . . . . 9.8200000000000003 110.767 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -60.85 -36.39 79.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.211 -0.663 . . . . 9.1999999999999993 109.211 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.88 87.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 9.5 109.967 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -63.23 -22.82 67.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.455 -0.793 . . . . 11.26 110.558 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.44 -7.79 0.26 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.404 -0.816 . . . . 12.640000000000001 113.156 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 48' ' ' TYR . 42.2 t -163.4 -35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.894 0.378 . . . . 12.960000000000001 110.94 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.66 -30.68 64.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 11.789999999999999 110.635 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.89 -0.671 . . . . 12.99 111.997 -179.669 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.838 0.351 . . . . 7.25 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -120.11 107.07 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 4.7400000000000002 110.853 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.76 -83.0 0.35 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.808 -0.71 . . . . 2.96 112.457 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.57 -10.4 7.86 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.891 -0.671 . . . . 1.3700000000000001 112.673 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.85 -61.61 7.01 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.354 -0.927 . . . . 2.1400000000000001 111.503 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 7' ' ' PHE . 6.8 p -64.76 -44.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.152 0.501 . . . . 1.25 111.309 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 28.5 t80 -56.79 -43.74 81.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.334 -0.848 . . . . 1.6100000000000001 111.344 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 11' ' ' LEU . 58.3 m -65.66 -31.57 72.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.62 -0.432 . . . . 0.38 110.205 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -37.53 83.33 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.986 -1.116 . . . . 2.1800000000000002 107.986 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 73.4 mt -64.19 -40.06 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 114.272 -1.331 . . . . 0.33000000000000002 108.033 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' THR . 39.2 mt -66.87 -38.79 86.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.918 -1.492 . . . . 1.3999999999999999 109.512 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.4 85.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.767 -1.106 . . . . 0.17000000000000001 109.597 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -65.41 -58.22 6.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.048 -0.978 . . . . 0.23999999999999999 110.061 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.63 78.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 123.269 0.355 . . . . 0.20999999999999999 110.571 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -57.62 -43.24 94.39 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.034 -1.226 . . . . 0.17000000000000001 110.034 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.1 mmt180 -70.29 -33.09 71.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.242 -0.479 . . . . 4.5300000000000002 110.412 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.7 mt -65.93 -61.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.373 -1.343 . . . . 0.28000000000000003 107.373 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 48.3 t80 -53.31 -39.36 63.96 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.476 -2.147 . . . . 0.29999999999999999 110.281 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.3 mt-10 -62.51 -54.46 39.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 110.89 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 17' ' ' ILE . 22.2 m -63.81 -26.18 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.323 -0.992 . . . . 0.16 108.323 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -73.02 -30.58 63.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.444 -1.253 . . . . 1.6599999999999999 108.755 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -75.65 -40.62 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.626 -1.17 . . . . 0.22 111.003 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 9.7 mm-40 -57.16 -41.86 79.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.631 -0.507 . . . . 2.6400000000000001 109.631 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -67.73 -28.99 73.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.817 -0.913 . . . . 0.42999999999999999 110.817 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.0 t60 -60.36 -47.95 83.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.226 -0.657 . . . . 0.73999999999999999 109.226 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.952 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.5 m95 -77.45 -6.6 54.06 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.32 -0.855 . . . . 1.5600000000000001 111.47 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 6.6 mm-40 -69.68 -40.38 76.4 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.592 -0.843 . . . . 0.85999999999999999 108.939 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.0 -22.2 45.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.249 -0.887 . . . . 1.49 110.703 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 26' ' ' TRP . 21.4 m -60.99 -32.65 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 C-N-CA 120.338 -0.545 . . . . 1.1899999999999999 111.424 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -51.44 -6.89 0.2 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 119.67 -1.252 . . . . 1.52 110.707 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.573 ' H ' ' C ' ' A' ' 29' ' ' VAL . 14.7 mmt -104.89 -68.13 0.87 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 3.02 110.411 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -60.6 -40.55 92.22 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.819 -0.628 . . . . 1.9199999999999999 110.586 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -65.9 -39.23 90.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.522 -0.763 . . . . 1.79 109.538 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -61.72 -34.73 76.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.345 -0.843 . . . . 2.48 110.997 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 36' ' ' LEU . 58.9 m -58.85 -24.19 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 3.1699999999999999 110.952 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -148.15 34.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.047 0.451 . . . . 2.7999999999999998 111.849 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.24 -40.18 0.24 Allowed Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.405 -1.478 . . . . 2.46 109.405 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -79.14 -49.94 11.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.961 -1.119 . . . . 3.4300000000000002 108.169 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.72 60.18 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.306 -1.316 . . . . 3.5299999999999998 111.091 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -65.12 -39.43 93.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.74 -0.384 . . . . 3.8900000000000001 111.021 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.0 mtm -46.64 -36.38 6.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 4.8899999999999997 110.409 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -70.34 -42.65 71.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.029 -0.532 . . . . 8.1099999999999994 109.734 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 40' ' ' THR . 25.9 mt -58.73 -50.37 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.755 . . . . 6.1399999999999997 110.074 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 42.4 m-80 -61.63 -51.09 69.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.277 -0.874 . . . . 7.25 111.198 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' GLY . 8.1 mmm180 -53.38 -47.56 69.38 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.35 -0.386 . . . . 9.8200000000000003 110.163 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -67.02 -40.96 87.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.41 -0.959 . . . . 9.1999999999999993 108.41 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -68.94 -2.81 10.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.129 -0.941 . . . . 9.5 110.084 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -122.91 -12.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 11.26 112.004 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . -59.17 -13.57 21.4 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.899 -0.667 . . . . 12.640000000000001 112.579 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -166.7 -31.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.241 0.543 . . . . 12.960000000000001 110.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 24.1 mmt -71.08 -28.59 64.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 11.789999999999999 111.157 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.56 37.85 3.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 12.99 112.703 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.43 -3.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.769 -0.729 . . . . 15.68 112.415 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.6 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.773 -0.727 . . . . 15.710000000000001 112.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -54.47 10.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 14.92 110.814 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mt -110.73 -21.68 11.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.854 -0.612 . . . . 16.219999999999999 111.046 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 47.3 23.29 0.32 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.455 -0.793 . . . . 19.829999999999998 112.137 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.45 30.1 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.997 -0.621 . . . . 17.620000000000001 112.953 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.329 -0.843 . . . . 17.91 110.805 179.875 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.838 0.351 . . . . 7.25 110.802 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -168.22 110.79 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 4.7400000000000002 110.921 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.67 -95.14 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.933 -0.651 . . . . 2.96 112.001 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 6' ' ' VAL . . . -75.85 5.14 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.539 -0.839 . . . . 1.3700000000000001 112.238 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.78 4.89 4.97 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.725 -0.75 . . . . 2.1400000000000001 111.423 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 4' ' ' GLY . 1.3 p -170.99 -30.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.664 -0.768 . . . . 1.25 110.01 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -61.64 -28.78 69.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 1.6100000000000001 109.949 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 90.0 m -70.2 -37.06 74.99 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.38 110.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -44.16 92.33 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 108.127 -1.064 . . . . 2.1800000000000002 108.127 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -57.06 -32.21 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 113.669 -1.605 . . . . 0.33000000000000002 108.009 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' THR . 20.2 mt -76.66 -38.75 54.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.681 -1.6 . . . . 1.3999999999999999 110.279 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.19 -51.65 50.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.644 -1.162 . . . . 0.17000000000000001 110.503 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.96 -53.59 55.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.075 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.47 79.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.721 0.296 . . . . 0.20999999999999999 110.956 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -56.52 -41.45 88.79 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.892 -1.283 . . . . 0.17000000000000001 109.892 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.5 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.6 mmt180 -71.35 -35.12 71.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.821 -0.689 . . . . 4.5300000000000002 110.548 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.3 mt -66.81 -61.16 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 107.88 -1.155 . . . . 0.28000000000000003 107.88 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.5 t80 -52.48 -41.25 63.2 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.78 -2.009 . . . . 0.29999999999999999 110.41 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.4 mm-40 -60.24 -53.55 56.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.924 -0.58 . . . . 2.2999999999999998 110.969 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 17.2 m -68.31 -25.34 31.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 21.6 mmm -73.71 -28.22 61.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.842 -1.072 . . . . 1.6599999999999999 108.791 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -78.83 -42.55 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.79 -1.095 . . . . 0.22 111.357 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 7.4 pt-20 -57.09 -39.65 75.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.915 0.388 . . . . 2.6400000000000001 110.014 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -70.99 -28.44 70.49 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.094 -0.802 . . . . 0.42999999999999999 111.094 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.499 ' O ' HG13 ' A' ' 29' ' ' VAL . 77.9 t60 -58.77 -45.35 89.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.356 -0.609 . . . . 0.73999999999999999 109.356 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.924 ' O ' HG22 ' A' ' 29' ' ' VAL . 81.4 m95 -78.67 -6.35 55.48 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.587 -0.733 . . . . 1.5600000000000001 111.443 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 28.8 mm-40 -71.64 -40.75 69.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.616 -0.834 . . . . 0.85999999999999999 108.871 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 32' ' ' LEU . 1.2 t -80.14 -20.72 44.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.295 -0.866 . . . . 1.49 110.657 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' O ' ' A' ' 26' ' ' TRP . 32.7 m -59.43 -33.66 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 120.184 -0.606 . . . . 1.1899999999999999 111.072 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -50.52 -9.8 0.3 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.324 -1.417 . . . . 1.52 110.719 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' VAL . 91.1 mmm -102.27 -69.65 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.454 0.702 . . . . 3.02 110.255 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 2.3 pp -60.17 -43.03 96.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.394 -0.821 . . . . 1.9199999999999999 110.73 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 33.9 t80 -66.27 -32.7 74.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.211 -0.904 . . . . 1.79 109.796 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -59.67 -33.62 71.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.796 -0.638 . . . . 2.48 110.608 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 m -56.1 -17.65 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.451 -0.574 . . . . 3.1699999999999999 109.451 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -148.74 29.24 0.84 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.181 -0.918 . . . . 2.7999999999999998 110.243 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -139.98 6.24 2.84 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 110.164 -1.174 . . . . 2.46 110.164 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 37' ' ' GLY . 12.4 tptt -154.8 -43.45 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.532 -1.334 . . . . 3.4300000000000002 108.575 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.83 -18.36 79.64 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.06 -0.973 . . . . 3.5299999999999998 111.967 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 36' ' ' LEU . 12.8 t -169.83 35.62 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.205 0.446 . . . . 3.8900000000000001 112.205 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.476 ' HB3' ' C ' ' A' ' 37' ' ' GLY . 11.3 ptt? -55.47 -32.79 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.952 -0.567 . . . . 4.8899999999999997 111.032 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -66.04 -59.07 4.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.437 -0.347 . . . . 8.1099999999999994 110.486 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.46 HD12 ' OG1' ' A' ' 40' ' ' THR . 55.2 mt -50.44 -44.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 6.1399999999999997 110.187 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -64.02 -44.6 92.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 7.25 110.876 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.58 HH21 ' HB3' ' A' ' 48' ' ' TYR . 4.6 tpm_? -60.57 -53.57 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 9.8200000000000003 110.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -60.15 -36.38 77.42 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.183 -0.673 . . . . 9.1999999999999993 109.183 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.8 92.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 9.5 109.731 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.58 ' HB3' HH21 ' A' ' 45' ' ' ARG . 0.3 OUTLIER -66.05 -21.09 66.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.345 -0.843 . . . . 11.26 110.62 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.28 -2.75 0.27 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.657 -0.701 . . . . 12.640000000000001 113.21 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 48' ' ' TYR . 33.3 t -165.23 -36.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.757 0.313 . . . . 12.960000000000001 110.824 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 95.2 mmm -71.78 -32.85 68.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 11.789999999999999 110.355 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -83.62 42.17 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.657 . . . . 12.99 112.224 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.88 9.71 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.079 -0.808 . . . . 15.68 111.079 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 56' ' ' LEU . . . -96.4 -82.76 1.64 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.421 . . . . 15.710000000000001 112.768 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.464 ' C ' HD12 ' A' ' 56' ' ' LEU . 20.3 m -75.72 21.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 14.92 111.307 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 56' ' ' LEU . 3.4 mp 56.99 32.52 21.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.795 -0.639 . . . . 16.219999999999999 110.519 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -56.72 -21.56 28.92 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.239 -0.437 . . . . 19.829999999999998 111.255 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.43 -0.93 0.94 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.836 -0.697 . . . . 17.620000000000001 112.588 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.263 -0.875 . . . . 17.91 110.959 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.743 0.306 . . . . 7.25 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -66.56 -50.13 64.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.236 0.541 . . . . 4.7400000000000002 110.851 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.63 68.13 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.272 -0.876 . . . . 2.96 112.702 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 6' ' ' VAL . . . 171.14 -26.55 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.937 -0.649 . . . . 1.3700000000000001 112.051 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.23 15.02 7.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 2.1400000000000001 111.556 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 4' ' ' GLY . 1.4 p -172.0 -38.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.197 -0.502 . . . . 1.25 110.854 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 10' ' ' ILE . 28.1 t80 -61.89 -30.03 70.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.527 -0.546 . . . . 1.6100000000000001 109.527 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 28.8 m -72.7 -36.17 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.38 110.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -63.92 -43.52 95.67 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.171 -1.048 . . . . 2.1800000000000002 108.171 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' PHE . 66.6 mt -57.0 -32.29 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 113.544 -1.662 . . . . 0.33000000000000002 107.947 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 8' ' ' THR . 27.2 mt -77.72 -37.68 48.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.5 -1.682 . . . . 1.3999999999999999 110.236 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 -50.1 63.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.725 -1.125 . . . . 0.17000000000000001 110.274 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -61.45 -55.25 33.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.047 -0.979 . . . . 0.23999999999999999 110.133 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.89 -44.93 82.79 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 120.729 0.299 . . . . 0.20999999999999999 110.635 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.54 -42.08 95.81 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.059 -1.217 . . . . 0.17000000000000001 110.059 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.2 mmt180 -71.08 -34.53 71.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -0.632 . . . . 4.5300000000000002 110.423 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.1 mt -66.29 -61.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.794 -1.188 . . . . 0.28000000000000003 107.794 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.7 t80 -53.37 -40.66 65.15 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.503 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.2 mt-10 -61.51 -54.56 41.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.862 -0.608 . . . . 2.2999999999999998 111.207 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 17' ' ' ILE . 23.0 m -65.07 -26.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.484 -0.932 . . . . 0.16 108.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.68 -31.48 66.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.504 -1.225 . . . . 1.6599999999999999 108.713 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 5.1 t -76.89 -48.0 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.494 -1.23 . . . . 0.22 110.823 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 13.5 mm-40 -57.33 -45.01 84.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.25 -0.648 . . . . 2.6400000000000001 109.25 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.21 -29.38 75.18 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.147 -0.933 . . . . 0.42999999999999999 110.912 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 29' ' ' VAL . 56.9 t60 -59.62 -47.05 87.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.346 -0.613 . . . . 0.73999999999999999 109.346 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.949 ' O ' HG22 ' A' ' 29' ' ' VAL . 75.0 m95 -78.16 -15.46 58.82 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 111.486 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.3 mm-40 -63.04 -36.58 84.05 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.831 -1.174 . . . . 0.85999999999999999 107.831 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.7 m -75.03 -30.64 61.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.434 -1.712 . . . . 1.49 110.89 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.4 m -65.05 -37.35 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 112.864 0.69 . . . . 1.1899999999999999 112.864 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -11.17 0.27 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 119.315 -1.422 . . . . 1.52 110.82 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.529 ' N ' ' C ' ' A' ' 29' ' ' VAL . 9.3 mmt -105.5 -68.09 0.88 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.998 0.519 . . . . 3.02 110.891 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.2 pp -59.56 -34.1 72.26 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.119 -0.491 . . . . 1.9199999999999999 110.812 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 1.7 t80 -70.24 -39.45 75.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.622 -0.717 . . . . 1.79 109.717 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.31 -37.91 73.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.039 -0.982 . . . . 2.48 111.543 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -59.27 -30.23 68.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 110.978 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.7 32.12 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 2.7999999999999998 111.015 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' MET . . . -119.5 -48.39 0.34 Allowed Glycine 0 C--O 1.215 -1.086 0 N-CA-C 109.623 -1.391 . . . . 2.46 109.623 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -67.03 -47.53 71.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.564 -1.273 . . . . 3.4300000000000002 107.564 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.73 71.03 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.551 -1.204 . . . . 3.5299999999999998 110.247 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 40' ' ' THR . 12.6 t -172.16 74.39 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.148 1.166 . . . . 3.8900000000000001 114.148 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' GLY . 1.5 mtp -78.04 -49.8 13.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.685 -0.689 . . . . 4.8899999999999997 111.031 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -57.79 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 8.1099999999999994 110.85 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HB ' ' OG1' ' A' ' 40' ' ' THR . 48.6 mt -53.99 -39.87 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 6.1399999999999997 110.215 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' ' 40' ' ' THR . 1.1 m-80 -59.04 -39.58 82.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 7.25 110.236 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 41' ' ' MET . 9.4 mtm180 -62.78 -51.45 67.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.12 -0.491 . . . . 9.8200000000000003 110.532 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -60.49 -37.57 81.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.181 -0.674 . . . . 9.1999999999999993 109.181 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.07 92.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.926 -1.034 . . . . 9.5 110.026 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -65.62 -24.48 67.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.452 -0.795 . . . . 11.26 110.633 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.21 2.73 0.15 Allowed Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.499 -0.773 . . . . 12.640000000000001 113.536 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' TYR . 69.8 m -163.06 -38.16 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.965 0.383 . . . . 12.960000000000001 110.538 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.69 -24.92 60.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 11.789999999999999 110.817 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.52 -8.83 57.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.846 -0.693 . . . . 12.99 112.404 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 -26.71 30.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.819 -0.705 . . . . 15.68 112.397 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 150.49 53.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 15.710000000000001 112.497 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 57' ' ' ARG . 60.0 p 39.03 44.09 0.86 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.758 0.79 . . . . 14.92 112.063 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp 68.18 -22.42 0.13 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.955 -1.475 . . . . 16.219999999999999 112.731 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 55' ' ' SER . 10.9 ptm180 -82.72 25.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.421 . . . . 19.829999999999998 110.407 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -146.88 21.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 17.620000000000001 112.384 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.231 -0.89 . . . . 17.91 110.869 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 26.9 ptt? . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.914 0.388 . . . . 7.25 110.979 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -148.78 98.39 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 4.7400000000000002 110.78 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.55 -78.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.787 -0.721 . . . . 2.96 112.316 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.38 -4.21 43.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.777 -0.725 . . . . 1.3700000000000001 112.241 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 1' ' ' MET . . . -97.45 23.89 33.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.91 -0.662 . . . . 2.1400000000000001 111.923 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -163.51 -53.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 123.355 0.662 . . . . 1.25 109.23 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 33.0 t80 -61.58 -39.64 91.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.515 -0.766 . . . . 1.6100000000000001 110.582 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.709 ' HA ' HD23 ' A' ' 11' ' ' LEU . 94.2 m -67.63 -29.87 69.29 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.155 0.503 . . . . 0.38 109.932 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.48 -41.27 84.83 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.291 -1.374 . . . . 2.1800000000000002 107.291 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.7 mt -66.11 -36.02 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 113.729 -1.578 . . . . 0.33000000000000002 109.085 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.746 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -70.54 -41.29 72.69 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.395 -1.275 . . . . 1.3999999999999999 108.836 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -55.38 30.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.646 -1.616 . . . . 0.17000000000000001 110.01 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.21 -51.77 66.44 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.28 -0.873 . . . . 0.23999999999999999 110.558 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.76 74.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.424 -0.511 . . . . 0.20999999999999999 110.09 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -60.55 -51.37 59.12 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.722 -0.752 . . . . 0.17000000000000001 111.278 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -71.68 -28.7 63.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.679 0.276 . . . . 4.5300000000000002 110.795 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.6 mt -66.54 -59.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 106.71 -1.589 . . . . 0.28000000000000003 106.71 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CE1' HG21 ' A' ' 22' ' ' VAL . 33.8 t80 -55.18 -38.66 68.63 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.616 -2.084 . . . . 0.29999999999999999 109.587 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.4 mt-10 -60.74 -51.1 70.78 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.597 -0.728 . . . . 2.2999999999999998 110.953 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 17' ' ' ILE . 18.8 m -68.5 -28.53 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.952 -0.759 . . . . 0.16 108.952 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -72.04 -27.66 62.86 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.977 -1.011 . . . . 1.6599999999999999 108.813 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 18' ' ' PHE . 3.4 t -83.31 -43.25 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.532 -1.213 . . . . 0.22 111.785 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.1 -40.83 82.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.893 0.377 . . . . 2.6400000000000001 110.022 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.51 -35.31 91.79 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.088 -1.205 . . . . 0.42999999999999999 110.088 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.611 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.0 t60 -62.43 -41.86 99.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.501 -0.925 . . . . 0.73999999999999999 108.501 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 22.9 m95 -74.31 -15.06 60.97 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.715 -1.13 . . . . 1.5600000000000001 110.929 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -42.61 58.71 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.85999999999999999 109.861 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.39 -22.17 55.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.241 -0.89 . . . . 1.49 111.207 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 26' ' ' TRP . 33.3 m -61.07 -36.07 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 119.97 -0.692 . . . . 1.1899999999999999 110.684 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.52 -11.0 0.13 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 119.832 -1.175 . . . . 1.52 111.036 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' VAL . 17.3 mmt -102.02 -67.62 0.86 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.337 0.655 . . . . 3.02 110.743 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.669 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -59.2 -38.41 79.82 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.816 -0.629 . . . . 1.9199999999999999 110.801 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.9 t80 -65.93 -39.33 90.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.638 -0.71 . . . . 1.79 109.708 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -38.58 82.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.355 -0.839 . . . . 2.48 111.301 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' HD23 ' A' ' 36' ' ' LEU . 47.9 t -53.94 -28.78 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 3.1699999999999999 110.38 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.503 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.6 OUTLIER -141.35 38.09 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 2.7999999999999998 110.71 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.511 ' HA2' HG22 ' A' ' 40' ' ' THR . . . -125.4 -33.8 0.7 Allowed Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 109.779 -1.328 . . . . 2.46 109.779 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -76.14 -52.15 10.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.193 -1.04 . . . . 3.4300000000000002 108.193 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.45 63.36 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.438 -1.256 . . . . 3.5299999999999998 111.13 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.516 ' OG1' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -67.18 -22.74 65.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.809 0.3 . . . . 3.8900000000000001 111.809 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 22.5 ptt? -38.68 -48.08 1.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.144 -0.48 . . . . 4.8899999999999997 111.817 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -56.95 -48.89 77.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 8.1099999999999994 110.181 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.516 HD12 ' OG1' ' A' ' 40' ' ' THR . 46.4 mt -53.1 -41.6 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 6.1399999999999997 110.231 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -60.99 -40.93 95.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.676 -0.693 . . . . 7.25 110.737 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 41' ' ' MET . 32.3 mtm180 -63.03 -53.02 60.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 9.8200000000000003 110.799 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -60.4 -36.69 78.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.243 -0.651 . . . . 9.1999999999999993 109.243 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.35 87.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.031 -0.986 . . . . 9.5 110.073 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -63.89 -20.49 65.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.542 -0.754 . . . . 11.26 110.807 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.11 -5.45 0.45 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.688 -0.687 . . . . 12.640000000000001 113.168 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.36 -34.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 12.960000000000001 110.66 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.1 mmm -73.39 -24.75 60.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 11.789999999999999 110.955 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.41 51.4 0.88 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 12.99 112.56 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.84 -5.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.792 -0.718 . . . . 15.68 112.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -134.56 -22.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.702 . . . . 15.710000000000001 112.198 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -69.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.898 0.38 . . . . 14.92 110.971 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.8 mp -70.14 -30.26 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 16.219999999999999 111.054 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -81.52 24.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 19.829999999999998 110.282 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . -167.97 13.62 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.702 -0.681 . . . . 17.620000000000001 112.555 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.219 -0.896 . . . . 17.91 110.948 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.894 0.378 . . . . 7.25 111.001 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -129.11 1.75 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 4.7400000000000002 110.863 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.92 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 2.96 112.408 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.606 ' HA2' ' CD2' ' A' ' 7' ' ' PHE . . . -65.93 -4.53 21.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.616 -0.802 . . . . 1.3700000000000001 112.361 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.42 27.8 3.58 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.796 -0.922 . . . . 2.1400000000000001 110.796 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 4' ' ' GLY . 71.1 t -162.5 -44.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 123.318 0.647 . . . . 1.25 109.757 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CD2' ' HA2' ' A' ' 4' ' ' GLY . 0.1 OUTLIER -63.17 -34.88 78.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.896 0.379 . . . . 1.6100000000000001 110.035 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 -36.03 75.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.1 -0.5 . . . . 0.38 110.806 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -34.88 79.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.037 -1.098 . . . . 2.1800000000000002 108.037 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 7' ' ' PHE . 71.6 mt -64.48 -42.68 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.043 -1.435 . . . . 0.33000000000000002 108.074 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -66.65 -37.53 85.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.011 -1.449 . . . . 1.3999999999999999 109.612 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.93 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.739 -1.119 . . . . 0.17000000000000001 109.69 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.31 -58.79 5.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.861 -1.063 . . . . 0.23999999999999999 109.999 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 -42.94 76.9 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.916 0.389 . . . . 0.20999999999999999 110.582 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.28 -55.31 25.09 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.711 -0.956 . . . . 0.17000000000000001 110.711 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.2 mtp180 -69.33 -32.15 71.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.834 -0.683 . . . . 4.5300000000000002 111.666 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.0 mt -61.92 -60.76 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.167 -1.79 . . . . 0.28000000000000003 106.167 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.9 t80 -54.93 -40.96 70.46 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.29 -2.232 . . . . 0.29999999999999999 110.323 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -62.56 -54.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.778 -0.646 . . . . 2.2999999999999998 111.205 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 16' ' ' ARG . 17.9 m -63.86 -26.59 40.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.236 -1.024 . . . . 0.16 108.236 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -72.65 -31.04 64.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.529 -1.214 . . . . 1.6599999999999999 108.819 177.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 18' ' ' PHE . 8.6 t -78.15 -44.45 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.677 -1.147 . . . . 0.22 111.167 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 7.1 mm-40 -57.85 -42.88 85.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.519 -0.549 . . . . 2.6400000000000001 109.519 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -29.52 74.99 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.872 -0.891 . . . . 0.42999999999999999 110.872 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.431 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.7 t60 -60.25 -48.23 82.63 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.221 -0.659 . . . . 0.73999999999999999 109.221 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.939 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.9 m95 -77.98 -6.82 55.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.386 -0.825 . . . . 1.5600000000000001 111.605 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.6 mm-40 -70.09 -40.52 74.91 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.391 -0.924 . . . . 0.85999999999999999 108.996 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -78.85 -21.74 47.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.352 -0.84 . . . . 1.49 110.677 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 26' ' ' TRP . 24.4 m -60.69 -33.39 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 120.281 -0.568 . . . . 1.1899999999999999 111.099 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -52.43 -5.09 0.17 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 119.744 -1.217 . . . . 1.52 110.843 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.602 ' H ' ' C ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -107.91 -67.23 0.98 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.485 0.714 . . . . 3.02 110.265 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.5 pp -59.68 -40.8 89.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.888 -0.596 . . . . 1.9199999999999999 110.237 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -67.1 -41.93 85.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.278 -0.874 . . . . 1.79 109.49 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 2.48 111.256 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 36' ' ' LEU . 61.3 m -57.96 -15.74 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.492 . . . . 3.1699999999999999 109.805 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.741 ' HA ' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -160.04 33.0 0.18 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.48 -0.782 . . . . 2.7999999999999998 110.792 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.66 ' HA2' ' HG3' ' A' ' 41' ' ' MET . . . -141.67 8.05 2.52 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.302 -1.119 . . . . 2.46 110.302 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HD2' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -165.05 -40.55 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.663 -1.269 . . . . 3.4300000000000002 108.661 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.29 -18.4 79.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.498 -1.228 . . . . 3.5299999999999998 112.053 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.741 HG22 ' HA ' ' A' ' 36' ' ' LEU . 6.5 t -170.59 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.395 0.887 . . . . 3.8900000000000001 113.395 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.66 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -46.14 -40.63 11.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.816 0.341 . . . . 4.8899999999999997 111.108 178.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 5.8 tpm_? -59.73 -54.87 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 8.1099999999999994 111.127 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.493 HD12 ' OG1' ' A' ' 40' ' ' THR . 55.8 mt -58.76 -42.15 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 6.1399999999999997 111.111 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' ND2' HG23 ' A' ' 40' ' ' THR . 1.7 m-80 -59.88 -48.11 83.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.597 -0.274 . . . . 7.25 111.212 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -51.64 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 9.8200000000000003 111.113 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -61.37 -34.45 75.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.107 -0.701 . . . . 9.1999999999999993 109.107 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.19 -41.91 85.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.185 -0.916 . . . . 9.5 109.989 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.08 -23.19 67.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.695 -0.684 . . . . 11.26 110.628 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.55 1.53 0.28 Allowed Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.632 -0.713 . . . . 12.640000000000001 113.118 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.33 -38.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 12.960000000000001 110.724 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.0 mmt -73.36 -28.24 61.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.969 -0.56 . . . . 11.789999999999999 110.828 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.23 25.46 27.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.822 -0.704 . . . . 12.99 112.545 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.61 10.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 15.68 112.211 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.03 -39.59 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.005 -0.617 . . . . 15.710000000000001 112.334 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 57' ' ' ARG . 58.4 m -72.09 -8.82 56.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.74 0.305 . . . . 14.92 110.988 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.74 21.07 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 16.219999999999999 110.589 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 55' ' ' SER . 12.7 ptm180 -82.03 23.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.52 . . . . 19.829999999999998 111.118 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.5 -24.88 29.49 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.751 -0.737 . . . . 17.620000000000001 112.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.333 -0.842 . . . . 17.91 111.068 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.522 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 26.5 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.649 0.261 . . . . 7.25 110.942 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -60.71 -33.99 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.064 0.459 . . . . 4.7400000000000002 111.019 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.6 30.0 5.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.584 -0.735 . . . . 2.96 112.614 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.4 38.9 63.62 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 109.91 -1.276 . . . . 1.3700000000000001 109.91 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.522 ' H ' ' HB2' ' A' ' 1' ' ' MET . . . 78.92 24.96 60.89 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 108.143 -1.983 . . . . 2.1400000000000001 108.143 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 78.12 -6.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 113.613 -1.293 . . . . 1.25 109.717 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.9 t80 -63.42 -44.85 93.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.331 -1.304 . . . . 1.6100000000000001 110.789 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 16.7 m -60.98 -30.78 70.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.891 -0.411 . . . . 0.38 109.891 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -46.82 72.84 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.527 -0.916 . . . . 2.1800000000000002 108.527 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 50.6 mt -55.28 -30.27 24.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.069 -1.423 . . . . 0.33000000000000002 108.087 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' THR . 30.0 mt -79.07 -42.15 27.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.586 -1.643 . . . . 1.3999999999999999 110.764 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -49.04 65.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 0.17000000000000001 110.239 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -59.72 -59.27 5.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.66 -1.155 . . . . 0.23999999999999999 110.018 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.37 87.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.006 0.431 . . . . 0.20999999999999999 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.657 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -51.7 -52.03 35.95 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.828 -1.177 . . . . 0.17000000000000001 110.391 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.7 ttt180 -71.83 -34.36 69.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 124.136 0.551 . . . . 4.5300000000000002 111.453 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.7 mt -63.86 -62.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.113 -1.439 . . . . 0.28000000000000003 107.113 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 22' ' ' VAL . 70.3 t80 -51.68 -42.06 61.87 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.322 -2.217 . . . . 0.29999999999999999 110.141 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -62.78 -56.38 18.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.819 -0.628 . . . . 2.2999999999999998 111.173 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 16' ' ' ARG . 18.6 m -60.59 -27.16 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.978 -1.119 . . . . 0.16 107.978 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 5.7 mmt -73.29 -31.65 64.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.334 -1.303 . . . . 1.6599999999999999 108.553 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.7 t -75.31 -42.08 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.613 -1.176 . . . . 0.22 111.075 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.5 mm-40 -58.92 -46.7 87.28 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.485 -0.561 . . . . 2.6400000000000001 109.485 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -59.58 -34.7 82.74 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.097 -1.201 . . . . 0.42999999999999999 110.097 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.619 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.9 t60 -63.15 -41.91 99.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.385 -0.969 . . . . 0.73999999999999999 108.385 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.881 ' O ' HG22 ' A' ' 29' ' ' VAL . 23.2 m95 -73.82 -15.75 61.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.578 -1.192 . . . . 1.5600000000000001 110.828 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 7.9 mm-40 -72.79 -44.63 61.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.382 0.611 . . . . 0.85999999999999999 109.637 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.528 ' O ' ' HG3' ' A' ' 31' ' ' MET . 0.5 OUTLIER -78.2 -19.94 52.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.047 -0.979 . . . . 1.49 111.211 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.0 m -56.32 -32.98 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 119.365 -0.934 . . . . 1.1899999999999999 109.895 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.73 -9.96 0.07 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.877 -1.154 . . . . 1.52 111.597 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.606 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.44 -57.99 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.266 0.226 . . . . 3.02 111.459 179.019 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.1 pp -64.84 -32.19 73.77 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.719 . . . . 1.9199999999999999 109.803 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -72.6 -48.32 40.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.63 -1.168 . . . . 1.79 109.152 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.55 -43.04 75.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.9 -1.045 . . . . 2.48 111.771 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.457 ' HB3' HD23 ' A' ' 36' ' ' LEU . 48.3 t -54.0 -21.72 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 3.1699999999999999 110.908 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -155.95 44.27 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 2.7999999999999998 110.672 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 40' ' ' THR . . . -132.52 -30.07 0.51 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 109.142 -1.583 . . . . 2.46 109.142 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 41' ' ' MET . 5.1 tptp -75.19 -50.57 15.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 113.647 -1.277 . . . . 3.4300000000000002 107.847 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.67 -38.27 32.5 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.118 -1.401 . . . . 3.5299999999999998 110.214 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.694 HG22 ' HA2' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -69.88 -12.49 61.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.473 . . . . 3.8900000000000001 111.956 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -39.52 -46.37 1.72 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.78 0.324 . . . . 4.8899999999999997 111.542 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -67.71 -41.2 83.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.285 0.565 . . . . 8.1099999999999994 109.982 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 40' ' ' THR . 61.0 mt -63.23 -33.1 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.2 -0.909 . . . . 6.1399999999999997 111.878 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.89 4.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 111.919 0.341 . . . . 7.25 111.919 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 7.9 ttp180 -55.06 -47.05 75.36 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.545 0.212 . . . . 9.8200000000000003 111.298 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -63.65 -34.06 77.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.115 -0.698 . . . . 9.1999999999999993 109.115 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.21 -48.26 68.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.176 -0.92 . . . . 9.5 110.102 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -18.09 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.856 . . . . 11.26 111.286 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.28 -9.14 1.36 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.833 -0.698 . . . . 12.640000000000001 112.679 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 t -166.55 -31.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.709 0.29 . . . . 12.960000000000001 111.101 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.1 mmm -71.85 -31.03 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 11.789999999999999 111.078 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.27 52.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.887 -0.673 . . . . 12.99 112.535 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.89 16.79 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 15.68 112.603 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 56' ' ' LEU . . . -149.62 -41.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.693 -0.765 . . . . 15.710000000000001 112.599 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.48 ' C ' HD12 ' A' ' 56' ' ' LEU . 49.9 m -75.22 24.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 14.92 111.218 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 56' ' ' LEU . 3.8 mp 61.26 29.05 18.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.882 -0.599 . . . . 16.219999999999999 110.425 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 36.98 40.12 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.401 -0.818 . . . . 19.829999999999998 111.722 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.32 -30.6 0.96 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.883 -0.675 . . . . 17.620000000000001 112.671 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.188 -0.91 . . . . 17.91 111.048 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.749 0.309 . . . . 7.25 110.851 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 t 58.8 17.44 5.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.082 -0.508 . . . . 4.7400000000000002 111.082 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.37 33.19 2.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.874 -0.679 . . . . 2.96 112.306 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.44 -12.39 33.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.955 -0.641 . . . . 1.3700000000000001 112.498 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.78 -61.81 6.8 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.371 -0.918 . . . . 2.1400000000000001 111.431 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.5 p -63.99 -44.54 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 1.25 111.235 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 29.9 t80 -58.34 -42.27 86.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.485 -0.78 . . . . 1.6100000000000001 111.299 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -65.53 -31.63 72.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.692 -0.403 . . . . 0.38 110.295 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.16 85.03 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.843 -1.169 . . . . 2.1800000000000002 107.843 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.2 mt -64.52 -39.64 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 114.158 -1.383 . . . . 0.33000000000000002 108.153 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.78 -38.26 83.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.895 -1.502 . . . . 1.3999999999999999 109.753 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.39 79.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.747 -1.115 . . . . 0.17000000000000001 109.855 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -57.15 10.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.073 -0.967 . . . . 0.23999999999999999 110.187 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.74 78.88 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.78 0.324 . . . . 0.20999999999999999 110.471 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -61.09 -40.51 98.62 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 109.941 -1.264 . . . . 0.17000000000000001 109.941 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.6 mmt180 -71.23 -34.86 71.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.2 -0.5 . . . . 4.5300000000000002 110.151 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.9 mt -66.0 -58.85 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 107.902 -1.148 . . . . 0.28000000000000003 107.902 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' VAL . 26.3 t80 -55.99 -39.6 72.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.895 -1.957 . . . . 0.29999999999999999 110.043 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.2 mm-40 -61.24 -51.57 68.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.922 -0.581 . . . . 2.2999999999999998 110.709 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 21.6 m -69.23 -26.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.017 -0.734 . . . . 0.16 109.017 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -72.68 -29.34 63.33 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.219 -0.9 . . . . 1.6599999999999999 108.685 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.1 t -79.54 -45.44 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.718 -1.128 . . . . 0.22 110.732 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 8.4 pt-20 -59.76 -40.22 87.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.188 -0.671 . . . . 2.6400000000000001 109.188 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -62.72 -35.45 91.92 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.114 -1.194 . . . . 0.42999999999999999 110.114 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.64 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.9 t60 -62.3 -38.34 89.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.73999999999999999 108.422 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.815 ' O ' HG22 ' A' ' 29' ' ' VAL . 36.5 m95 -76.3 -17.03 59.64 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.966 -1.015 . . . . 1.5600000000000001 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 16.2 mm-40 -73.43 -41.86 62.74 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.248 -1.019 . . . . 0.85999999999999999 108.248 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 m -68.97 -31.13 69.76 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.435 -1.711 . . . . 1.49 111.257 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.3 m -62.09 -36.69 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 120.347 -0.541 . . . . 1.1899999999999999 111.407 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.37 -8.76 0.19 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.031 -1.08 . . . . 1.52 111.655 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.553 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -113.61 -55.67 2.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.157 0.183 . . . . 3.02 111.34 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.4 pp -64.99 -26.52 68.33 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.48 0.657 . . . . 1.9199999999999999 109.534 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 6.1 t80 -72.93 -47.42 45.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.014 -0.994 . . . . 1.79 109.091 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.51 -40.35 91.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.584 -1.189 . . . . 2.48 110.828 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.5 ' HB2' HD23 ' A' ' 36' ' ' LEU . 52.5 m -48.31 -31.37 5.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 3.1699999999999999 110.434 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.4 OUTLIER -141.8 39.35 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.804 -0.635 . . . . 2.7999999999999998 110.725 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 40' ' ' THR . . . -126.3 -31.9 0.76 Allowed Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.997 -1.241 . . . . 2.46 109.997 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 41' ' ' MET . 12.5 tptt -77.17 -49.44 15.19 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.922 -1.14 . . . . 3.4300000000000002 107.922 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.5 59.44 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 114.043 -1.435 . . . . 3.5299999999999998 110.994 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -63.65 -29.35 70.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.088 0.471 . . . . 3.8900000000000001 110.6 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtt -48.9 -32.29 8.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.45 -0.795 . . . . 4.8899999999999997 110.434 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.414 ' HG3' ' ND2' ' A' ' 46' ' ' ASN . 2.5 tpm_? -64.37 -41.26 96.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.389 -0.597 . . . . 8.1099999999999994 109.389 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' OG1' ' A' ' 40' ' ' THR . 20.8 mt -65.14 -49.57 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.155 -0.93 . . . . 6.1399999999999997 110.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -60.02 -43.72 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 7.25 111.299 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -49.3 73.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 9.8200000000000003 110.903 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.414 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 91.2 m-20 -62.64 -36.8 83.98 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.695 . . . . 9.1999999999999993 109.125 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.65 90.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 9.5 110.035 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -67.24 -18.94 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 11.26 110.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.72 1.72 0.47 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.878 -0.601 . . . . 12.640000000000001 113.265 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 48' ' ' TYR . 48.1 t -166.13 -34.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.346 . . . . 12.960000000000001 110.752 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -73.73 -22.3 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 11.789999999999999 111.084 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.41 17.69 5.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 12.99 112.562 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -139.09 -22.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.694 -0.765 . . . . 15.68 112.459 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.07 -19.89 3.17 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.777 -0.725 . . . . 15.710000000000001 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 57' ' ' ARG . 34.8 m -72.91 -44.87 60.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.764 0.316 . . . . 14.92 111.435 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.32 17.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.438 . . . . 16.219999999999999 111.145 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 55' ' ' SER . 74.0 mtp180 -86.38 31.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 19.829999999999998 110.773 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.35 -35.19 1.48 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.758 -0.734 . . . . 17.620000000000001 112.577 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.218 -0.896 . . . . 17.91 110.896 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.761 0.315 . . . . 7.25 110.981 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -146.42 16.76 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 4.7400000000000002 110.911 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.84 -65.47 0.59 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 2.96 112.554 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.57 -4.58 46.17 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.806 -0.711 . . . . 1.3700000000000001 112.853 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.54 -62.25 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.407 -0.901 . . . . 2.1400000000000001 111.643 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.7 p -63.67 -43.65 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.019 0.438 . . . . 1.25 111.297 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.6 t80 -57.3 -43.16 82.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.519 -0.764 . . . . 1.6100000000000001 111.072 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 11' ' ' LEU . 62.2 m -65.83 -31.08 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.68 -0.408 . . . . 0.38 109.914 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.15 83.97 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.965 -1.124 . . . . 2.1800000000000002 107.965 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 72.7 mt -63.59 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.313 -1.312 . . . . 0.33000000000000002 108.08 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 8' ' ' THR . 38.4 mt -67.44 -38.21 84.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.896 -1.502 . . . . 1.3999999999999999 109.751 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.46 -46.06 77.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.77 -1.105 . . . . 0.17000000000000001 110.034 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.87 -55.63 21.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.11 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.6 77.28 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.20999999999999999 110.389 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.12 -41.6 94.73 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.954 -1.259 . . . . 0.17000000000000001 109.954 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.9 mmt180 -70.8 -33.54 70.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.103 -0.549 . . . . 4.5300000000000002 110.279 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.25 -62.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.636 -1.246 . . . . 0.28000000000000003 107.636 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 t80 -51.68 -41.23 61.27 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.218 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.8 mt-10 -61.85 -55.63 27.87 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 111.17 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ILE . 26.7 m -63.59 -26.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.371 -0.974 . . . . 0.16 108.371 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -72.07 -31.45 66.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.492 -1.231 . . . . 1.6599999999999999 108.441 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' PHE . 7.0 t -75.42 -45.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.534 -1.212 . . . . 0.22 110.717 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 8.1 mm-40 -59.62 -45.76 90.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.12 -0.696 . . . . 2.6400000000000001 109.12 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.11 85.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . 81.8 t60 -63.67 -39.02 93.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.55 -0.907 . . . . 0.73999999999999999 108.55 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.877 ' O ' HG22 ' A' ' 29' ' ' VAL . 28.2 m95 -76.22 -16.48 59.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.853 -1.067 . . . . 1.5600000000000001 110.503 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -73.86 -41.67 61.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.337 -0.616 . . . . 0.85999999999999999 109.337 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -75.63 -22.71 56.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.078 -0.965 . . . . 1.49 111.032 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 26' ' ' TRP . 34.5 m -60.85 -33.99 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 C-N-CA 119.871 -0.732 . . . . 1.1899999999999999 110.248 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -48.56 -10.58 0.12 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.781 -1.2 . . . . 1.52 110.806 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' VAL . 19.4 mmt -101.19 -68.18 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.374 0.67 . . . . 3.02 110.446 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -59.64 -41.35 90.3 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.859 -0.61 . . . . 1.9199999999999999 110.675 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.1 t80 -64.68 -37.11 86.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 1.79 109.504 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -59.81 -34.12 72.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.475 -0.784 . . . . 2.48 110.696 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.5 m -59.71 -27.85 66.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.953 -0.567 . . . . 3.1699999999999999 110.154 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.9 OUTLIER -138.41 35.53 2.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 2.7999999999999998 110.936 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -128.15 -37.79 0.41 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 109.742 -1.343 . . . . 2.46 109.742 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -77.96 -51.79 9.84 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.005 -1.109 . . . . 3.4300000000000002 108.005 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.98 -30.32 61.46 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.103 -1.408 . . . . 3.5299999999999998 111.272 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -64.3 -33.26 75.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.682 -0.407 . . . . 3.8900000000000001 110.82 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 32.7 mtp -46.65 -37.58 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.708 -0.678 . . . . 4.8899999999999997 110.619 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -71.57 -36.9 71.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.883 -0.599 . . . . 8.1099999999999994 110.0 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 40' ' ' THR . 22.5 mt -65.4 -50.48 72.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 6.1399999999999997 110.201 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -60.14 -48.94 79.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 7.25 111.538 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -60.66 -51.61 68.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.595 -0.275 . . . . 9.8200000000000003 111.19 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -62.24 -34.5 76.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.19 -0.67 . . . . 9.1999999999999993 109.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 -40.62 88.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.387 -0.824 . . . . 9.5 109.885 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.36 -24.06 67.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.382 -0.826 . . . . 11.26 110.499 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.61 2.99 0.27 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.617 -0.719 . . . . 12.640000000000001 113.33 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 48' ' ' TYR . 70.8 m -163.5 -39.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 12.960000000000001 110.542 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.3 mtt -72.92 -28.95 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 11.789999999999999 110.523 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.66 -14.89 33.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.906 -0.664 . . . . 12.99 111.904 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.04 -32.01 76.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.851 -0.69 . . . . 15.68 112.091 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.82 43.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.158 -0.544 . . . . 15.710000000000001 111.838 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 99.1 p 46.81 49.48 14.24 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.809 0.814 . . . . 14.92 111.389 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER 37.34 29.43 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.569 -1.65 . . . . 16.219999999999999 112.446 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -82.72 62.16 6.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.962 0.41 . . . . 19.829999999999998 110.886 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.48 -32.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 17.620000000000001 112.378 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 17.91 110.974 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.899 0.381 . . . . 7.25 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.3 p -132.31 118.69 19.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 4.7400000000000002 110.568 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 106.44 -79.16 0.26 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 2.96 112.155 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.05 87.93 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.766 -0.73 . . . . 1.3700000000000001 112.341 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.52 24.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.331 -0.938 . . . . 2.1400000000000001 111.392 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.3 p -65.0 -45.17 95.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.986 0.422 . . . . 1.25 111.21 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.576 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.8 t80 -57.31 -42.42 81.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.589 -0.732 . . . . 1.6100000000000001 110.582 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 m -67.43 -32.67 73.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.72 -0.392 . . . . 0.38 110.066 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -35.12 79.9 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.711 -1.218 . . . . 2.1800000000000002 107.711 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 68.4 mt -65.27 -41.59 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.011 -1.45 . . . . 0.33000000000000002 107.854 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.35 -37.87 88.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.095 -1.412 . . . . 1.3999999999999999 109.252 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.89 81.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.734 -1.121 . . . . 0.17000000000000001 109.383 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.66 -58.07 8.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.95 -1.023 . . . . 0.23999999999999999 110.037 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.79 76.87 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.002 0.43 . . . . 0.20999999999999999 109.885 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.39 -41.62 63.38 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.67 -1.372 . . . . 0.17000000000000001 109.67 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.6 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -72.66 -37.89 67.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.053 -0.574 . . . . 4.5300000000000002 110.86 178.357 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.5 mt -67.09 -63.08 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 122.623 1.201 . . . . 0.28000000000000003 108.08 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 21' ' ' MET . 53.6 t80 -50.62 -39.8 51.17 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 112.654 -2.066 . . . . 0.29999999999999999 110.394 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.667 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -61.84 -53.78 51.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.916 0.388 . . . . 2.2999999999999998 110.885 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 17' ' ' ILE . 13.2 m -64.92 -26.11 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.011 -1.107 . . . . 0.16 108.011 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 5.4 mmt -74.96 -26.98 59.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.434 -1.257 . . . . 1.6599999999999999 108.549 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' PHE . 2.6 t -78.02 -36.39 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.482 -1.235 . . . . 0.22 111.35 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 5.8 pt-20 -58.76 -44.6 90.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.801 -0.444 . . . . 2.6400000000000001 109.801 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -64.0 -33.05 86.21 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.653 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.1 t60 -62.23 -37.09 84.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.356 -0.979 . . . . 0.73999999999999999 108.356 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.862 ' O ' HG22 ' A' ' 29' ' ' VAL . 19.0 m95 -74.22 -16.4 60.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.952 -1.022 . . . . 1.5600000000000001 110.166 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 11.1 mm-40 -75.23 -42.78 54.61 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -78.17 -18.92 54.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.821 -1.081 . . . . 1.49 111.259 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 ' O ' ' A' ' 26' ' ' TRP . 31.0 m -57.61 -33.36 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 119.811 -0.756 . . . . 1.1899999999999999 110.193 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.05 -11.99 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.738 -1.22 . . . . 1.52 111.502 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 13.9 mmt -103.89 -65.08 1.04 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.981 0.512 . . . . 3.02 110.898 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.676 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -60.0 -34.39 73.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.241 -0.436 . . . . 1.9199999999999999 110.727 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.12 -34.81 78.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 1.79 109.379 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 31' ' ' MET . 3.2 t70 -59.55 -34.04 72.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.379 -0.828 . . . . 2.48 110.453 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -74.13 -5.47 41.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.404 0.621 . . . . 3.1699999999999999 109.476 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 2.3 mt -126.28 6.11 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.026 -0.988 . . . . 2.7999999999999998 110.059 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.25 -56.33 0.62 Allowed Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 106.868 -2.493 . . . . 2.46 106.868 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -62.23 -32.53 73.21 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.19 -1.505 . . . . 3.4300000000000002 107.001 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.54 46.88 23.55 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 107.662 -2.175 . . . . 3.5299999999999998 107.662 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.44 ' OG1' ' HB ' ' A' ' 43' ' ' ILE . 1.9 t 39.14 35.24 0.13 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.654 -1.773 . . . . 3.8900000000000001 109.143 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mtt -46.73 -27.12 1.09 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 115.035 -0.984 . . . . 4.8899999999999997 111.081 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -65.66 -65.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 8.1099999999999994 110.046 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HB ' ' OG1' ' A' ' 40' ' ' THR . 54.1 mt -53.97 -40.0 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.061 -0.518 . . . . 6.1399999999999997 110.462 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -59.12 -41.32 87.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 7.25 110.569 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.57 -51.97 65.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.241 -0.436 . . . . 9.8200000000000003 110.767 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -60.85 -36.39 79.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.211 -0.663 . . . . 9.1999999999999993 109.211 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.88 87.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 9.5 109.967 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -63.23 -22.82 67.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.455 -0.793 . . . . 11.26 110.558 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.44 -7.79 0.26 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.404 -0.816 . . . . 12.640000000000001 113.156 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 48' ' ' TYR . 42.2 t -163.4 -35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.894 0.378 . . . . 12.960000000000001 110.94 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.66 -30.68 64.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 11.789999999999999 110.635 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.73 6.31 47.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.89 -0.671 . . . . 12.99 111.997 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.6 -57.72 0.65 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.445 -0.662 . . . . 15.68 111.445 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 56' ' ' LEU . . . -72.69 0.68 42.16 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.692 -0.766 . . . . 15.710000000000001 111.242 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m 55.36 11.9 0.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.1 -0.704 . . . . 14.92 109.1 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' GLY . 84.0 mt -79.3 2.36 21.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.877 -1.056 . . . . 16.219999999999999 108.969 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -61.03 -3.38 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.643 -1.162 . . . . 19.829999999999998 111.022 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . -119.86 -17.9 4.48 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.884 -0.674 . . . . 17.620000000000001 112.588 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.197 -0.906 . . . . 17.91 110.947 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 7' ' ' PHE . 6.8 p . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 121.152 0.501 . . . . 1.25 111.309 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 28.5 t80 -56.79 -43.74 81.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.334 -0.848 . . . . 1.6100000000000001 111.344 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 11' ' ' LEU . 58.3 m -65.66 -31.57 72.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.62 -0.432 . . . . 0.38 110.205 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -37.53 83.33 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.986 -1.116 . . . . 2.1800000000000002 107.986 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 73.4 mt -64.19 -40.06 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 114.272 -1.331 . . . . 0.33000000000000002 108.033 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' THR . 39.2 mt -66.87 -38.79 86.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.918 -1.492 . . . . 1.3999999999999999 109.512 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.4 85.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.767 -1.106 . . . . 0.17000000000000001 109.597 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -65.41 -58.22 6.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.048 -0.978 . . . . 0.23999999999999999 110.061 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.63 78.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 123.269 0.355 . . . . 0.20999999999999999 110.571 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -57.62 -43.24 94.39 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.034 -1.226 . . . . 0.17000000000000001 110.034 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.1 mmt180 -70.29 -33.09 71.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.242 -0.479 . . . . 4.5300000000000002 110.412 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.7 mt -65.93 -61.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.373 -1.343 . . . . 0.28000000000000003 107.373 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 48.3 t80 -53.31 -39.36 63.96 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.476 -2.147 . . . . 0.29999999999999999 110.281 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.3 mt-10 -62.51 -54.46 39.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 110.89 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 17' ' ' ILE . 22.2 m -63.81 -26.18 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.323 -0.992 . . . . 0.16 108.323 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -73.02 -30.58 63.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.444 -1.253 . . . . 1.6599999999999999 108.755 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -75.65 -40.62 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.626 -1.17 . . . . 0.22 111.003 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 9.7 mm-40 -57.16 -41.86 79.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.631 -0.507 . . . . 2.6400000000000001 109.631 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -67.73 -28.99 73.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.817 -0.913 . . . . 0.42999999999999999 110.817 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.0 t60 -60.36 -47.95 83.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.226 -0.657 . . . . 0.73999999999999999 109.226 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.952 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.5 m95 -77.45 -6.6 54.06 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.32 -0.855 . . . . 1.5600000000000001 111.47 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 6.6 mm-40 -69.68 -40.38 76.4 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.592 -0.843 . . . . 0.85999999999999999 108.939 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.0 -22.2 45.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.249 -0.887 . . . . 1.49 110.703 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 26' ' ' TRP . 21.4 m -60.99 -32.65 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 C-N-CA 120.338 -0.545 . . . . 1.1899999999999999 111.424 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -51.44 -6.89 0.2 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 119.67 -1.252 . . . . 1.52 110.707 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.573 ' H ' ' C ' ' A' ' 29' ' ' VAL . 14.7 mmt -104.89 -68.13 0.87 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 3.02 110.411 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -60.6 -40.55 92.22 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.819 -0.628 . . . . 1.9199999999999999 110.586 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -65.9 -39.23 90.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.522 -0.763 . . . . 1.79 109.538 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -61.72 -34.73 76.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.345 -0.843 . . . . 2.48 110.997 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 36' ' ' LEU . 58.9 m -58.85 -24.19 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 3.1699999999999999 110.952 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -148.15 34.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.047 0.451 . . . . 2.7999999999999998 111.849 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.503 -0.692 0 N-CA-C 109.405 -1.478 . . . . 2.46 109.405 177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.9 mt . . . . . 0 CA--C 1.518 -0.288 0 CA-C-O 121.028 0.442 . . . . 6.1399999999999997 110.074 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 42.4 m-80 -61.63 -51.09 69.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.277 -0.874 . . . . 7.25 111.198 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' GLY . 8.1 mmm180 -53.38 -47.56 69.38 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.35 -0.386 . . . . 9.8200000000000003 110.163 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -67.02 -40.96 87.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.41 -0.959 . . . . 9.1999999999999993 108.41 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -68.94 -2.81 10.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.129 -0.941 . . . . 9.5 110.084 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -122.91 -12.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 11.26 112.004 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . -59.17 -13.57 21.4 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.899 -0.667 . . . . 12.640000000000001 112.579 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -166.7 -31.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.241 0.543 . . . . 12.960000000000001 110.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 24.1 mmt -71.08 -28.59 64.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 11.789999999999999 111.157 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 12.99 112.703 -179.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.446 -0.662 0 CA-C-O 121.114 0.483 . . . . 1.25 110.01 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -61.64 -28.78 69.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 1.6100000000000001 109.949 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 90.0 m -70.2 -37.06 74.99 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.38 110.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -44.16 92.33 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 108.127 -1.064 . . . . 2.1800000000000002 108.127 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -57.06 -32.21 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 113.669 -1.605 . . . . 0.33000000000000002 108.009 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' THR . 20.2 mt -76.66 -38.75 54.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.681 -1.6 . . . . 1.3999999999999999 110.279 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.19 -51.65 50.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.644 -1.162 . . . . 0.17000000000000001 110.503 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.96 -53.59 55.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.075 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.47 79.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.721 0.296 . . . . 0.20999999999999999 110.956 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -56.52 -41.45 88.79 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.892 -1.283 . . . . 0.17000000000000001 109.892 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.5 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.6 mmt180 -71.35 -35.12 71.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.821 -0.689 . . . . 4.5300000000000002 110.548 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.3 mt -66.81 -61.16 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 107.88 -1.155 . . . . 0.28000000000000003 107.88 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.5 t80 -52.48 -41.25 63.2 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.78 -2.009 . . . . 0.29999999999999999 110.41 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.4 mm-40 -60.24 -53.55 56.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.924 -0.58 . . . . 2.2999999999999998 110.969 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 17.2 m -68.31 -25.34 31.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 21.6 mmm -73.71 -28.22 61.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.842 -1.072 . . . . 1.6599999999999999 108.791 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -78.83 -42.55 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.79 -1.095 . . . . 0.22 111.357 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 7.4 pt-20 -57.09 -39.65 75.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.915 0.388 . . . . 2.6400000000000001 110.014 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -70.99 -28.44 70.49 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.094 -0.802 . . . . 0.42999999999999999 111.094 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.499 ' O ' HG13 ' A' ' 29' ' ' VAL . 77.9 t60 -58.77 -45.35 89.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.356 -0.609 . . . . 0.73999999999999999 109.356 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.924 ' O ' HG22 ' A' ' 29' ' ' VAL . 81.4 m95 -78.67 -6.35 55.48 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.587 -0.733 . . . . 1.5600000000000001 111.443 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 28.8 mm-40 -71.64 -40.75 69.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.616 -0.834 . . . . 0.85999999999999999 108.871 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 32' ' ' LEU . 1.2 t -80.14 -20.72 44.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.295 -0.866 . . . . 1.49 110.657 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' O ' ' A' ' 26' ' ' TRP . 32.7 m -59.43 -33.66 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 120.184 -0.606 . . . . 1.1899999999999999 111.072 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -50.52 -9.8 0.3 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.324 -1.417 . . . . 1.52 110.719 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' VAL . 91.1 mmm -102.27 -69.65 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.454 0.702 . . . . 3.02 110.255 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 2.3 pp -60.17 -43.03 96.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.394 -0.821 . . . . 1.9199999999999999 110.73 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 33.9 t80 -66.27 -32.7 74.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.211 -0.904 . . . . 1.79 109.796 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -59.67 -33.62 71.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.796 -0.638 . . . . 2.48 110.608 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 m -56.1 -17.65 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.451 -0.574 . . . . 3.1699999999999999 109.451 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.407 ' HB2' ' ND2' ' A' ' 44' ' ' ASN . 0.9 OUTLIER -148.74 29.24 0.84 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.181 -0.918 . . . . 2.7999999999999998 110.243 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.526 0 N-CA-C 110.164 -1.174 . . . . 2.46 110.164 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.767 0.318 . . . . 6.1399999999999997 110.187 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 36' ' ' LEU . 7.6 m-80 -64.02 -44.6 92.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 7.25 110.876 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.58 HH21 ' HB3' ' A' ' 48' ' ' TYR . 4.6 tpm_? -60.57 -53.57 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 9.8200000000000003 110.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.15 -36.38 77.42 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.183 -0.673 . . . . 9.1999999999999993 109.183 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.8 92.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 9.5 109.731 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.58 ' HB3' HH21 ' A' ' 45' ' ' ARG . 0.3 OUTLIER -66.05 -21.09 66.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.345 -0.843 . . . . 11.26 110.62 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.28 -2.75 0.27 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.657 -0.701 . . . . 12.640000000000001 113.21 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 48' ' ' TYR . 33.3 t -165.23 -36.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.757 0.313 . . . . 12.960000000000001 110.824 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 95.2 mmm -71.78 -32.85 68.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 11.789999999999999 110.355 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.657 . . . . 12.99 112.224 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' O ' ' OD2' ' A' ' 9' ' ' ASP . 1.4 p . . . . . 0 N--CA 1.446 -0.626 0 CA-C-O 120.986 0.422 . . . . 1.25 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 10' ' ' ILE . 28.1 t80 -61.89 -30.03 70.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.527 -0.546 . . . . 1.6100000000000001 109.527 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 28.8 m -72.7 -36.17 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.38 110.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -63.92 -43.52 95.67 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.171 -1.048 . . . . 2.1800000000000002 108.171 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' PHE . 66.6 mt -57.0 -32.29 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 113.544 -1.662 . . . . 0.33000000000000002 107.947 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 8' ' ' THR . 27.2 mt -77.72 -37.68 48.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.5 -1.682 . . . . 1.3999999999999999 110.236 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 -50.1 63.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.725 -1.125 . . . . 0.17000000000000001 110.274 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -61.45 -55.25 33.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.047 -0.979 . . . . 0.23999999999999999 110.133 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.89 -44.93 82.79 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 120.729 0.299 . . . . 0.20999999999999999 110.635 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.54 -42.08 95.81 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.059 -1.217 . . . . 0.17000000000000001 110.059 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.2 mmt180 -71.08 -34.53 71.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -0.632 . . . . 4.5300000000000002 110.423 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.1 mt -66.29 -61.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.794 -1.188 . . . . 0.28000000000000003 107.794 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.7 t80 -53.37 -40.66 65.15 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.503 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.2 mt-10 -61.51 -54.56 41.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.862 -0.608 . . . . 2.2999999999999998 111.207 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 17' ' ' ILE . 23.0 m -65.07 -26.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.484 -0.932 . . . . 0.16 108.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.68 -31.48 66.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.504 -1.225 . . . . 1.6599999999999999 108.713 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 5.1 t -76.89 -48.0 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.494 -1.23 . . . . 0.22 110.823 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 13.5 mm-40 -57.33 -45.01 84.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.25 -0.648 . . . . 2.6400000000000001 109.25 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.21 -29.38 75.18 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.147 -0.933 . . . . 0.42999999999999999 110.912 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 29' ' ' VAL . 56.9 t60 -59.62 -47.05 87.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.346 -0.613 . . . . 0.73999999999999999 109.346 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.949 ' O ' HG22 ' A' ' 29' ' ' VAL . 75.0 m95 -78.16 -15.46 58.82 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 111.486 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.3 mm-40 -63.04 -36.58 84.05 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.831 -1.174 . . . . 0.85999999999999999 107.831 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.7 m -75.03 -30.64 61.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.434 -1.712 . . . . 1.49 110.89 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.4 m -65.05 -37.35 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 112.864 0.69 . . . . 1.1899999999999999 112.864 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -11.17 0.27 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 119.315 -1.422 . . . . 1.52 110.82 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.529 ' N ' ' C ' ' A' ' 29' ' ' VAL . 9.3 mmt -105.5 -68.09 0.88 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.998 0.519 . . . . 3.02 110.891 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.2 pp -59.56 -34.1 72.26 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.119 -0.491 . . . . 1.9199999999999999 110.812 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 1.7 t80 -70.24 -39.45 75.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.622 -0.717 . . . . 1.79 109.717 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.31 -37.91 73.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.039 -0.982 . . . . 2.48 111.543 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -59.27 -30.23 68.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 110.978 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.7 32.12 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 2.7999999999999998 111.015 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 C--O 1.215 -1.086 0 N-CA-C 109.623 -1.391 . . . . 2.46 109.623 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.6 mt . . . . . 0 CA--C 1.519 -0.228 0 CA-C-O 120.785 0.326 . . . . 6.1399999999999997 110.215 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -59.04 -39.58 82.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 7.25 110.236 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -62.78 -51.45 67.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.12 -0.491 . . . . 9.8200000000000003 110.532 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -60.49 -37.57 81.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.181 -0.674 . . . . 9.1999999999999993 109.181 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.07 92.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.926 -1.034 . . . . 9.5 110.026 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -65.62 -24.48 67.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.452 -0.795 . . . . 11.26 110.633 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.21 2.73 0.15 Allowed Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.499 -0.773 . . . . 12.640000000000001 113.536 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' TYR . 69.8 m -163.06 -38.16 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.965 0.383 . . . . 12.960000000000001 110.538 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.69 -24.92 60.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 11.789999999999999 110.817 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.846 -0.693 . . . . 12.99 112.404 179.929 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 109.23 -0.656 . . . . 1.25 109.23 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 33.0 t80 -61.58 -39.64 91.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.515 -0.766 . . . . 1.6100000000000001 110.582 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.709 ' HA ' HD23 ' A' ' 11' ' ' LEU . 94.2 m -67.63 -29.87 69.29 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.155 0.503 . . . . 0.38 109.932 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.48 -41.27 84.83 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.291 -1.374 . . . . 2.1800000000000002 107.291 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.7 mt -66.11 -36.02 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 113.729 -1.578 . . . . 0.33000000000000002 109.085 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.746 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -70.54 -41.29 72.69 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.395 -1.275 . . . . 1.3999999999999999 108.836 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -55.38 30.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.646 -1.616 . . . . 0.17000000000000001 110.01 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.21 -51.77 66.44 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.28 -0.873 . . . . 0.23999999999999999 110.558 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.76 74.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.424 -0.511 . . . . 0.20999999999999999 110.09 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -60.55 -51.37 59.12 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.722 -0.752 . . . . 0.17000000000000001 111.278 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -71.68 -28.7 63.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.679 0.276 . . . . 4.5300000000000002 110.795 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.6 mt -66.54 -59.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 106.71 -1.589 . . . . 0.28000000000000003 106.71 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CE1' HG21 ' A' ' 22' ' ' VAL . 33.8 t80 -55.18 -38.66 68.63 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.616 -2.084 . . . . 0.29999999999999999 109.587 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.4 mt-10 -60.74 -51.1 70.78 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.597 -0.728 . . . . 2.2999999999999998 110.953 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 17' ' ' ILE . 18.8 m -68.5 -28.53 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.952 -0.759 . . . . 0.16 108.952 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -72.04 -27.66 62.86 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.977 -1.011 . . . . 1.6599999999999999 108.813 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 18' ' ' PHE . 3.4 t -83.31 -43.25 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.532 -1.213 . . . . 0.22 111.785 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.1 -40.83 82.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.893 0.377 . . . . 2.6400000000000001 110.022 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.51 -35.31 91.79 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.088 -1.205 . . . . 0.42999999999999999 110.088 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.611 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.0 t60 -62.43 -41.86 99.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.501 -0.925 . . . . 0.73999999999999999 108.501 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 22.9 m95 -74.31 -15.06 60.97 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.715 -1.13 . . . . 1.5600000000000001 110.929 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -42.61 58.71 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.85999999999999999 109.861 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.39 -22.17 55.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.241 -0.89 . . . . 1.49 111.207 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 26' ' ' TRP . 33.3 m -61.07 -36.07 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 119.97 -0.692 . . . . 1.1899999999999999 110.684 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.52 -11.0 0.13 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 119.832 -1.175 . . . . 1.52 111.036 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' VAL . 17.3 mmt -102.02 -67.62 0.86 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.337 0.655 . . . . 3.02 110.743 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.669 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -59.2 -38.41 79.82 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.816 -0.629 . . . . 1.9199999999999999 110.801 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.9 t80 -65.93 -39.33 90.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.638 -0.71 . . . . 1.79 109.708 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -38.58 82.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.355 -0.839 . . . . 2.48 111.301 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' HD23 ' A' ' 36' ' ' LEU . 47.9 t -53.94 -28.78 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 3.1699999999999999 110.38 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -141.35 38.09 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 2.7999999999999998 110.71 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.505 -0.576 0 N-CA-C 109.779 -1.328 . . . . 2.46 109.779 177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.4 mt . . . . . 0 N--CA 1.454 -0.244 0 CA-C-O 120.908 0.385 . . . . 6.1399999999999997 110.231 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.99 -40.93 95.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.676 -0.693 . . . . 7.25 110.737 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -63.03 -53.02 60.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 9.8200000000000003 110.799 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -60.4 -36.69 78.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.243 -0.651 . . . . 9.1999999999999993 109.243 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.35 87.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.031 -0.986 . . . . 9.5 110.073 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -63.89 -20.49 65.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.542 -0.754 . . . . 11.26 110.807 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.11 -5.45 0.45 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.688 -0.687 . . . . 12.640000000000001 113.168 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.36 -34.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 12.960000000000001 110.66 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.1 mmm -73.39 -24.75 60.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 11.789999999999999 110.955 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 12.99 112.56 -179.842 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 71.1 t . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 109.757 -0.46 . . . . 1.25 109.757 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -63.17 -34.88 78.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.896 0.379 . . . . 1.6100000000000001 110.035 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 -36.03 75.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.1 -0.5 . . . . 0.38 110.806 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -34.88 79.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.037 -1.098 . . . . 2.1800000000000002 108.037 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 7' ' ' PHE . 71.6 mt -64.48 -42.68 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.043 -1.435 . . . . 0.33000000000000002 108.074 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -66.65 -37.53 85.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.011 -1.449 . . . . 1.3999999999999999 109.612 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.93 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.739 -1.119 . . . . 0.17000000000000001 109.69 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.31 -58.79 5.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.861 -1.063 . . . . 0.23999999999999999 109.999 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 -42.94 76.9 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.916 0.389 . . . . 0.20999999999999999 110.582 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.28 -55.31 25.09 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.711 -0.956 . . . . 0.17000000000000001 110.711 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.2 mtp180 -69.33 -32.15 71.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.834 -0.683 . . . . 4.5300000000000002 111.666 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.0 mt -61.92 -60.76 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.167 -1.79 . . . . 0.28000000000000003 106.167 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.9 t80 -54.93 -40.96 70.46 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.29 -2.232 . . . . 0.29999999999999999 110.323 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -62.56 -54.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.778 -0.646 . . . . 2.2999999999999998 111.205 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 16' ' ' ARG . 17.9 m -63.86 -26.59 40.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.236 -1.024 . . . . 0.16 108.236 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -72.65 -31.04 64.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.529 -1.214 . . . . 1.6599999999999999 108.819 177.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 18' ' ' PHE . 8.6 t -78.15 -44.45 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.677 -1.147 . . . . 0.22 111.167 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 7.1 mm-40 -57.85 -42.88 85.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.519 -0.549 . . . . 2.6400000000000001 109.519 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -29.52 74.99 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.872 -0.891 . . . . 0.42999999999999999 110.872 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.431 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.7 t60 -60.25 -48.23 82.63 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.221 -0.659 . . . . 0.73999999999999999 109.221 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.939 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.9 m95 -77.98 -6.82 55.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.386 -0.825 . . . . 1.5600000000000001 111.605 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.6 mm-40 -70.09 -40.52 74.91 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.391 -0.924 . . . . 0.85999999999999999 108.996 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -78.85 -21.74 47.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.352 -0.84 . . . . 1.49 110.677 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 26' ' ' TRP . 24.4 m -60.69 -33.39 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 120.281 -0.568 . . . . 1.1899999999999999 111.099 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -52.43 -5.09 0.17 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 119.744 -1.217 . . . . 1.52 110.843 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.602 ' H ' ' C ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -107.91 -67.23 0.98 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.485 0.714 . . . . 3.02 110.265 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.5 pp -59.68 -40.8 89.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.888 -0.596 . . . . 1.9199999999999999 110.237 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -67.1 -41.93 85.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.278 -0.874 . . . . 1.79 109.49 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 2.48 111.256 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 36' ' ' LEU . 61.3 m -57.96 -15.74 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.492 . . . . 3.1699999999999999 109.805 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -160.04 33.0 0.18 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.48 -0.782 . . . . 2.7999999999999998 110.792 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.505 -0.534 0 N-CA-C 110.302 -1.119 . . . . 2.46 110.302 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.227 -0.097 0 CA-C-O 120.444 0.164 . . . . 6.1399999999999997 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.403 ' OD1' ' HB2' ' A' ' 36' ' ' LEU . 1.7 m-80 -59.88 -48.11 83.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.597 -0.274 . . . . 7.25 111.212 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -51.64 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 9.8200000000000003 111.113 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.37 -34.45 75.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.107 -0.701 . . . . 9.1999999999999993 109.107 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.19 -41.91 85.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.185 -0.916 . . . . 9.5 109.989 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.08 -23.19 67.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.695 -0.684 . . . . 11.26 110.628 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.55 1.53 0.28 Allowed Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.632 -0.713 . . . . 12.640000000000001 113.118 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.33 -38.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 12.960000000000001 110.724 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.0 mmt -73.36 -28.24 61.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.969 -0.56 . . . . 11.789999999999999 110.828 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.822 -0.704 . . . . 12.99 112.545 -179.653 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.858 0.837 . . . . 1.25 109.717 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.9 t80 -63.42 -44.85 93.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.331 -1.304 . . . . 1.6100000000000001 110.789 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 16.7 m -60.98 -30.78 70.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.891 -0.411 . . . . 0.38 109.891 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -46.82 72.84 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.527 -0.916 . . . . 2.1800000000000002 108.527 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 50.6 mt -55.28 -30.27 24.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.069 -1.423 . . . . 0.33000000000000002 108.087 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' THR . 30.0 mt -79.07 -42.15 27.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.586 -1.643 . . . . 1.3999999999999999 110.764 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -49.04 65.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 0.17000000000000001 110.239 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -59.72 -59.27 5.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.66 -1.155 . . . . 0.23999999999999999 110.018 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.37 87.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.006 0.431 . . . . 0.20999999999999999 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.657 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -51.7 -52.03 35.95 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.828 -1.177 . . . . 0.17000000000000001 110.391 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.7 ttt180 -71.83 -34.36 69.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 124.136 0.551 . . . . 4.5300000000000002 111.453 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.7 mt -63.86 -62.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.113 -1.439 . . . . 0.28000000000000003 107.113 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 22' ' ' VAL . 70.3 t80 -51.68 -42.06 61.87 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.322 -2.217 . . . . 0.29999999999999999 110.141 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -62.78 -56.38 18.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.819 -0.628 . . . . 2.2999999999999998 111.173 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 16' ' ' ARG . 18.6 m -60.59 -27.16 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.978 -1.119 . . . . 0.16 107.978 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 5.7 mmt -73.29 -31.65 64.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.334 -1.303 . . . . 1.6599999999999999 108.553 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.7 t -75.31 -42.08 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.613 -1.176 . . . . 0.22 111.075 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.5 mm-40 -58.92 -46.7 87.28 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.485 -0.561 . . . . 2.6400000000000001 109.485 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -59.58 -34.7 82.74 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.097 -1.201 . . . . 0.42999999999999999 110.097 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.619 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.9 t60 -63.15 -41.91 99.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.385 -0.969 . . . . 0.73999999999999999 108.385 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.881 ' O ' HG22 ' A' ' 29' ' ' VAL . 23.2 m95 -73.82 -15.75 61.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.578 -1.192 . . . . 1.5600000000000001 110.828 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 7.9 mm-40 -72.79 -44.63 61.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.382 0.611 . . . . 0.85999999999999999 109.637 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.528 ' O ' ' HG3' ' A' ' 31' ' ' MET . 0.5 OUTLIER -78.2 -19.94 52.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.047 -0.979 . . . . 1.49 111.211 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.0 m -56.32 -32.98 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 119.365 -0.934 . . . . 1.1899999999999999 109.895 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.73 -9.96 0.07 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.877 -1.154 . . . . 1.52 111.597 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.606 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.44 -57.99 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.266 0.226 . . . . 3.02 111.459 179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.1 pp -64.84 -32.19 73.77 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.719 . . . . 1.9199999999999999 109.803 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -72.6 -48.32 40.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.63 -1.168 . . . . 1.79 109.152 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.55 -43.04 75.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.9 -1.045 . . . . 2.48 111.771 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.457 ' HB3' HD23 ' A' ' 36' ' ' LEU . 48.3 t -54.0 -21.72 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 3.1699999999999999 110.908 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -155.95 44.27 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 2.7999999999999998 110.672 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.504 -0.617 0 N-CA-C 109.142 -1.583 . . . . 2.46 109.142 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.0 mt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 111.878 0.325 . . . . 6.1399999999999997 111.878 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -59.89 4.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 111.919 0.341 . . . . 7.25 111.919 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 7.9 ttp180 -55.06 -47.05 75.36 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.545 0.212 . . . . 9.8200000000000003 111.298 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.65 -34.06 77.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.115 -0.698 . . . . 9.1999999999999993 109.115 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.21 -48.26 68.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.176 -0.92 . . . . 9.5 110.102 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -18.09 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.856 . . . . 11.26 111.286 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.28 -9.14 1.36 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.833 -0.698 . . . . 12.640000000000001 112.679 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 t -166.55 -31.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.709 0.29 . . . . 12.960000000000001 111.101 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.1 mmm -71.85 -31.03 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 11.789999999999999 111.078 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.887 -0.673 . . . . 12.99 112.535 -179.553 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.5 p . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.089 0.471 . . . . 1.25 111.235 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 29.9 t80 -58.34 -42.27 86.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.485 -0.78 . . . . 1.6100000000000001 111.299 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -65.53 -31.63 72.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.692 -0.403 . . . . 0.38 110.295 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.16 85.03 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.843 -1.169 . . . . 2.1800000000000002 107.843 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.2 mt -64.52 -39.64 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 114.158 -1.383 . . . . 0.33000000000000002 108.153 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.78 -38.26 83.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.895 -1.502 . . . . 1.3999999999999999 109.753 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.39 79.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.747 -1.115 . . . . 0.17000000000000001 109.855 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -57.15 10.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.073 -0.967 . . . . 0.23999999999999999 110.187 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.74 78.88 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.78 0.324 . . . . 0.20999999999999999 110.471 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -61.09 -40.51 98.62 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 109.941 -1.264 . . . . 0.17000000000000001 109.941 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.6 mmt180 -71.23 -34.86 71.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.2 -0.5 . . . . 4.5300000000000002 110.151 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.9 mt -66.0 -58.85 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 107.902 -1.148 . . . . 0.28000000000000003 107.902 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' VAL . 26.3 t80 -55.99 -39.6 72.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.895 -1.957 . . . . 0.29999999999999999 110.043 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.2 mm-40 -61.24 -51.57 68.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.922 -0.581 . . . . 2.2999999999999998 110.709 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 21.6 m -69.23 -26.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.017 -0.734 . . . . 0.16 109.017 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -72.68 -29.34 63.33 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.219 -0.9 . . . . 1.6599999999999999 108.685 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.1 t -79.54 -45.44 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.718 -1.128 . . . . 0.22 110.732 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 8.4 pt-20 -59.76 -40.22 87.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.188 -0.671 . . . . 2.6400000000000001 109.188 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -62.72 -35.45 91.92 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.114 -1.194 . . . . 0.42999999999999999 110.114 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.64 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.9 t60 -62.3 -38.34 89.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.73999999999999999 108.422 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.815 ' O ' HG22 ' A' ' 29' ' ' VAL . 36.5 m95 -76.3 -17.03 59.64 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.966 -1.015 . . . . 1.5600000000000001 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 16.2 mm-40 -73.43 -41.86 62.74 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.248 -1.019 . . . . 0.85999999999999999 108.248 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 m -68.97 -31.13 69.76 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.435 -1.711 . . . . 1.49 111.257 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.3 m -62.09 -36.69 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 120.347 -0.541 . . . . 1.1899999999999999 111.407 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.37 -8.76 0.19 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.031 -1.08 . . . . 1.52 111.655 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.553 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -113.61 -55.67 2.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.157 0.183 . . . . 3.02 111.34 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.4 pp -64.99 -26.52 68.33 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.48 0.657 . . . . 1.9199999999999999 109.534 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 6.1 t80 -72.93 -47.42 45.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.014 -0.994 . . . . 1.79 109.091 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.51 -40.35 91.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.584 -1.189 . . . . 2.48 110.828 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.5 ' HB2' HD23 ' A' ' 36' ' ' LEU . 52.5 m -48.31 -31.37 5.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 3.1699999999999999 110.434 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.4 OUTLIER -141.8 39.35 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.804 -0.635 . . . . 2.7999999999999998 110.725 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.506 -0.512 0 N-CA-C 109.997 -1.241 . . . . 2.46 109.997 177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mt . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.012 0.435 . . . . 6.1399999999999997 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -60.02 -43.72 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 7.25 111.299 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -49.3 73.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 9.8200000000000003 110.903 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.64 -36.8 83.98 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.695 . . . . 9.1999999999999993 109.125 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.65 90.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 9.5 110.035 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -67.24 -18.94 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 11.26 110.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.72 1.72 0.47 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.878 -0.601 . . . . 12.640000000000001 113.265 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 48' ' ' TYR . 48.1 t -166.13 -34.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.346 . . . . 12.960000000000001 110.752 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -73.73 -22.3 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 11.789999999999999 111.084 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 12.99 112.562 -179.769 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.7 p . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 121.019 0.438 . . . . 1.25 111.297 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.6 t80 -57.3 -43.16 82.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.519 -0.764 . . . . 1.6100000000000001 111.072 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 11' ' ' LEU . 62.2 m -65.83 -31.08 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.68 -0.408 . . . . 0.38 109.914 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.15 83.97 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.965 -1.124 . . . . 2.1800000000000002 107.965 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 72.7 mt -63.59 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.313 -1.312 . . . . 0.33000000000000002 108.08 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 8' ' ' THR . 38.4 mt -67.44 -38.21 84.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.896 -1.502 . . . . 1.3999999999999999 109.751 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.46 -46.06 77.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.77 -1.105 . . . . 0.17000000000000001 110.034 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.87 -55.63 21.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.11 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.6 77.28 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.20999999999999999 110.389 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.12 -41.6 94.73 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.954 -1.259 . . . . 0.17000000000000001 109.954 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.9 mmt180 -70.8 -33.54 70.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.103 -0.549 . . . . 4.5300000000000002 110.279 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.25 -62.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.636 -1.246 . . . . 0.28000000000000003 107.636 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 t80 -51.68 -41.23 61.27 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.218 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.8 mt-10 -61.85 -55.63 27.87 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 111.17 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ILE . 26.7 m -63.59 -26.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.371 -0.974 . . . . 0.16 108.371 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -72.07 -31.45 66.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.492 -1.231 . . . . 1.6599999999999999 108.441 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' PHE . 7.0 t -75.42 -45.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.534 -1.212 . . . . 0.22 110.717 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 8.1 mm-40 -59.62 -45.76 90.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.12 -0.696 . . . . 2.6400000000000001 109.12 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.11 85.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . 81.8 t60 -63.67 -39.02 93.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.55 -0.907 . . . . 0.73999999999999999 108.55 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.877 ' O ' HG22 ' A' ' 29' ' ' VAL . 28.2 m95 -76.22 -16.48 59.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.853 -1.067 . . . . 1.5600000000000001 110.503 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -73.86 -41.67 61.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.337 -0.616 . . . . 0.85999999999999999 109.337 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -75.63 -22.71 56.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.078 -0.965 . . . . 1.49 111.032 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 26' ' ' TRP . 34.5 m -60.85 -33.99 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 C-N-CA 119.871 -0.732 . . . . 1.1899999999999999 110.248 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -48.56 -10.58 0.12 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.781 -1.2 . . . . 1.52 110.806 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' VAL . 19.4 mmt -101.19 -68.18 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.374 0.67 . . . . 3.02 110.446 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -59.64 -41.35 90.3 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.859 -0.61 . . . . 1.9199999999999999 110.675 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.1 t80 -64.68 -37.11 86.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 1.79 109.504 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -59.81 -34.12 72.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.475 -0.784 . . . . 2.48 110.696 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.5 m -59.71 -27.85 66.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.953 -0.567 . . . . 3.1699999999999999 110.154 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.41 35.53 2.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 2.7999999999999998 110.936 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . . . . . . 0 CA--C 1.507 -0.431 0 N-CA-C 109.742 -1.343 . . . . 2.46 109.742 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.087 0.47 . . . . 6.1399999999999997 110.201 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -60.14 -48.94 79.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 7.25 111.538 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -60.66 -51.61 68.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.595 -0.275 . . . . 9.8200000000000003 111.19 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.24 -34.5 76.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.19 -0.67 . . . . 9.1999999999999993 109.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 -40.62 88.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.387 -0.824 . . . . 9.5 109.885 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.36 -24.06 67.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.382 -0.826 . . . . 11.26 110.499 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.61 2.99 0.27 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.617 -0.719 . . . . 12.640000000000001 113.33 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 48' ' ' TYR . 70.8 m -163.5 -39.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 12.960000000000001 110.542 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.3 mtt -72.92 -28.95 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 11.789999999999999 110.523 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.906 -0.664 . . . . 12.99 111.904 179.832 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.3 p . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.986 0.422 . . . . 1.25 111.21 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.576 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.8 t80 -57.31 -42.42 81.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.589 -0.732 . . . . 1.6100000000000001 110.582 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 m -67.43 -32.67 73.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.72 -0.392 . . . . 0.38 110.066 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -35.12 79.9 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.711 -1.218 . . . . 2.1800000000000002 107.711 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 68.4 mt -65.27 -41.59 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.011 -1.45 . . . . 0.33000000000000002 107.854 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.35 -37.87 88.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.095 -1.412 . . . . 1.3999999999999999 109.252 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.89 81.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.734 -1.121 . . . . 0.17000000000000001 109.383 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.66 -58.07 8.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.95 -1.023 . . . . 0.23999999999999999 110.037 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.79 76.87 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.002 0.43 . . . . 0.20999999999999999 109.885 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.39 -41.62 63.38 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.67 -1.372 . . . . 0.17000000000000001 109.67 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.6 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -72.66 -37.89 67.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.053 -0.574 . . . . 4.5300000000000002 110.86 178.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.5 mt -67.09 -63.08 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 122.623 1.201 . . . . 0.28000000000000003 108.08 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 21' ' ' MET . 53.6 t80 -50.62 -39.8 51.17 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 112.654 -2.066 . . . . 0.29999999999999999 110.394 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.667 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -61.84 -53.78 51.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.916 0.388 . . . . 2.2999999999999998 110.885 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 17' ' ' ILE . 13.2 m -64.92 -26.11 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.011 -1.107 . . . . 0.16 108.011 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 5.4 mmt -74.96 -26.98 59.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.434 -1.257 . . . . 1.6599999999999999 108.549 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' PHE . 2.6 t -78.02 -36.39 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.482 -1.235 . . . . 0.22 111.35 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 5.8 pt-20 -58.76 -44.6 90.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.801 -0.444 . . . . 2.6400000000000001 109.801 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -64.0 -33.05 86.21 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.653 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.1 t60 -62.23 -37.09 84.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.356 -0.979 . . . . 0.73999999999999999 108.356 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.862 ' O ' HG22 ' A' ' 29' ' ' VAL . 19.0 m95 -74.22 -16.4 60.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.952 -1.022 . . . . 1.5600000000000001 110.166 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 11.1 mm-40 -75.23 -42.78 54.61 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -78.17 -18.92 54.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.821 -1.081 . . . . 1.49 111.259 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 ' O ' ' A' ' 26' ' ' TRP . 31.0 m -57.61 -33.36 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 119.811 -0.756 . . . . 1.1899999999999999 110.193 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.05 -11.99 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.738 -1.22 . . . . 1.52 111.502 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 13.9 mmt -103.89 -65.08 1.04 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.981 0.512 . . . . 3.02 110.898 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.676 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -60.0 -34.39 73.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.241 -0.436 . . . . 1.9199999999999999 110.727 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.12 -34.81 78.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 1.79 109.379 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 31' ' ' MET . 3.2 t70 -59.55 -34.04 72.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.379 -0.828 . . . . 2.48 110.453 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -74.13 -5.47 41.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.404 0.621 . . . . 3.1699999999999999 109.476 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 2.3 mt -126.28 6.11 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.026 -0.988 . . . . 2.7999999999999998 110.059 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.501 0 N-CA-C 106.868 -2.493 . . . . 2.46 106.868 178.174 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.694 0.283 . . . . 6.1399999999999997 110.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -59.12 -41.32 87.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 7.25 110.569 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.57 -51.97 65.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.241 -0.436 . . . . 9.8200000000000003 110.767 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -60.85 -36.39 79.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.211 -0.663 . . . . 9.1999999999999993 109.211 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.88 87.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 9.5 109.967 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -63.23 -22.82 67.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.455 -0.793 . . . . 11.26 110.558 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.44 -7.79 0.26 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.404 -0.816 . . . . 12.640000000000001 113.156 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 48' ' ' TYR . 42.2 t -163.4 -35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.894 0.378 . . . . 12.960000000000001 110.94 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.66 -30.68 64.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 11.789999999999999 110.635 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.397 0 C-N-CA 120.89 -0.671 . . . . 12.99 111.997 -179.669 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.3 mtp . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.838 0.351 . . . . 7.25 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -120.11 107.07 12.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 4.7400000000000002 110.853 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 125.76 -83.0 0.35 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.808 -0.71 . . . . 2.96 112.457 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.57 -10.4 7.86 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.891 -0.671 . . . . 1.3700000000000001 112.673 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.85 -61.61 7.01 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.354 -0.927 . . . . 2.1400000000000001 111.503 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG13 ' N ' ' A' ' 7' ' ' PHE . 6.8 p -64.76 -44.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.152 0.501 . . . . 1.25 111.309 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.491 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 28.5 t80 -56.79 -43.74 81.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.334 -0.848 . . . . 1.6100000000000001 111.344 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.439 ' HA ' HD12 ' A' ' 11' ' ' LEU . 58.3 m -65.66 -31.57 72.66 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.62 -0.432 . . . . 0.38 110.205 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.37 -37.53 83.33 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 107.986 -1.116 . . . . 2.1800000000000002 107.986 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 73.4 mt -64.19 -40.06 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 CA-C-N 114.272 -1.331 . . . . 0.33000000000000002 108.033 177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 8' ' ' THR . 39.2 mt -66.87 -38.79 86.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.918 -1.492 . . . . 1.3999999999999999 109.512 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.46 -40.4 85.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.767 -1.106 . . . . 0.17000000000000001 109.597 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -65.41 -58.22 6.41 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.048 -0.978 . . . . 0.23999999999999999 110.061 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.8 -45.63 78.2 Favored 'General case' 0 CA--C 1.515 -0.389 0 O-C-N 123.269 0.355 . . . . 0.20999999999999999 110.571 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -57.62 -43.24 94.39 Favored Glycine 0 N--CA 1.443 -0.879 0 N-CA-C 110.034 -1.226 . . . . 0.17000000000000001 110.034 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.1 mmt180 -70.29 -33.09 71.13 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.242 -0.479 . . . . 4.5300000000000002 110.412 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.7 mt -65.93 -61.3 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.373 -1.343 . . . . 0.28000000000000003 107.373 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 22' ' ' VAL . 48.3 t80 -53.31 -39.36 63.96 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 112.476 -2.147 . . . . 0.29999999999999999 110.281 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.3 mt-10 -62.51 -54.46 39.62 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.946 -0.57 . . . . 2.2999999999999998 110.89 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 17' ' ' ILE . 22.2 m -63.81 -26.18 39.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.323 -0.992 . . . . 0.16 108.323 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -73.02 -30.58 63.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.444 -1.253 . . . . 1.6599999999999999 108.755 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -75.65 -40.62 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 114.626 -1.17 . . . . 0.22 111.003 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 9.7 mm-40 -57.16 -41.86 79.98 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.631 -0.507 . . . . 2.6400000000000001 109.631 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -67.73 -28.99 73.46 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 110.817 -0.913 . . . . 0.42999999999999999 110.817 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.0 t60 -60.36 -47.95 83.85 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 109.226 -0.657 . . . . 0.73999999999999999 109.226 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.952 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.5 m95 -77.45 -6.6 54.06 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.32 -0.855 . . . . 1.5600000000000001 111.47 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 6.6 mm-40 -69.68 -40.38 76.4 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 119.592 -0.843 . . . . 0.85999999999999999 108.939 177.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.0 -22.2 45.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.249 -0.887 . . . . 1.49 110.703 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.952 HG22 ' O ' ' A' ' 26' ' ' TRP . 21.4 m -60.99 -32.65 53.08 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 C-N-CA 120.338 -0.545 . . . . 1.1899999999999999 111.424 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -51.44 -6.89 0.2 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 119.67 -1.252 . . . . 1.52 110.707 177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.573 ' H ' ' C ' ' A' ' 29' ' ' VAL . 14.7 mmt -104.89 -68.13 0.87 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.483 0.713 . . . . 3.02 110.411 178.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.631 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -60.6 -40.55 92.22 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-N 115.819 -0.628 . . . . 1.9199999999999999 110.586 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' O ' ' N ' ' A' ' 37' ' ' GLY . 1.7 t80 -65.9 -39.23 90.4 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.522 -0.763 . . . . 1.79 109.538 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -61.72 -34.73 76.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.345 -0.843 . . . . 2.48 110.997 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' HD23 ' A' ' 36' ' ' LEU . 58.9 m -58.85 -24.19 61.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.81 -0.632 . . . . 3.1699999999999999 110.952 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 35' ' ' SER . 0.5 OUTLIER -148.15 34.51 0.81 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.047 0.451 . . . . 2.7999999999999998 111.849 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -131.24 -40.18 0.24 Allowed Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 109.405 -1.478 . . . . 2.46 109.405 177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.5 tptt -79.14 -49.94 11.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.961 -1.119 . . . . 3.4300000000000002 108.169 178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.94 -28.72 60.18 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 114.306 -1.316 . . . . 3.5299999999999998 111.091 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 43' ' ' ILE . 0.8 OUTLIER -65.12 -39.43 93.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.74 -0.384 . . . . 3.8900000000000001 111.021 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.0 mtm -46.64 -36.38 6.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.978 -0.555 . . . . 4.8899999999999997 110.409 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -70.34 -42.65 71.6 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.029 -0.532 . . . . 8.1099999999999994 109.734 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 40' ' ' THR . 25.9 mt -58.73 -50.37 79.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.755 . . . . 6.1399999999999997 110.074 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 42.4 m-80 -61.63 -51.09 69.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.277 -0.874 . . . . 7.25 111.198 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 49' ' ' GLY . 8.1 mmm180 -53.38 -47.56 69.38 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.35 -0.386 . . . . 9.8200000000000003 110.163 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 54.1 m-80 -67.02 -40.96 87.37 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.41 -0.959 . . . . 9.1999999999999993 108.41 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 51' ' ' MET . . . -68.94 -2.81 10.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.129 -0.941 . . . . 9.5 110.084 178.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 0.6 OUTLIER -122.91 -12.79 7.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.825 -0.625 . . . . 11.26 112.004 178.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 45' ' ' ARG . . . -59.17 -13.57 21.4 Favored Glycine 0 CA--C 1.517 0.18 0 C-N-CA 120.899 -0.667 . . . . 12.640000000000001 112.579 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -166.7 -31.68 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.241 0.543 . . . . 12.960000000000001 110.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.67 ' HB2' ' O ' ' A' ' 47' ' ' ALA . 24.1 mmt -71.08 -28.59 64.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.451 -0.795 . . . . 11.789999999999999 111.157 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -112.56 37.85 3.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 12.99 112.703 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.43 -3.01 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.769 -0.729 . . . . 15.68 112.415 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.6 -48.36 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.773 -0.727 . . . . 15.710000000000001 112.435 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.61 -54.47 10.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 14.92 110.814 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 mt -110.73 -21.68 11.96 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.854 -0.612 . . . . 16.219999999999999 111.046 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 47.3 23.29 0.32 Allowed 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 115.455 -0.793 . . . . 19.829999999999998 112.137 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 55.45 30.1 54.86 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.997 -0.621 . . . . 17.620000000000001 112.953 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.329 -0.843 . . . . 17.91 110.805 179.875 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.838 0.351 . . . . 7.25 110.802 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -168.22 110.79 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 4.7400000000000002 110.921 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.67 -95.14 0.29 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.933 -0.651 . . . . 2.96 112.001 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 6' ' ' VAL . . . -75.85 5.14 41.42 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.539 -0.839 . . . . 1.3700000000000001 112.238 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.78 4.89 4.97 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.725 -0.75 . . . . 2.1400000000000001 111.423 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 4' ' ' GLY . 1.3 p -170.99 -30.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 CA-C-N 114.664 -0.768 . . . . 1.25 110.01 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -61.64 -28.78 69.62 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.835 -0.621 . . . . 1.6100000000000001 109.949 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 90.0 m -70.2 -37.06 74.99 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 115.971 -0.558 . . . . 0.38 110.173 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -44.16 92.33 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 108.127 -1.064 . . . . 2.1800000000000002 108.127 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.3 mt -57.06 -32.21 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-N 113.669 -1.605 . . . . 0.33000000000000002 108.009 177.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 8' ' ' THR . 20.2 mt -76.66 -38.75 54.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.681 -1.6 . . . . 1.3999999999999999 110.279 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.19 -51.65 50.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.644 -1.162 . . . . 0.17000000000000001 110.503 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -60.96 -53.59 55.39 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.075 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.47 79.87 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 120.721 0.296 . . . . 0.20999999999999999 110.956 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -56.52 -41.45 88.79 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 109.892 -1.283 . . . . 0.17000000000000001 109.892 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.5 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.6 mmt180 -71.35 -35.12 71.05 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.821 -0.689 . . . . 4.5300000000000002 110.548 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.3 mt -66.81 -61.16 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.942 0 N-CA-C 107.88 -1.155 . . . . 0.28000000000000003 107.88 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 32.5 t80 -52.48 -41.25 63.2 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 112.78 -2.009 . . . . 0.29999999999999999 110.41 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.4 mm-40 -60.24 -53.55 56.39 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.924 -0.58 . . . . 2.2999999999999998 110.969 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 23' ' ' GLU . 17.2 m -68.31 -25.34 31.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 21.6 mmm -73.71 -28.22 61.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 114.842 -1.072 . . . . 1.6599999999999999 108.791 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.3 t -78.83 -42.55 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.79 -1.095 . . . . 0.22 111.357 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 7.4 pt-20 -57.09 -39.65 75.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.915 0.388 . . . . 2.6400000000000001 110.014 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -70.99 -28.44 70.49 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.094 -0.802 . . . . 0.42999999999999999 111.094 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.499 ' O ' HG13 ' A' ' 29' ' ' VAL . 77.9 t60 -58.77 -45.35 89.98 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.356 -0.609 . . . . 0.73999999999999999 109.356 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.924 ' O ' HG22 ' A' ' 29' ' ' VAL . 81.4 m95 -78.67 -6.35 55.48 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.587 -0.733 . . . . 1.5600000000000001 111.443 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 28.8 mm-40 -71.64 -40.75 69.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 119.616 -0.834 . . . . 0.85999999999999999 108.871 176.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.467 HG23 HD23 ' A' ' 32' ' ' LEU . 1.2 t -80.14 -20.72 44.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.295 -0.866 . . . . 1.49 110.657 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.924 HG22 ' O ' ' A' ' 26' ' ' TRP . 32.7 m -59.43 -33.66 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 C-N-CA 120.184 -0.606 . . . . 1.1899999999999999 111.072 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -50.52 -9.8 0.3 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.324 -1.417 . . . . 1.52 110.719 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' VAL . 91.1 mmm -102.27 -69.65 0.78 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.454 0.702 . . . . 3.02 110.255 178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.564 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 2.3 pp -60.17 -43.03 96.16 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.394 -0.821 . . . . 1.9199999999999999 110.73 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.628 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 33.9 t80 -66.27 -32.7 74.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.211 -0.904 . . . . 1.79 109.796 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.4 OUTLIER -59.67 -33.62 71.79 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.796 -0.638 . . . . 2.48 110.608 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.7 m -56.1 -17.65 7.65 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.451 -0.574 . . . . 3.1699999999999999 109.451 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.708 ' HA ' HG22 ' A' ' 40' ' ' THR . 0.9 OUTLIER -148.74 29.24 0.84 Allowed 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.181 -0.918 . . . . 2.7999999999999998 110.243 179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' O ' ' HD2' ' A' ' 38' ' ' LYS . . . -139.98 6.24 2.84 Favored Glycine 0 CA--C 1.506 -0.526 0 N-CA-C 110.164 -1.174 . . . . 2.46 110.164 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 37' ' ' GLY . 12.4 tptt -154.8 -43.45 0.09 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 113.532 -1.334 . . . . 3.4300000000000002 108.575 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.83 -18.36 79.64 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.06 -0.973 . . . . 3.5299999999999998 111.967 178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.708 HG22 ' HA ' ' A' ' 36' ' ' LEU . 12.8 t -169.83 35.62 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.205 0.446 . . . . 3.8900000000000001 112.205 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.476 ' HB3' ' C ' ' A' ' 37' ' ' GLY . 11.3 ptt? -55.47 -32.79 63.1 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.952 -0.567 . . . . 4.8899999999999997 111.032 178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' HG3' ' ND2' ' A' ' 46' ' ' ASN . 6.3 tpp180 -66.04 -59.07 4.16 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.437 -0.347 . . . . 8.1099999999999994 110.486 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.46 HD12 ' OG1' ' A' ' 40' ' ' THR . 55.2 mt -50.44 -44.2 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.767 0.318 . . . . 6.1399999999999997 110.187 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.563 HD22 HG23 ' A' ' 40' ' ' THR . 7.6 m-80 -64.02 -44.6 92.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 7.25 110.876 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.58 HH21 ' HB3' ' A' ' 48' ' ' TYR . 4.6 tpm_? -60.57 -53.57 55.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.863 -0.608 . . . . 9.8200000000000003 110.937 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.402 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 38.6 m-80 -60.15 -36.38 77.42 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.183 -0.673 . . . . 9.1999999999999993 109.183 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.8 92.18 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.278 -0.874 . . . . 9.5 109.731 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.58 ' HB3' HH21 ' A' ' 45' ' ' ARG . 0.3 OUTLIER -66.05 -21.09 66.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.345 -0.843 . . . . 11.26 110.62 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.28 -2.75 0.27 Allowed Glycine 0 CA--C 1.521 0.432 0 CA-C-N 115.657 -0.701 . . . . 12.640000000000001 113.21 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 48' ' ' TYR . 33.3 t -165.23 -36.71 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.757 0.313 . . . . 12.960000000000001 110.824 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.514 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 95.2 mmm -71.78 -32.85 68.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.241 -0.436 . . . . 11.789999999999999 110.355 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA3' ' CD2' ' A' ' 48' ' ' TYR . . . -83.62 42.17 3.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.919 -0.657 . . . . 12.99 112.224 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.88 9.71 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.079 -0.808 . . . . 15.68 111.079 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 56' ' ' LEU . . . -96.4 -82.76 1.64 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.357 -0.421 . . . . 15.710000000000001 112.768 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.464 ' C ' HD12 ' A' ' 56' ' ' LEU . 20.3 m -75.72 21.21 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.879 0.371 . . . . 14.92 111.307 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 56' ' ' LEU . 3.4 mp 56.99 32.52 21.79 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.795 -0.639 . . . . 16.219999999999999 110.519 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -56.72 -21.56 28.92 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.239 -0.437 . . . . 19.829999999999998 111.255 -179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.43 -0.93 0.94 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.836 -0.697 . . . . 17.620000000000001 112.588 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.263 -0.875 . . . . 17.91 110.959 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.743 0.306 . . . . 7.25 110.873 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -66.56 -50.13 64.12 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.236 0.541 . . . . 4.7400000000000002 110.851 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.83 21.63 68.13 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.272 -0.876 . . . . 2.96 112.702 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 6' ' ' VAL . . . 171.14 -26.55 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.937 -0.649 . . . . 1.3700000000000001 112.051 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.23 15.02 7.3 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.727 -0.749 . . . . 2.1400000000000001 111.556 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 4' ' ' GLY . 1.4 p -172.0 -38.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 115.197 -0.502 . . . . 1.25 110.854 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.426 ' HA ' HD12 ' A' ' 10' ' ' ILE . 28.1 t80 -61.89 -30.03 70.6 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.527 -0.546 . . . . 1.6100000000000001 109.527 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 28.8 m -72.7 -36.17 67.78 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 115.625 -0.716 . . . . 0.38 110.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.413 ' OD2' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -63.92 -43.52 95.67 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.171 -1.048 . . . . 2.1800000000000002 108.171 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 7' ' ' PHE . 66.6 mt -57.0 -32.29 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 CA-C-N 113.544 -1.662 . . . . 0.33000000000000002 107.947 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 8' ' ' THR . 27.2 mt -77.72 -37.68 48.87 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 113.5 -1.682 . . . . 1.3999999999999999 110.236 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 -50.1 63.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.725 -1.125 . . . . 0.17000000000000001 110.274 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -61.45 -55.25 33.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.047 -0.979 . . . . 0.23999999999999999 110.133 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.89 -44.93 82.79 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 120.729 0.299 . . . . 0.20999999999999999 110.635 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.54 -42.08 95.81 Favored Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 110.059 -1.217 . . . . 0.17000000000000001 110.059 179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 20' ' ' VAL . 5.2 mmt180 -71.08 -34.53 71.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.937 -0.632 . . . . 4.5300000000000002 110.423 178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.1 mt -66.29 -61.17 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 N-CA-C 107.794 -1.188 . . . . 0.28000000000000003 107.794 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 22' ' ' VAL . 37.7 t80 -53.37 -40.66 65.15 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.503 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.2 mt-10 -61.51 -54.56 41.65 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-N 115.862 -0.608 . . . . 2.2999999999999998 111.207 -179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 17' ' ' ILE . 23.0 m -65.07 -26.75 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.484 -0.932 . . . . 0.16 108.484 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -71.68 -31.48 66.83 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.504 -1.225 . . . . 1.6599999999999999 108.713 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 18' ' ' PHE . 5.1 t -76.89 -48.0 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 114.494 -1.23 . . . . 0.22 110.823 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 13.5 mm-40 -57.33 -45.01 84.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.25 -0.648 . . . . 2.6400000000000001 109.25 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.21 -29.38 75.18 Favored Glycine 0 N--CA 1.442 -0.905 0 CA-C-N 115.147 -0.933 . . . . 0.42999999999999999 110.912 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.462 ' O ' HG13 ' A' ' 29' ' ' VAL . 56.9 t60 -59.62 -47.05 87.11 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 109.346 -0.613 . . . . 0.73999999999999999 109.346 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.949 ' O ' HG22 ' A' ' 29' ' ' VAL . 75.0 m95 -78.16 -15.46 58.82 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.579 -0.737 . . . . 1.5600000000000001 111.486 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.3 mm-40 -63.04 -36.58 84.05 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.831 -1.174 . . . . 0.85999999999999999 107.831 177.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.7 m -75.03 -30.64 61.13 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 113.434 -1.712 . . . . 1.49 110.89 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.949 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.4 m -65.05 -37.35 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.593 0 N-CA-C 112.864 0.69 . . . . 1.1899999999999999 112.864 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -49.56 -11.17 0.27 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 119.315 -1.422 . . . . 1.52 110.82 178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.529 ' N ' ' C ' ' A' ' 29' ' ' VAL . 9.3 mmt -105.5 -68.09 0.88 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 122.998 0.519 . . . . 3.02 110.891 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.781 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.2 pp -59.56 -34.1 72.26 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 116.119 -0.491 . . . . 1.9199999999999999 110.812 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.474 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 1.7 t80 -70.24 -39.45 75.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.622 -0.717 . . . . 1.79 109.717 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.31 -37.91 73.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.039 -0.982 . . . . 2.48 111.543 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.3 t -59.27 -30.23 68.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.144 -0.48 . . . . 3.1699999999999999 110.978 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.7 32.12 3.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 2.7999999999999998 111.015 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 41' ' ' MET . . . -119.5 -48.39 0.34 Allowed Glycine 0 C--O 1.215 -1.086 0 N-CA-C 109.623 -1.391 . . . . 2.46 109.623 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -67.03 -47.53 71.12 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.564 -1.273 . . . . 3.4300000000000002 107.564 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.73 71.03 Favored Glycine 0 N--CA 1.438 -1.177 0 CA-C-N 114.551 -1.204 . . . . 3.5299999999999998 110.247 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.624 HG23 ' O ' ' A' ' 40' ' ' THR . 12.6 t -172.16 74.39 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 114.148 1.166 . . . . 3.8900000000000001 114.148 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.703 ' N ' ' O ' ' A' ' 37' ' ' GLY . 1.5 mtp -78.04 -49.8 13.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.685 -0.689 . . . . 4.8899999999999997 111.031 178.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.03 -57.79 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.281 -0.418 . . . . 8.1099999999999994 110.85 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' HB ' ' OG1' ' A' ' 40' ' ' THR . 48.6 mt -53.99 -39.87 42.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 6.1399999999999997 110.215 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.45 ' ND2' HG23 ' A' ' 40' ' ' THR . 1.1 m-80 -59.04 -39.58 82.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.224 -0.444 . . . . 7.25 110.236 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 41' ' ' MET . 9.4 mtm180 -62.78 -51.45 67.04 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 116.12 -0.491 . . . . 9.8200000000000003 110.532 179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -60.49 -37.57 81.5 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.181 -0.674 . . . . 9.1999999999999993 109.181 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.07 92.99 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.926 -1.034 . . . . 9.5 110.026 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -65.62 -24.48 67.06 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.452 -0.795 . . . . 11.26 110.633 179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.21 2.73 0.15 Allowed Glycine 0 CA--C 1.521 0.466 0 CA-C-N 115.499 -0.773 . . . . 12.640000000000001 113.536 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 48' ' ' TYR . 69.8 m -163.06 -38.16 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.965 0.383 . . . . 12.960000000000001 110.538 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.0 mmt -73.69 -24.92 60.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 11.789999999999999 110.817 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.52 -8.83 57.13 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.846 -0.693 . . . . 12.99 112.404 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.11 -26.71 30.38 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.819 -0.705 . . . . 15.68 112.397 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' HG2' ' A' ' 57' ' ' ARG . . . 150.49 53.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.879 -0.677 . . . . 15.710000000000001 112.497 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 57' ' ' ARG . 60.0 p 39.03 44.09 0.86 Allowed 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.758 0.79 . . . . 14.92 112.063 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 mp 68.18 -22.42 0.13 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 113.955 -1.475 . . . . 16.219999999999999 112.731 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' H ' ' C ' ' A' ' 55' ' ' SER . 10.9 ptm180 -82.72 25.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.985 0.421 . . . . 19.829999999999998 110.407 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -146.88 21.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.865 -0.683 . . . . 17.620000000000001 112.384 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.231 -0.89 . . . . 17.91 110.869 -179.974 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HB2' ' HA3' ' A' ' 5' ' ' GLY . 26.9 ptt? . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.914 0.388 . . . . 7.25 110.979 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -148.78 98.39 2.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 4.7400000000000002 110.78 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.55 -78.17 0.24 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.787 -0.721 . . . . 2.96 112.316 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.38 -4.21 43.24 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.777 -0.725 . . . . 1.3700000000000001 112.241 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA3' ' HB2' ' A' ' 1' ' ' MET . . . -97.45 23.89 33.87 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.91 -0.662 . . . . 2.1400000000000001 111.923 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 96.0 t -163.51 -53.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 123.355 0.662 . . . . 1.25 109.23 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 33.0 t80 -61.58 -39.64 91.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.515 -0.766 . . . . 1.6100000000000001 110.582 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.709 ' HA ' HD23 ' A' ' 11' ' ' LEU . 94.2 m -67.63 -29.87 69.29 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.155 0.503 . . . . 0.38 109.932 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.48 -41.27 84.83 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.291 -1.374 . . . . 2.1800000000000002 107.291 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.406 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.7 mt -66.11 -36.02 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 0 CA-C-N 113.729 -1.578 . . . . 0.33000000000000002 109.085 177.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.746 ' C ' HD12 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -70.54 -41.29 72.69 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.395 -1.275 . . . . 1.3999999999999999 108.836 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.8 -55.38 30.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.646 -1.616 . . . . 0.17000000000000001 110.01 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.61 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -62.21 -51.77 66.44 Favored 'General case' 0 C--O 1.214 -0.787 0 CA-C-N 115.28 -0.873 . . . . 0.23999999999999999 110.558 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.09 -40.76 74.14 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.424 -0.511 . . . . 0.20999999999999999 110.09 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -60.55 -51.37 59.12 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.722 -0.752 . . . . 0.17000000000000001 111.278 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.576 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -71.68 -28.7 63.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.679 0.276 . . . . 4.5300000000000002 110.795 179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.61 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.6 mt -66.54 -59.37 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 106.71 -1.589 . . . . 0.28000000000000003 106.71 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.434 ' CE1' HG21 ' A' ' 22' ' ' VAL . 33.8 t80 -55.18 -38.66 68.63 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 112.616 -2.084 . . . . 0.29999999999999999 109.587 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 2.4 mt-10 -60.74 -51.1 70.78 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.597 -0.728 . . . . 2.2999999999999998 110.953 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 17' ' ' ILE . 18.8 m -68.5 -28.53 40.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 108.952 -0.759 . . . . 0.16 108.952 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -72.04 -27.66 62.86 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 114.977 -1.011 . . . . 1.6599999999999999 108.813 178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 18' ' ' PHE . 3.4 t -83.31 -43.25 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 CA-C-N 114.532 -1.213 . . . . 0.22 111.785 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -58.1 -40.83 82.13 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 120.893 0.377 . . . . 2.6400000000000001 110.022 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.51 -35.31 91.79 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 110.088 -1.205 . . . . 0.42999999999999999 110.088 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.611 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.0 t60 -62.43 -41.86 99.02 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.501 -0.925 . . . . 0.73999999999999999 108.501 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 22.9 m95 -74.31 -15.06 60.97 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.715 -1.13 . . . . 1.5600000000000001 110.929 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -74.48 -42.61 58.71 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.85999999999999999 109.861 177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.39 -22.17 55.11 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.241 -0.89 . . . . 1.49 111.207 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 26' ' ' TRP . 33.3 m -61.07 -36.07 69.94 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 C-N-CA 119.97 -0.692 . . . . 1.1899999999999999 110.684 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.52 -11.0 0.13 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 119.832 -1.175 . . . . 1.52 111.036 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' VAL . 17.3 mmt -102.02 -67.62 0.86 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.337 0.655 . . . . 3.02 110.743 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.669 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.7 pp -59.2 -38.41 79.82 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 115.816 -0.629 . . . . 1.9199999999999999 110.801 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.9 t80 -65.93 -39.33 90.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.638 -0.71 . . . . 1.79 109.708 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.93 -38.58 82.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.355 -0.839 . . . . 2.48 111.301 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.401 ' HB3' HD23 ' A' ' 36' ' ' LEU . 47.9 t -53.94 -28.78 39.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 3.1699999999999999 110.38 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.503 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.6 OUTLIER -141.35 38.09 1.71 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 2.7999999999999998 110.71 179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.511 ' HA2' HG22 ' A' ' 40' ' ' THR . . . -125.4 -33.8 0.7 Allowed Glycine 0 CA--C 1.505 -0.576 0 N-CA-C 109.779 -1.328 . . . . 2.46 109.779 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -76.14 -52.15 10.71 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 108.193 -1.04 . . . . 3.4300000000000002 108.193 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.45 63.36 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 114.438 -1.256 . . . . 3.5299999999999998 111.13 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.516 ' OG1' HD12 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -67.18 -22.74 65.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 111.809 0.3 . . . . 3.8900000000000001 111.809 -179.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.482 ' O ' ' HG3' ' A' ' 45' ' ' ARG . 22.5 ptt? -38.68 -48.08 1.43 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.144 -0.48 . . . . 4.8899999999999997 111.817 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -56.95 -48.89 77.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.851 0.358 . . . . 8.1099999999999994 110.181 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.516 HD12 ' OG1' ' A' ' 40' ' ' THR . 46.4 mt -53.1 -41.6 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.751 -0.659 . . . . 6.1399999999999997 110.231 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -60.99 -40.93 95.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.676 -0.693 . . . . 7.25 110.737 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 41' ' ' MET . 32.3 mtm180 -63.03 -53.02 60.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.315 -0.402 . . . . 9.8200000000000003 110.799 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -60.4 -36.69 78.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.243 -0.651 . . . . 9.1999999999999993 109.243 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.35 87.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.031 -0.986 . . . . 9.5 110.073 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -63.89 -20.49 65.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.542 -0.754 . . . . 11.26 110.807 -179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.11 -5.45 0.45 Allowed Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.688 -0.687 . . . . 12.640000000000001 113.168 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.427 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.36 -34.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.865 0.364 . . . . 12.960000000000001 110.66 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 96.1 mmm -73.39 -24.75 60.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.032 -0.531 . . . . 11.789999999999999 110.955 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.41 51.4 0.88 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.739 -0.743 . . . . 12.99 112.56 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 174.84 -5.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.792 -0.718 . . . . 15.68 112.454 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -134.56 -22.44 0.69 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.702 . . . . 15.710000000000001 112.198 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -69.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.898 0.38 . . . . 14.92 110.971 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 58' ' ' GLY . 8.8 mp -70.14 -30.26 67.38 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.026 -0.534 . . . . 16.219999999999999 111.054 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -81.52 24.26 0.58 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.124 -0.489 . . . . 19.829999999999998 110.282 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . -167.97 13.62 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.702 -0.681 . . . . 17.620000000000001 112.555 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.8 p . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.219 -0.896 . . . . 17.91 110.948 -179.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.894 0.378 . . . . 7.25 111.001 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -129.11 1.75 5.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.137 -0.483 . . . . 4.7400000000000002 110.863 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 98.92 -56.3 0.96 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.721 -0.752 . . . . 2.96 112.408 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.606 ' HA2' ' CD2' ' A' ' 7' ' ' PHE . . . -65.93 -4.53 21.37 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.616 -0.802 . . . . 1.3700000000000001 112.361 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.42 27.8 3.58 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.796 -0.922 . . . . 2.1400000000000001 110.796 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 4' ' ' GLY . 71.1 t -162.5 -44.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 C-N-CA 123.318 0.647 . . . . 1.25 109.757 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.606 ' CD2' ' HA2' ' A' ' 4' ' ' GLY . 0.1 OUTLIER -63.17 -34.88 78.6 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.896 0.379 . . . . 1.6100000000000001 110.035 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.4 m -69.85 -36.03 75.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.1 -0.5 . . . . 0.38 110.806 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -34.88 79.48 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 108.037 -1.098 . . . . 2.1800000000000002 108.037 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 7' ' ' PHE . 71.6 mt -64.48 -42.68 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 114.043 -1.435 . . . . 0.33000000000000002 108.074 177.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 32.7 mt -66.65 -37.53 85.01 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.011 -1.449 . . . . 1.3999999999999999 109.612 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.6 -42.93 81.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.739 -1.119 . . . . 0.17000000000000001 109.69 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.565 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.31 -58.79 5.52 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.861 -1.063 . . . . 0.23999999999999999 109.999 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.94 -42.94 76.9 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 120.916 0.389 . . . . 0.20999999999999999 110.582 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.28 -55.31 25.09 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 110.711 -0.956 . . . . 0.17000000000000001 110.711 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.2 mtp180 -69.33 -32.15 71.07 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.834 -0.683 . . . . 4.5300000000000002 111.666 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.0 mt -61.92 -60.76 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 N-CA-C 106.167 -1.79 . . . . 0.28000000000000003 106.167 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.516 ' O ' HG23 ' A' ' 22' ' ' VAL . 57.9 t80 -54.93 -40.96 70.46 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 112.29 -2.232 . . . . 0.29999999999999999 110.323 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.8 OUTLIER -62.56 -54.97 31.88 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 115.778 -0.646 . . . . 2.2999999999999998 111.205 -179.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 16' ' ' ARG . 17.9 m -63.86 -26.59 40.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.236 -1.024 . . . . 0.16 108.236 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -72.65 -31.04 64.8 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.529 -1.214 . . . . 1.6599999999999999 108.819 177.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 18' ' ' PHE . 8.6 t -78.15 -44.45 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 114.677 -1.147 . . . . 0.22 111.167 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 7.1 mm-40 -57.85 -42.88 85.36 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.519 -0.549 . . . . 2.6400000000000001 109.519 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -66.41 -29.52 74.99 Favored Glycine 0 N--CA 1.442 -0.956 0 N-CA-C 110.872 -0.891 . . . . 0.42999999999999999 110.872 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.431 ' O ' HG13 ' A' ' 29' ' ' VAL . 59.7 t60 -60.25 -48.23 82.63 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.221 -0.659 . . . . 0.73999999999999999 109.221 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.939 ' O ' HG22 ' A' ' 29' ' ' VAL . 83.9 m95 -77.98 -6.82 55.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.386 -0.825 . . . . 1.5600000000000001 111.605 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 12.6 mm-40 -70.09 -40.52 74.91 Favored 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 119.391 -0.924 . . . . 0.85999999999999999 108.996 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.414 HG23 HD23 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -78.85 -21.74 47.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.352 -0.84 . . . . 1.49 110.677 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.939 HG22 ' O ' ' A' ' 26' ' ' TRP . 24.4 m -60.69 -33.39 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 C-N-CA 120.281 -0.568 . . . . 1.1899999999999999 111.099 -178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -52.43 -5.09 0.17 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 119.744 -1.217 . . . . 1.52 110.843 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.602 ' H ' ' C ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -107.91 -67.23 0.98 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.485 0.714 . . . . 3.02 110.265 178.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.668 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.5 pp -59.68 -40.8 89.01 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.888 -0.596 . . . . 1.9199999999999999 110.237 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.507 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -67.1 -41.93 85.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.278 -0.874 . . . . 1.79 109.49 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.2 OUTLIER -59.69 -30.29 68.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.634 -0.712 . . . . 2.48 111.256 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 36' ' ' LEU . 61.3 m -57.96 -15.74 9.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.132 0.492 . . . . 3.1699999999999999 109.805 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.741 ' HA ' HG22 ' A' ' 40' ' ' THR . 0.4 OUTLIER -160.04 33.0 0.18 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.48 -0.782 . . . . 2.7999999999999998 110.792 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.66 ' HA2' ' HG3' ' A' ' 41' ' ' MET . . . -141.67 8.05 2.52 Favored Glycine 0 CA--C 1.505 -0.534 0 N-CA-C 110.302 -1.119 . . . . 2.46 110.302 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.53 ' HD2' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -165.05 -40.55 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 113.663 -1.269 . . . . 3.4300000000000002 108.661 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.29 -18.4 79.28 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.498 -1.228 . . . . 3.5299999999999998 112.053 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.741 HG22 ' HA ' ' A' ' 36' ' ' LEU . 6.5 t -170.59 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 113.395 0.887 . . . . 3.8900000000000001 113.395 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.66 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -46.14 -40.63 11.36 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 120.816 0.341 . . . . 4.8899999999999997 111.108 178.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.477 ' HA ' ' NE ' ' A' ' 42' ' ' ARG . 5.8 tpm_? -59.73 -54.87 41.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.018 -0.537 . . . . 8.1099999999999994 111.127 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.493 HD12 ' OG1' ' A' ' 40' ' ' THR . 55.8 mt -58.76 -42.15 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 6.1399999999999997 111.111 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' ND2' HG23 ' A' ' 40' ' ' THR . 1.7 m-80 -59.88 -48.11 83.02 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.597 -0.274 . . . . 7.25 111.212 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.34 -51.64 68.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.318 -0.401 . . . . 9.8200000000000003 111.113 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -61.37 -34.45 75.33 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.107 -0.701 . . . . 9.1999999999999993 109.107 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.19 -41.91 85.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.185 -0.916 . . . . 9.5 109.989 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.469 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.08 -23.19 67.23 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.695 -0.684 . . . . 11.26 110.628 -179.798 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.55 1.53 0.28 Allowed Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.632 -0.713 . . . . 12.640000000000001 113.118 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 48' ' ' TYR . 45.8 t -165.33 -38.28 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.909 0.385 . . . . 12.960000000000001 110.724 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 26.0 mmt -73.36 -28.24 61.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.969 -0.56 . . . . 11.789999999999999 110.828 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.23 25.46 27.61 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.822 -0.704 . . . . 12.99 112.545 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.61 10.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.796 -0.716 . . . . 15.68 112.211 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.03 -39.59 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.005 -0.617 . . . . 15.710000000000001 112.334 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 57' ' ' ARG . 58.4 m -72.09 -8.82 56.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.74 0.305 . . . . 14.92 110.988 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.6 mt -77.74 21.07 0.31 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.456 . . . . 16.219999999999999 110.589 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 55' ' ' SER . 12.7 ptm180 -82.03 23.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.055 -0.52 . . . . 19.829999999999998 111.118 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.5 -24.88 29.49 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.751 -0.737 . . . . 17.620000000000001 112.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.333 -0.842 . . . . 17.91 111.068 179.988 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.522 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 26.5 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.649 0.261 . . . . 7.25 110.942 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -60.71 -33.99 73.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.064 0.459 . . . . 4.7400000000000002 111.019 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.6 30.0 5.48 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.584 -0.735 . . . . 2.96 112.614 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 54.4 38.9 63.62 Favored Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 109.91 -1.276 . . . . 1.3700000000000001 109.91 -178.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.522 ' H ' ' HB2' ' A' ' 1' ' ' MET . . . 78.92 24.96 60.89 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 108.143 -1.983 . . . . 2.1400000000000001 108.143 -176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 78.12 -6.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 113.613 -1.293 . . . . 1.25 109.717 -178.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.461 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 35.9 t80 -63.42 -44.85 93.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.331 -1.304 . . . . 1.6100000000000001 110.789 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 16.7 m -60.98 -30.78 70.47 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 109.891 -0.411 . . . . 0.38 109.891 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.17 -46.82 72.84 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 108.527 -0.916 . . . . 2.1800000000000002 108.527 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 50.6 mt -55.28 -30.27 24.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.069 -1.423 . . . . 0.33000000000000002 108.087 177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 8' ' ' THR . 30.0 mt -79.07 -42.15 27.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 113.586 -1.643 . . . . 1.3999999999999999 110.764 179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -49.04 65.07 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.614 -1.175 . . . . 0.17000000000000001 110.239 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.599 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -59.72 -59.27 5.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.66 -1.155 . . . . 0.23999999999999999 110.018 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.37 87.72 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 121.006 0.431 . . . . 0.20999999999999999 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.657 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -51.7 -52.03 35.95 Favored Glycine 0 N--CA 1.435 -1.43 0 C-N-CA 119.828 -1.177 . . . . 0.17000000000000001 110.391 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.61 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.7 ttt180 -71.83 -34.36 69.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 124.136 0.551 . . . . 4.5300000000000002 111.453 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.7 mt -63.86 -62.98 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.113 -1.439 . . . . 0.28000000000000003 107.113 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.533 ' O ' HG23 ' A' ' 22' ' ' VAL . 70.3 t80 -51.68 -42.06 61.87 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.322 -2.217 . . . . 0.29999999999999999 110.141 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.0 OUTLIER -62.78 -56.38 18.0 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.819 -0.628 . . . . 2.2999999999999998 111.173 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.61 HG13 ' O ' ' A' ' 16' ' ' ARG . 18.6 m -60.59 -27.16 39.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 107.978 -1.119 . . . . 0.16 107.978 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 5.7 mmt -73.29 -31.65 64.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 114.334 -1.303 . . . . 1.6599999999999999 108.553 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.7 t -75.31 -42.08 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.613 -1.176 . . . . 0.22 111.075 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.5 mm-40 -58.92 -46.7 87.28 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 109.485 -0.561 . . . . 2.6400000000000001 109.485 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -59.58 -34.7 82.74 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 110.097 -1.201 . . . . 0.42999999999999999 110.097 178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.619 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.9 t60 -63.15 -41.91 99.36 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 108.385 -0.969 . . . . 0.73999999999999999 108.385 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.881 ' O ' HG22 ' A' ' 29' ' ' VAL . 23.2 m95 -73.82 -15.75 61.16 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.578 -1.192 . . . . 1.5600000000000001 110.828 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 7.9 mm-40 -72.79 -44.63 61.3 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-O 121.382 0.611 . . . . 0.85999999999999999 109.637 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.528 ' O ' ' HG3' ' A' ' 31' ' ' MET . 0.5 OUTLIER -78.2 -19.94 52.85 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.047 -0.979 . . . . 1.49 111.211 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.881 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.0 m -56.32 -32.98 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.913 0 C-N-CA 119.365 -0.934 . . . . 1.1899999999999999 109.895 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.73 -9.96 0.07 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 119.877 -1.154 . . . . 1.52 111.597 177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.606 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -109.44 -57.99 2.1 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.266 0.226 . . . . 3.02 111.459 179.019 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.62 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.1 pp -64.84 -32.19 73.77 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.611 0.719 . . . . 1.9199999999999999 109.803 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 37' ' ' GLY . 2.3 t80 -72.6 -48.32 40.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.63 -1.168 . . . . 1.79 109.152 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.55 -43.04 75.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.9 -1.045 . . . . 2.48 111.771 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.457 ' HB3' HD23 ' A' ' 36' ' ' LEU . 48.3 t -54.0 -21.72 8.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 3.1699999999999999 110.908 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.457 HD23 ' HB3' ' A' ' 35' ' ' SER . 0.5 OUTLIER -155.95 44.27 0.43 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.919 -0.582 . . . . 2.7999999999999998 110.672 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 40' ' ' THR . . . -132.52 -30.07 0.51 Allowed Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 109.142 -1.583 . . . . 2.46 109.142 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 41' ' ' MET . 5.1 tptp -75.19 -50.57 15.8 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-N 113.647 -1.277 . . . . 3.4300000000000002 107.847 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.67 -38.27 32.5 Favored Glycine 0 N--CA 1.435 -1.385 0 CA-C-N 114.118 -1.401 . . . . 3.5299999999999998 110.214 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.694 HG22 ' HA2' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -69.88 -12.49 61.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.255 -0.473 . . . . 3.8900000000000001 111.956 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -39.52 -46.37 1.72 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.78 0.324 . . . . 4.8899999999999997 111.542 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -67.71 -41.2 83.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.285 0.565 . . . . 8.1099999999999994 109.982 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.493 HD12 ' HA ' ' A' ' 40' ' ' THR . 61.0 mt -63.23 -33.1 59.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.2 -0.909 . . . . 6.1399999999999997 111.878 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.41 HD22 HG23 ' A' ' 40' ' ' THR . 1.0 OUTLIER -59.6 -59.89 4.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 111.919 0.341 . . . . 7.25 111.919 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 45' ' ' ARG . 7.9 ttp180 -55.06 -47.05 75.36 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.545 0.212 . . . . 9.8200000000000003 111.298 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -63.65 -34.06 77.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.115 -0.698 . . . . 9.1999999999999993 109.115 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.21 -48.26 68.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.176 -0.92 . . . . 9.5 110.102 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -18.09 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.316 -0.856 . . . . 11.26 111.286 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -54.28 -9.14 1.36 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.833 -0.698 . . . . 12.640000000000001 112.679 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 t -166.55 -31.04 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.709 0.29 . . . . 12.960000000000001 111.101 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 93.1 mmm -71.85 -31.03 66.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.309 -0.405 . . . . 11.789999999999999 111.078 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.27 52.12 1.09 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.887 -0.673 . . . . 12.99 112.535 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 153.89 16.79 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.713 -0.756 . . . . 15.68 112.603 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 56' ' ' LEU . . . -149.62 -41.31 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.693 -0.765 . . . . 15.710000000000001 112.599 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.48 ' C ' HD12 ' A' ' 56' ' ' LEU . 49.9 m -75.22 24.94 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.829 0.347 . . . . 14.92 111.218 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 56' ' ' LEU . 3.8 mp 61.26 29.05 18.48 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.882 -0.599 . . . . 16.219999999999999 110.425 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 36.98 40.12 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.401 -0.818 . . . . 19.829999999999998 111.722 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 151.32 -30.6 0.96 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.883 -0.675 . . . . 17.620000000000001 112.671 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.188 -0.91 . . . . 17.91 111.048 179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 120.749 0.309 . . . . 7.25 110.851 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.9 t 58.8 17.44 5.22 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.082 -0.508 . . . . 4.7400000000000002 111.082 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -130.37 33.19 2.94 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.874 -0.679 . . . . 2.96 112.306 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 80.44 -12.39 33.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.955 -0.641 . . . . 1.3700000000000001 112.498 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.78 -61.81 6.8 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.371 -0.918 . . . . 2.1400000000000001 111.431 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.5 p -63.99 -44.54 97.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.089 0.471 . . . . 1.25 111.235 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' HG13 ' A' ' 6' ' ' VAL . 29.9 t80 -58.34 -42.27 86.49 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.485 -0.78 . . . . 1.6100000000000001 111.299 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 85.2 m -65.53 -31.63 72.79 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.692 -0.403 . . . . 0.38 110.295 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.14 -38.16 85.03 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.843 -1.169 . . . . 2.1800000000000002 107.843 178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 76.2 mt -64.52 -39.64 86.3 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 CA-C-N 114.158 -1.383 . . . . 0.33000000000000002 108.153 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.7 mt -67.78 -38.26 83.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.895 -1.502 . . . . 1.3999999999999999 109.753 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.3 -44.39 79.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.747 -1.115 . . . . 0.17000000000000001 109.855 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -64.3 -57.15 10.24 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.073 -0.967 . . . . 0.23999999999999999 110.187 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.51 -42.74 78.88 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 120.78 0.324 . . . . 0.20999999999999999 110.471 179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -61.09 -40.51 98.62 Favored Glycine 0 N--CA 1.44 -1.071 0 N-CA-C 109.941 -1.264 . . . . 0.17000000000000001 109.941 178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.468 ' O ' HG13 ' A' ' 20' ' ' VAL . 9.6 mmt180 -71.23 -34.86 71.19 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.2 -0.5 . . . . 4.5300000000000002 110.151 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 13' ' ' ALA . 1.9 mt -66.0 -58.85 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.959 0 N-CA-C 107.902 -1.148 . . . . 0.28000000000000003 107.902 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.42 ' O ' HG23 ' A' ' 22' ' ' VAL . 26.3 t80 -55.99 -39.6 72.11 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 112.895 -1.957 . . . . 0.29999999999999999 110.043 178.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 1.2 mm-40 -61.24 -51.57 68.39 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.922 -0.581 . . . . 2.2999999999999998 110.709 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 17' ' ' ILE . 21.6 m -69.23 -26.94 32.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.017 -0.734 . . . . 0.16 109.017 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.411 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -72.68 -29.34 63.33 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.219 -0.9 . . . . 1.6599999999999999 108.685 178.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 18' ' ' PHE . 4.1 t -79.54 -45.44 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-N 114.718 -1.128 . . . . 0.22 110.732 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 8.4 pt-20 -59.76 -40.22 87.45 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.188 -0.671 . . . . 2.6400000000000001 109.188 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -62.72 -35.45 91.92 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.114 -1.194 . . . . 0.42999999999999999 110.114 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.64 ' O ' HG13 ' A' ' 29' ' ' VAL . 78.9 t60 -62.3 -38.34 89.02 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.73999999999999999 108.422 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.815 ' O ' HG22 ' A' ' 29' ' ' VAL . 36.5 m95 -76.3 -17.03 59.64 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 114.966 -1.015 . . . . 1.5600000000000001 110.492 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 16.2 mm-40 -73.43 -41.86 62.74 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 108.248 -1.019 . . . . 0.85999999999999999 108.248 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 m -68.97 -31.13 69.76 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 113.435 -1.711 . . . . 1.49 111.257 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.815 HG22 ' O ' ' A' ' 26' ' ' TRP . 27.3 m -62.09 -36.69 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 C-N-CA 120.347 -0.541 . . . . 1.1899999999999999 111.407 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.37 -8.76 0.19 Allowed Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.031 -1.08 . . . . 1.52 111.655 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.553 ' HG3' ' H ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -113.61 -55.67 2.49 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.157 0.183 . . . . 3.02 111.34 179.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.808 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 4.4 pp -64.99 -26.52 68.33 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.48 0.657 . . . . 1.9199999999999999 109.534 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 6.1 t80 -72.93 -47.42 45.76 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.014 -0.994 . . . . 1.79 109.091 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -60.51 -40.35 91.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.584 -1.189 . . . . 2.48 110.828 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.5 ' HB2' HD23 ' A' ' 36' ' ' LEU . 52.5 m -48.31 -31.37 5.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.791 -0.64 . . . . 3.1699999999999999 110.434 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.4 OUTLIER -141.8 39.35 1.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.804 -0.635 . . . . 2.7999999999999998 110.725 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 40' ' ' THR . . . -126.3 -31.9 0.76 Allowed Glycine 0 CA--C 1.506 -0.512 0 N-CA-C 109.997 -1.241 . . . . 2.46 109.997 177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 41' ' ' MET . 12.5 tptt -77.17 -49.44 15.19 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.922 -1.14 . . . . 3.4300000000000002 107.922 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.85 -30.5 59.44 Favored Glycine 0 N--CA 1.438 -1.19 0 CA-C-N 114.043 -1.435 . . . . 3.5299999999999998 110.994 178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -63.65 -29.35 70.6 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.088 0.471 . . . . 3.8900000000000001 110.6 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 18.8 mtt -48.9 -32.29 8.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.45 -0.795 . . . . 4.8899999999999997 110.434 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.414 ' HG3' ' ND2' ' A' ' 46' ' ' ASN . 2.5 tpm_? -64.37 -41.26 96.8 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.389 -0.597 . . . . 8.1099999999999994 109.389 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' OG1' ' A' ' 40' ' ' THR . 20.8 mt -65.14 -49.57 78.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.155 -0.93 . . . . 6.1399999999999997 110.497 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -60.02 -43.72 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.487 -0.779 . . . . 7.25 111.299 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -49.3 73.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 9.8200000000000003 110.903 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.414 ' ND2' ' HG3' ' A' ' 42' ' ' ARG . 91.2 m-20 -62.64 -36.8 83.98 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.125 -0.695 . . . . 9.1999999999999993 109.125 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.79 -42.65 90.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 9.5 110.035 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.449 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -67.24 -18.94 65.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 11.26 110.95 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.72 1.72 0.47 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.878 -0.601 . . . . 12.640000000000001 113.265 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 48' ' ' TYR . 48.1 t -166.13 -34.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.828 0.346 . . . . 12.960000000000001 110.752 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.5 mmt -73.73 -22.3 59.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 11.789999999999999 111.084 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -129.41 17.69 5.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.753 -0.737 . . . . 12.99 112.562 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -139.09 -22.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.694 -0.765 . . . . 15.68 112.459 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.07 -19.89 3.17 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.777 -0.725 . . . . 15.710000000000001 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.487 ' C ' ' H ' ' A' ' 57' ' ' ARG . 34.8 m -72.91 -44.87 60.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.764 0.316 . . . . 14.92 111.435 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.9 mt -71.32 17.09 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.235 -0.438 . . . . 16.219999999999999 111.145 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 55' ' ' SER . 74.0 mtp180 -86.38 31.46 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 19.829999999999998 110.773 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.35 -35.19 1.48 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.758 -0.734 . . . . 17.620000000000001 112.577 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.218 -0.896 . . . . 17.91 110.896 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.761 0.315 . . . . 7.25 110.981 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -146.42 16.76 1.32 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 4.7400000000000002 110.911 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 132.84 -65.47 0.59 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.795 -0.717 . . . . 2.96 112.554 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.57 -4.58 46.17 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.806 -0.711 . . . . 1.3700000000000001 112.853 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.54 -62.25 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.407 -0.901 . . . . 2.1400000000000001 111.643 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.7 p -63.67 -43.65 98.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.019 0.438 . . . . 1.25 111.297 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.6 t80 -57.3 -43.16 82.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.519 -0.764 . . . . 1.6100000000000001 111.072 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.412 ' HA ' HD12 ' A' ' 11' ' ' LEU . 62.2 m -65.83 -31.08 71.83 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.68 -0.408 . . . . 0.38 109.914 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.47 -38.15 83.97 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 107.965 -1.124 . . . . 2.1800000000000002 107.965 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 72.7 mt -63.59 -40.11 87.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 114.313 -1.312 . . . . 0.33000000000000002 108.08 177.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 8' ' ' THR . 38.4 mt -67.44 -38.21 84.16 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.896 -1.502 . . . . 1.3999999999999999 109.751 178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.46 -46.06 77.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.77 -1.105 . . . . 0.17000000000000001 110.034 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.87 -55.63 21.35 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.109 -0.95 . . . . 0.23999999999999999 110.11 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.56 -45.6 77.28 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.20999999999999999 110.389 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -58.12 -41.6 94.73 Favored Glycine 0 N--CA 1.442 -0.91 0 N-CA-C 109.954 -1.259 . . . . 0.17000000000000001 109.954 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.487 ' O ' HG13 ' A' ' 20' ' ' VAL . 1.9 mmt180 -70.8 -33.54 70.83 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.103 -0.549 . . . . 4.5300000000000002 110.279 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 13' ' ' ALA . 2.5 mt -67.25 -62.23 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 107.636 -1.246 . . . . 0.28000000000000003 107.636 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 36.7 t80 -51.68 -41.23 61.27 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 112.688 -2.051 . . . . 0.29999999999999999 110.218 178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 3.8 mt-10 -61.85 -55.63 27.87 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.75 -0.659 . . . . 2.2999999999999998 111.17 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 17' ' ' ILE . 26.7 m -63.59 -26.45 40.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.371 -0.974 . . . . 0.16 108.371 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' PHE . 4.4 mmt -72.07 -31.45 66.12 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 114.492 -1.231 . . . . 1.6599999999999999 108.441 177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 18' ' ' PHE . 7.0 t -75.42 -45.37 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 114.534 -1.212 . . . . 0.22 110.717 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 8.1 mm-40 -59.62 -45.76 90.98 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.12 -0.696 . . . . 2.6400000000000001 109.12 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.94 -35.11 85.94 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.628 ' O ' HG13 ' A' ' 29' ' ' VAL . 81.8 t60 -63.67 -39.02 93.27 Favored 'General case' 0 CA--C 1.516 -0.36 0 N-CA-C 108.55 -0.907 . . . . 0.73999999999999999 108.55 177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.877 ' O ' HG22 ' A' ' 29' ' ' VAL . 28.2 m95 -76.22 -16.48 59.82 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 114.853 -1.067 . . . . 1.5600000000000001 110.503 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -73.86 -41.67 61.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.337 -0.616 . . . . 0.85999999999999999 109.337 177.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.8 OUTLIER -75.63 -22.71 56.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.078 -0.965 . . . . 1.49 111.032 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 26' ' ' TRP . 34.5 m -60.85 -33.99 57.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 C-N-CA 119.871 -0.732 . . . . 1.1899999999999999 110.248 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -48.56 -10.58 0.12 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 119.781 -1.2 . . . . 1.52 110.806 177.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' VAL . 19.4 mmt -101.19 -68.18 0.83 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.374 0.67 . . . . 3.02 110.446 178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -59.64 -41.35 90.3 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.859 -0.61 . . . . 1.9199999999999999 110.675 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.486 ' HB3' ' O ' ' A' ' 29' ' ' VAL . 4.1 t80 -64.68 -37.11 86.46 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.61 -0.723 . . . . 1.79 109.504 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' GLY . 0.5 OUTLIER -59.81 -34.12 72.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.475 -0.784 . . . . 2.48 110.696 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 51.5 m -59.71 -27.85 66.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.953 -0.567 . . . . 3.1699999999999999 110.154 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.5 ' O ' ' HB ' ' A' ' 40' ' ' THR . 0.9 OUTLIER -138.41 35.53 2.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.829 -0.623 . . . . 2.7999999999999998 110.936 179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 33' ' ' PHE . . . -128.15 -37.79 0.41 Allowed Glycine 0 CA--C 1.507 -0.431 0 N-CA-C 109.742 -1.343 . . . . 2.46 109.742 177.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -77.96 -51.79 9.84 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.005 -1.109 . . . . 3.4300000000000002 108.005 178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.98 -30.32 61.46 Favored Glycine 0 N--CA 1.439 -1.158 0 CA-C-N 114.103 -1.408 . . . . 3.5299999999999998 111.272 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.5 ' HB ' ' O ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -64.3 -33.26 75.42 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 120.682 -0.407 . . . . 3.8900000000000001 110.82 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 32.7 mtp -46.65 -37.58 8.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.708 -0.678 . . . . 4.8899999999999997 110.619 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -71.57 -36.9 71.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.883 -0.599 . . . . 8.1099999999999994 110.0 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 40' ' ' THR . 22.5 mt -65.4 -50.48 72.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.816 -0.629 . . . . 6.1399999999999997 110.201 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -60.14 -48.94 79.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 7.25 111.538 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -60.66 -51.61 68.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.595 -0.275 . . . . 9.8200000000000003 111.19 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -62.24 -34.5 76.63 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.19 -0.67 . . . . 9.1999999999999993 109.19 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.62 -40.62 88.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.387 -0.824 . . . . 9.5 109.885 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.47 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.3 OUTLIER -64.36 -24.06 67.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.382 -0.826 . . . . 11.26 110.499 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.61 2.99 0.27 Allowed Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.617 -0.719 . . . . 12.640000000000001 113.33 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 48' ' ' TYR . 70.8 m -163.5 -39.81 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.884 0.374 . . . . 12.960000000000001 110.542 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 65.3 mtt -72.92 -28.95 62.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.014 -0.539 . . . . 11.789999999999999 110.523 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.66 -14.89 33.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.906 -0.664 . . . . 12.99 111.904 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.04 -32.01 76.14 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.851 -0.69 . . . . 15.68 112.091 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.82 43.13 0.26 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 121.158 -0.544 . . . . 15.710000000000001 111.838 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 56' ' ' LEU . 99.1 p 46.81 49.48 14.24 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 121.809 0.814 . . . . 14.92 111.389 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.481 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER 37.34 29.43 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.569 -1.65 . . . . 16.219999999999999 112.446 179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -82.72 62.16 6.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.962 0.41 . . . . 19.829999999999998 110.886 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.48 -32.69 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 17.620000000000001 112.378 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.1 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.167 -0.92 . . . . 17.91 110.974 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 mtt . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.899 0.381 . . . . 7.25 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.3 p -132.31 118.69 19.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 4.7400000000000002 110.568 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 106.44 -79.16 0.26 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.718 . . . . 2.96 112.155 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.44 -6.05 87.93 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.766 -0.73 . . . . 1.3700000000000001 112.341 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.86 -56.52 24.34 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.331 -0.938 . . . . 2.1400000000000001 111.392 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 7' ' ' PHE . 7.3 p -65.0 -45.17 95.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.986 0.422 . . . . 1.25 111.21 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.576 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 30.8 t80 -57.31 -42.42 81.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.589 -0.732 . . . . 1.6100000000000001 110.582 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 m -67.43 -32.67 73.71 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.72 -0.392 . . . . 0.38 110.066 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.57 -35.12 79.9 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.711 -1.218 . . . . 2.1800000000000002 107.711 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.576 ' HB ' ' O ' ' A' ' 7' ' ' PHE . 68.4 mt -65.27 -41.59 91.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.011 -1.45 . . . . 0.33000000000000002 107.854 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.35 -37.87 88.35 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.095 -1.412 . . . . 1.3999999999999999 109.252 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.89 81.42 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.734 -1.121 . . . . 0.17000000000000001 109.383 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' HG13 ' A' ' 17' ' ' ILE . . . -63.66 -58.07 8.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.95 -1.023 . . . . 0.23999999999999999 110.037 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.92 -47.79 76.87 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-O 121.002 0.43 . . . . 0.20999999999999999 109.885 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.667 ' O ' ' HB2' ' A' ' 19' ' ' GLU . . . -53.39 -41.62 63.38 Favored Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 109.67 -1.372 . . . . 0.17000000000000001 109.67 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.6 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.6 OUTLIER -72.66 -37.89 67.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.053 -0.574 . . . . 4.5300000000000002 110.86 178.357 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.5 mt -67.09 -63.08 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 122.623 1.201 . . . . 0.28000000000000003 108.08 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.493 ' HA ' ' HB2' ' A' ' 21' ' ' MET . 53.6 t80 -50.62 -39.8 51.17 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 112.654 -2.066 . . . . 0.29999999999999999 110.394 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.667 ' HB2' ' O ' ' A' ' 15' ' ' GLY . 0.6 OUTLIER -61.84 -53.78 51.17 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-O 120.916 0.388 . . . . 2.2999999999999998 110.885 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 17' ' ' ILE . 13.2 m -64.92 -26.11 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.011 -1.107 . . . . 0.16 108.011 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' A' ' 18' ' ' PHE . 5.4 mmt -74.96 -26.98 59.99 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.434 -1.257 . . . . 1.6599999999999999 108.549 177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 18' ' ' PHE . 2.6 t -78.02 -36.39 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.482 -1.235 . . . . 0.22 111.35 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 20' ' ' VAL . 5.8 pt-20 -58.76 -44.6 90.64 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.801 -0.444 . . . . 2.6400000000000001 109.801 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 27' ' ' GLU . . . -64.0 -33.05 86.21 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.991 -1.244 . . . . 0.42999999999999999 109.991 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.653 ' O ' HG13 ' A' ' 29' ' ' VAL . 79.1 t60 -62.23 -37.09 84.04 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.356 -0.979 . . . . 0.73999999999999999 108.356 177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.862 ' O ' HG22 ' A' ' 29' ' ' VAL . 19.0 m95 -74.22 -16.4 60.97 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.952 -1.022 . . . . 1.5600000000000001 110.166 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 11.1 mm-40 -75.23 -42.78 54.61 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 25' ' ' HIS . 0.7 OUTLIER -78.17 -18.92 54.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.821 -1.081 . . . . 1.49 111.259 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 ' O ' ' A' ' 26' ' ' TRP . 31.0 m -57.61 -33.36 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.852 0 C-N-CA 119.811 -0.756 . . . . 1.1899999999999999 110.193 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.05 -11.99 0.07 OUTLIER Glycine 0 CA--C 1.525 0.697 0 C-N-CA 119.738 -1.22 . . . . 1.52 111.502 177.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.528 ' O ' ' HB3' ' A' ' 34' ' ' ASP . 13.9 mmt -103.89 -65.08 1.04 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.981 0.512 . . . . 3.02 110.898 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.676 ' HG ' ' HA ' ' A' ' 29' ' ' VAL . 3.8 pp -60.0 -34.39 73.27 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.241 -0.436 . . . . 1.9199999999999999 110.727 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.12 -34.81 78.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.705 -0.68 . . . . 1.79 109.379 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 31' ' ' MET . 3.2 t70 -59.55 -34.04 72.17 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.379 -0.828 . . . . 2.48 110.453 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.5 t -74.13 -5.47 41.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.404 0.621 . . . . 3.1699999999999999 109.476 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 2.3 mt -126.28 6.11 7.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.026 -0.988 . . . . 2.7999999999999998 110.059 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -107.25 -56.33 0.62 Allowed Glycine 0 CA--C 1.49 -1.501 0 N-CA-C 106.868 -2.493 . . . . 2.46 106.868 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -62.23 -32.53 73.21 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 113.19 -1.505 . . . . 3.4300000000000002 107.001 174.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.54 46.88 23.55 Favored Glycine 0 CA--C 1.479 -2.214 0 N-CA-C 107.662 -2.175 . . . . 3.5299999999999998 107.662 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.533 HG23 ' ND2' ' A' ' 44' ' ' ASN . 1.9 t 39.14 35.24 0.13 Allowed 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.654 -1.773 . . . . 3.8900000000000001 109.143 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mtt -46.73 -27.12 1.09 Allowed 'General case' 0 C--N 1.346 0.422 0 CA-C-N 115.035 -0.984 . . . . 4.8899999999999997 111.081 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.6 ttp180 -65.66 -65.62 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 8.1099999999999994 110.046 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.44 ' HB ' ' OG1' ' A' ' 40' ' ' THR . 54.1 mt -53.97 -40.0 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 116.061 -0.518 . . . . 6.1399999999999997 110.462 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.533 ' ND2' HG23 ' A' ' 40' ' ' THR . 6.4 m-80 -59.12 -41.32 87.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 7.25 110.569 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -62.57 -51.97 65.25 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 116.241 -0.436 . . . . 9.8200000000000003 110.767 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -60.85 -36.39 79.02 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.211 -0.663 . . . . 9.1999999999999993 109.211 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.04 -40.88 87.26 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 9.5 109.967 178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 50' ' ' SER . 0.4 OUTLIER -63.23 -22.82 67.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.455 -0.793 . . . . 11.26 110.558 -179.845 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.44 -7.79 0.26 Allowed Glycine 0 CA--C 1.521 0.453 0 CA-C-N 115.404 -0.816 . . . . 12.640000000000001 113.156 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.425 ' H ' ' C ' ' A' ' 48' ' ' TYR . 42.2 t -163.4 -35.49 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.894 0.378 . . . . 12.960000000000001 110.94 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 24.6 mmt -72.66 -30.68 64.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.053 0.454 . . . . 11.789999999999999 110.635 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.73 6.31 47.8 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.89 -0.671 . . . . 12.99 111.997 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.6 -57.72 0.65 Allowed Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.445 -0.662 . . . . 15.68 111.445 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.453 ' C ' ' N ' ' A' ' 56' ' ' LEU . . . -72.69 0.68 42.16 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 120.692 -0.766 . . . . 15.710000000000001 111.242 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m 55.36 11.9 0.65 Allowed 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.1 -0.704 . . . . 14.92 109.1 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.453 ' N ' ' C ' ' A' ' 54' ' ' GLY . 84.0 mt -79.3 2.36 21.68 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.877 -1.056 . . . . 16.219999999999999 108.969 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -61.03 -3.38 0.78 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.643 -1.162 . . . . 19.829999999999998 111.022 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 56' ' ' LEU . . . -119.86 -17.9 4.48 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.884 -0.674 . . . . 17.620000000000001 112.588 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 p . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.197 -0.906 . . . . 17.91 110.947 -179.949 . . . . . . . . 0 0 . 1 stop_ save_